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ABSTRACT 
 
 
Gold nanoparticles (Au NPs) have attracted much interest in biological applications due 
to their excellent optoelectronic properties and ease of surface functionalization. However, while 
Au NPs are positioned to revolutionize nanotechnology based biomedical applications, our 
fundamental understanding at the nanoparticle-biomolecular interface and its resultant impact on 
cells is still limited. In particular, analysis of the spatial arrangement of nanoparticle’s surface 
ligands using scanning tunneling microscopy is a highly controversial topic. Addition of 
nanoparticles to cell culture media was shown to result in a hard and soft protein corona 
formation, which acted to mitigate/reduce the proposed chemical capabilities of nanoparticles. 
More critically but even less well understood is the precise orientation of proteins upon 
adsorption as well as the possible change in protein’s conformation, which can alter the protein’s 
intrinsic function. This dissertation will thus focus on developing our understanding at this 
interface, by probing the chemistries at this nanoparticle-biomolecular interface and 
subsequently, how the Au NPs influence cellular responses. 
The question of spatial location of different ligands on nanoparticle surfaces with 
diameters less than 100 nm is an important one that is difficult to quantitatively address. To 
investigate the spatial arrangement of biomolecules on Au NPs, the surface of 20, 50, and 90 nm 
Au NPs were functionalized with two different lipids, both single and mixed, using two different 
surface chemical procedures utilizing electrostatic or hydrophobic interactions. Mass 
spectrometry supported the presence of both lipids in the mixed-lipid systems on nanoparticles, 
and it was observed that the surface chemistry of Au NPs influenced the relative ratios of mixed 
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lipids incorporated. Electron microscopy evidence showed domain sizes for one lipid apparently 
a quarter to a half the projected diameter for 50 and 90 nm particles; but for 20 nm particles, 
there is no evidence for the existence of patches of the two lipids. 
To study the potential use of Au NPs to limit α-synuclein (α-syn) misfolding, the binding 
and orientation of α-syn on anionic and cationic Au NPs were investigated. On anionic Au NPs, 
α-syn was determined to interact with 20 and 90 nm Au NPs via multilayered adsorption, 
consisting of a strong electrostatic interaction between α-syn and Au NPs in the hard corona and 
a weaker noncovalent protein−protein interaction in the soft corona. On cationic PAH Au NPs, 
titration of α-syn into cationic Au NP at >2000 α-syn/cationic Au NP caused the flocculation and 
sedimentation of α-syn coated PAH Au NPs. The orientation of α-syn onto Au NPs was studied 
using protease digestion method, revealing that α-syn absorbs onto anionic Au NPs via its N-
terminus while on cationic Au NPs, a random orientation of α-syn was adopted. Comparison of 
the digestion pattern of α-syn on both Au NP with respect to free α-syn reveal an increase in the 
release of peptides from the N-terminus (amino acid 1–23, lysine position 10) and a decreased 
number of peptides in the non-amyloid component region (amino acid 59–97, lysine position 80) 
when adsorbed onto Au NPs, suggesting that the adsorption and binding orientation of α-syn 
depends on the surface charge of Au NPs. 
The aggregation of Au NPs in cell media is a common phenomenon that can influence 
NP-cell interactions. This interaction can be more precisely controlled by the formation of a 
protein corona on Au NPs before introduction into a high salt media. Cell viability assays 
showed that non-aggregated Au NPs were less toxic than their aggregated counterparts in human 
dermal fibroblast (HDF) cells. Fluorescence confocal imaging demonstrated that cellular F-actin 
fiber formation was less disrupted with non-aggregated Au NPs.  
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Differently functionalized Au NPs were found to induce different cellular responses 
when incubated with cells in vitro. Darkfield microscopy demonstrates that both prostate cancer 
cells (PC3) and HDF cells can “vacuum” Au NPs from the surface. Mean cumulative square 
distance of cells shows that PC3 migration decreases in the presence of Au NPs while for HDF, 
migration is dependent on the surface charge and shape of Au NPs. Preliminary investigations on 
the global impact of Au NPs with cells, based on gene expression analysis, demonstrated that 
genes related to cell proliferation were up-regulated while genes related to metabolism were 
down-regulated in HDF. In contrast, gene expression changes in PC3 were observed to strongly 
depend on surface functionalization of Au NPs, suggesting that Au NPs impact PC3 at a more 
fundamental molecular level. 
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CHAPTER 1 
An Introduction to Gold Nanoparticles* 
 
 
1.1.  Gold: From Bulk to Nano 
Gold, as a noble metal, has been mined and used since the early ages and throughout the 
world. The earliest well-dated gold artifacts have been found in the Varna Necropolis (4600–
4200 BC) in Bulgaria.1 Gold has been described in Egyptian hieroglyphs from as early as 2600 
BC.2 The earliest documented use of gold for decorative purposes in China dates back to the 
Shang dynasty (~1500–1050 BC).3 The Metamorphoses (Book XI, AD 8), told tales of Midas, 
the king with the touch of gold.4 In Naturalis Historia (Book XXXIII and XXXIV, AD 77–79), 
Pliny the Elder described mining methods used in Rome for the extraction of gold and the correct 
uses of gold based on gender and class.5 Gold has shaped much of mankind’s history and even 
till today, still holds great importance and value: gold medals or trophies are still given to the 
champions of competitions as a symbol of achievement. While the use of gold in the past has 
been mostly in ornaments and trade, applications of gold have expanded in modern times. In its 
bulk form, gold is still used throughout the world as an investment to hedge against economic 
disruptions. Gold thin films are used in office windows to reflect infrared light while transmit 
visible light, thereby efficiently regulating temperature within the building.6 The high 
conductivity and high corrosion resistance of gold allows for its applications where good 
                                                            
* Part of this chapter is reprinted with permission from: Catherine J. Murphy, Lucas B. Thompson, Davin J. 
Chernak, Jie An Yang, Sean T. Sivapalan, Stefano P. Boulos, Jingyu Huang, Alaaldin M. Alkilany, Patrick N. Sisco. 
Curr. Opin. Colloid Interface Sci., 2011, 16, 128-134.  (DOI: 10.1016/j.cocis.2011.01.001) Copyright 2011 Elsevier 
Ltd.. 
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connections are crucial such as in USB cable, artificial satellites and aircraft engines. Molecular 
gold compounds are used in the treatment of arthritis.7  
There is even greater value in gold on the nano-scale. The number of publications on gold 
nanotechnology has grown exponential since 1990, from ~20 to ~12,000 in 2012 (Figure 1.1). 
Over the years, the wet chemical synthesis method to make gold nanoparticles (Au NPs) have 
developed extensively, such that it is now possible to make Au NPs with excellent control over 
size and shape.8 This has led to much work focusing on understanding the surface chemistry of 
Au NPs, for its interaction with molecular targets or for self-assembly.9–11 Further understanding 
of Au NPs’ plasmonic properties has led to observations of extremely large field enhancements, 
huge light scattering and absorption and photothermal capabilities.12–14 All the understanding has 
cumulated in numerous applications: Au NPs are being explored as vesicles for drug and gene 
delivery for cancer and other diseases, as chemical sensing agents, as catalyst, and in imaging 
platforms.15–21  
 
1.2.  Properties of Gold Nanoparticles 
Nanoscale particles, or nanoparticles, are defined as particles with dimensions on the 
nanometer scale (1–100 nm). At this size, Au NPs exhibit properties that are fundamentally 
different from bulk gold. Under visible light, instead of the yellow color of bulk gold, Au NPs 
exhibit shape-dependent optical spectra when dispersed in solution, ranging from red for 
nanospheres, to green and brown as the aspect ratio increases (Figure 1.2). This interesting 
optical property is due to Au NP’s unique interaction with light, and is attributed to the collective 
oscillations of conduction band electrons in a metal when the metal particle size approaches the  
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Figure 1.1.  Exponential growth in the number of publications on gold nanotechnology over the 
past two decades. Data was obtained via SciFinder, topic search for publications in gold 
nanotechnology 19 July 2013: “ts = (gold*) and ts = (nano*)”. 
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Figure 1.2.  a) Normalized UV-vis spectra of short gold nanorods with aspect ratios A) 1.4 ± 0.3, 
B) 1.8 ± 0.5, C) 2.3 ± 0.6, D) 2.6 ± 0.4 and E) 2.8 ± 0.4. TEM images of gold nanorods 
corresponding to the spectra are shown on the right. All scale bars are 100 nm. b) Photograph of 
gold nanorods as their aspect ratio increases from left to right.   
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electron mean free path length (~10–100 nm).22–24 At specific wavelengths of visible light, the 
oscillating electromagnetic field is in resonance with the free electrons in Au NPs, which cause a 
collective oscillation of the electrons with respect to their positive metallic lattice. This 
phenomenon is termed as localized surface plasmon resonance (LSPR) and the reemitted electric 
field decays radiatively via light scattering or nonradiatively via conversion to heat.25 The 
resonance conditions can be determined from absorption and scattering spectroscopy. Gold 
nanospheres (isotropic) show one absorption maxima in water at ~520 nm, while gold nanorods 
(anisotropic) display two absorption maxima, one for the short axis (transverse band) at ~520 nm 
and the other for the long axis (longitudinal band) which is tunable from ~700–900 nm (Figure 
1.2a). As the aspect ratio of gold nanorods increases, the longitudinal band extends out into the 
far-IR region past 1500 nm.17,26 The elastic light scattering of Au NPs makes them visible at the 
single-particle level in darkfield optical microscopy, suitable for in vivo tracking.15,27 
The surface chemistry of Au NPs can be easily tuned and altered depending on function. 
In general, surface chemistry of Au NPs can be altered via electrostatic or covalent interactions. 
Citrate capped gold nanospheres and cetyltrimethylammonium bromide (CTAB) bilayer coated 
gold nanorods can be polyelectrolyte coated in a layer-by-layer fashion.28 This method affords a 
means to change the surface charge of the Au NPs as well as the ability to confer additional 
functionalities to the Au NPs. For example, Au NPs coated with poly(allylamine hydrochloride) 
(PAH) or poly(acrylic acid) (PAA) can be used in subsequent carbodiimide chemistry for the 
conjugation of small molecules, proteins and antibodies.11 Thiolated molecules changes the 
surface chemistry of Au NPs by displacing the weaker bound citrate or CTAB ligands for the 
stronger gold-sulfur covalent bonds.29 Thiolated methoxypolyethylene glycol (mPEG) can be 
used to displace CTAB on gold nanorods to reduce its cytotoxicity and improve its 
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bioavailability.30 The use of bifunctional molecules such as mercaptopropionic acid or thiol-
PEG-amine not only allows for functional modifications, but also helps improve the stability of  
Au NPs against aggregation.31,32  
 
1.3.  Wet Chemical Synthesis of Gold Nanoparticles 
The boiling citrate method is the most widely used method to synthesize gold 
nanospheres of 12–40 nm. First reported by Turkevich et al. in 1951,33 the synthesis only 
requires three starting materials, gold(III) chloride trihydrate (HAuCl4), sodium citrate and water. 
When the mixture is brought to boil, sodium citrate reduces Au3+ to Au0, forming gold 
nanospheres which are stabilized by citrate ions as ligands.34,35 By changing the sodium citrate 
concentration, the size of gold nanospheres can be easily tuned.36 More recently, it was 
discovered that sodium citrate also acts to regulate the solution’s pH and depending on the 
amount added, can push the formation of gold nanospheres either through a nucleation-growth 
pathway or a nucleation-aggregation-smoothing pathway (where small Au NPs first formed, 
which then aggregated into larger particles and subsequently smoothed out).37 Larger gold 
nanospheres (>40 nm) cannot be produced by the boiling citrate method, beyond which the 
nanoparticles tend to become prolate spheriod instead of spheres.38 Highly monodisperse gold 
nanospheres (50–175 nm) can be made by a seed-mediated synthesis using hydroquinone as the 
reducing agent.39   
The Murphy group, along with others, has developed two general synthetic methods to 
prepare short and long gold nanorods with relatively high yield, excellent shape monodispersity 
and reasonably tight control over the dimensions of the particles (Figure 1.3).17,26,40 In both 
methods, a seed-mediated synthesis is utilized, where HAuCl4 is reduced in the presence of the 
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Figure 1.3.  Synthesis of short and long gold nanorods. Ascorbic acid reduces Au3+ to Au+, changing the gold solution from yellow to 
colorless. AgNO3 controls the aspect ratio of short gold nanorods. 
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strong reducing agent sodium borohydride (NaBH4). The isotropic gold seeds made are ~1.5–4 
nm in diameter. In the short gold nanorods synthesis, these seeds are added to a growth solution 
containing more gold salt, cetyltrimethylammonium bromide (CTAB), a weaker reducing agent 
(ascorbic acid) and silver nitrate (AgNO3), which acts as an impurity. Here, ascorbic acid only 
reduces Au3+ to Au+, allowing for anisotropic growth as Au+ is further reduced to Au0 on the 
nanoparticle surface over a longer time period. The amount of AgNO3 added dictates the final 
aspect ratio of the nanorods. The amount of Ag in the nanorods is enough for a few monolayers 
of Ag on the surface of the gold core and XPS data suggest that Ag is preferentially localized on 
the surface.41,42 Gold nanorods made using this method are tunable in the range of 12 – 20 nm in 
diameter and 20 – 100 nm in length, covering aspect ratios up to 5.  
Long gold nanorods are made using a three step synthesis method starting from gold 
seeds.26 In this method, no AgNO3 is added, but the timing of reaction in each step is adjusted to 
vary the aspect ratio (Figure 1.3). For example, for the synthesis of long gold nanorods with 
aspect ratio 14, seeds solution is added to the first growth solution, mixed and allowed to 
incubate for 15 sec, following which an aliquot is taken and mixed with the second growth 
solution. After an incubation of 30 sec, another aliquot is taken and added to the third growth 
solution and stored overnight. Gold nanorods with aspect ratio 10–20 can be made using this 
method. 
 
1.4.  The Promise of Gold Nanoparticles 
Because of their excellent optoelectronic properties, Au NPs are used in many biological 
applications. For example, the surface plasmon of Au NPs can be utilized to absorb 
electromagnetic radiation, which results in the generation of highly localized heat.43 By exciting 
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Au NPs with pulsed lasers, enough heat can be generated to disrupt cells and bacteria, or even 
release drug molecules trapped on Au NP surfaces.44,45 U87 cells can be specifically targeted 
from a mixture also containing MCF7 when Au NPs are functionalized with RDG peptides, 
which can subsequently be killed using pulsed laser.46 The enhanced Raman can be used for 
chemical sensing.47,48 By functionalizing Au NPs with fluorescently labeled nuclear localization 
signal peptides, progenitor and differentiated human neuroblastoma cells can be distinguished 
using surface enhanced Raman spectroscopy (SERS).49 The light scattering and absorption of 
light by Au NPs have been used for in vivo and in vitro imaging.15,50 Because of their nano-
scaled size, when functionalized with multiple targeting groups Au NP conjugates show 
increased binding affinity as well as targeting selectivity for cells, and can be used in various 
delivery applications.51,52 In this sense, Au NPs have been used in gene regulation or 
delivery,53,54 or if coupled with the enhanced permeability and retention (EPR) effect, Au NPs 
can accumulate selectivity at tumor sites to exert their therapeutic effects.55  
 
1.5.  Issues in Biological Applications: Protein Corona Formation 
While the potential of Au NPs in biological applications is high, the understanding of the 
interfacial chemistry between nanoparticles and biomolecules is still little known (Figure 1.4). In 
this aspect, the protein adsorption event on nanoparticles has only been recently appreciated and 
might even be critical in helping understand why some applications works but others do not.56,57 
Nanoparticles when introduced into biological systems either in vitro or in vivo, will first 
encounter serum proteins in the cell media or the blood plasma. Serum proteins in cell media or 
in blood plasma contain more than 2,000 proteins, which consist of a combination of the 
subproteomes  derived  from  different  tissues.58  Proteins  are  responsible  for  the  biological 
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Figure 1.4.  Potential nanoparticle-biomolecular interactions. Serum proteins can coat 
nanoparticles to mask underlying functionalities and create a hard and soft protein corona. The 
orientation upon adsorption of proteins on nanoparticles may influence protein’s function and 
may alter conformation. 
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processes in cells, and collectively have a large range of isoelectric point (pI), hydrophobicity, 
affinities, structures and size, all of which contribute to their vastly different functions and 
interactions. Proteomic analysis suggested an estimate of at least ~10,000 different proteins in 
the U2OS (human osteosarcoma) cell line, with their abundance varying widely on seven orders 
of magnitude up to 20,000,000 copies.59 Low-copy-number proteins (less than 1000 
molecules/cell) also play an important role in many cell functions.60   
Any colloidal material introduced into this complex system will undoubtedly be covered 
by proteins.56 Indeed, this was observed in work done on biomaterials (micron-sized or larger) 
for medical applications, where upon the introduction into biological environment, are 
immediately be covered by proteins, the composition of which changes over time.61,62 In the case 
for nanoparticles, the high surface to volume ratio, coupled with the potentially high surface 
energy of a curved surface, allows for an amplified protein adsorption scenario when compared 
to medical devices (pacemaker, stent, hip replacement, etc.).56 In addition, in contrast to devices 
which are usually stationary, nanoparticles can access almost every organ.63,64 There is thus 
growing consensus that cellular response to nanoparticles in a biological medium may be due to 
the absorbed biomolecule layer and not the material itself. For example, it was also shown more 
recently that the targeting ability of transferrin bound nanoparticles is lost when these 
nanoparticles are placed in a biological environment, and it is believed that the surface 
functionalization is masked due to the serum protein adsorption onto nanoparticles.65 As such, 
understanding the nanoparticle-biomolecular interface is thus a matter of high importance and 
urgency: low-copy-number proteins may be rendered less bioavailable when trapped on 
nanoparticles, throwing cellular pathways into disarray. Alternatively, overexpressed/misfolded 
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proteins can be sequestered onto nanoparticles and removed, returning the cells to their normal 
homeostasis.66,67  
The protein corona is used to describe the proteins absorbed onto nanoparticles. It is now 
known that a plethora of proteins exist in the protein corona, which bind due to numerous non-
specific interactions with nanoparticles such as electrostatic interactions, hydrophobic 
interactions and avidity (protein-protein interactions). The wide array of interactions also means 
that proteins association to nanoparticles comprise of a large range of affinities for nanoparticle 
surface. In general, the protein corona can be characterized comprising of a hard and soft layer: 
the hard inner corona consist of strongly associated proteins and the soft outer corona consisting 
of weakly bound proteins in rapid exchange with free proteins in solution.68 Recent evidence had 
also shown that the hard protein corona is also susceptible to changes, albeit more slowly.69  
A more pertinent issue that arises from protein adsorption is the possible change in 
protein conformation when bound as well as its binding orientation.70 The native conformation of 
proteins frequently consist of α-helix and β-sheets, which are held together in their tertiary 
structure by hydrogen bonding, van der Waals, electrostatic and hydrophobic interactions 
between the amino acids.71 Upon adsorption, the interaction of proteins with nanoparticle’s 
surface can alter some of its intrinsic interactions, both on the protein’s surface or in its 
hydrophobic core, thereby disrupting protein function. Such interactions may be energetically 
favorable: the decrease in entropy upon protein adsorption to nanoparticles is more than 
compensated by the increase in entropy of water release.72 Using circular dichroism, 
conformational changes of proteins have been detected on nanoparticles.73 Protein structural 
changes have also been found to be dependent on the nanoparticle structure, size and degree of 
saturation.74–76 Nanoparticles can also induce a larger scale protein folding change with amyloid 
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proteins.77 Standard chemical  techniques are now  being used to explore  protein-nanoparticle 
interactions. In terms of protein orientation, NMR has been used to identify ubiquitin’s binding 
site to Au NPs.78 MALDI-MS had also been used to study the orientation of proteins on silica 
nanoparticles, which showed that nanoparticle size and protein structure influenced the protein’s 
orientation.79 Both the structural change and binding orientation of proteins onto nanoparticles 
can be potentially problematic as a loss of function or toxicity can be induced upon nanoparticle 
adsorption, which would limited the use of nanoparticles in biological applications. 
 
1.6.  Issues in Biological Applications: Toxicity and Cellular Changes 
Many investigations of Au NP interactions with cells in vitro has thus focused on the 
cellular toxicity induced by Au NPs.80,81 It is now known that while the Au NP core is non-toxic, 
toxicity can be induced by the ions, capping agents and biomolecular ligands used to make and 
coat Au NPs.82,83 Therefore, extra care must be taken to ensure that excess free ligands are 
removed before any toxicity studies: incomplete separation and removal of free ligands can 
induce a stronger toxicity response than from the nanoparticles.82 CTAB is toxic at 
submicromolar concentrations and if not sufficiently removed, can induce toxicity in cells. Such 
adverse effects on cells can be overcome by overcoating Au NPs with polyelectrolytes and 
extensive purification.82 
However, beyond just toxicity, the interaction of Au NPs with cells can result in changes 
in cell structures. Fluorescent staining to cells showed that actin fibers as well as tubulin 
cytoskeleton were disrupted after Au NP uptake.84,85 The presence of Au NPs in cells also caused 
lysosomes to be enlarged and the number of autophagosomes increased, probably a result of a 
purge response.86 On a more macroscopic scale, cell adhesion of MC3T3-osteoblast cells to 
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integrin coated Au NP surfaces was influenced by the spacing of Au NPs.87 Au NPs can also 
alter the polymerization and mechanical properties of 2 and 3 dimensional collagen matrix, 
which cumulatively influenced cardiac fibroblasts response behavior.88,89 
Indeed, the diverse cellular response after Au NP incubation signifies that a more 
fundamental understanding and analysis of the interaction is required. It can be expected that 
while the toxic and non-toxic physical processes can be observed and monitored, many changes 
in the chemical and cellular pathways would go unnoticed. These alterations should by no means 
be dismissed as unimportant; most cellular networks and pathways are inter-linked, with proteins 
serving multiple roles and functions.90 Such detailed understanding can be obtained from gene 
expression analysis, which would allow for all the changes in the cell to be accounted for. For 
example, Au NPs’ size and shape can induce different cellular pathways related to cellular stress 
and toxicity.91,92 Nucleic acid functionalized Au NPs as well as citrate Au NPs did not induce 
significant gene expression changes in HeLa cells,93,94 while mercaptohexadecanoic acid 
functionalized Au NPs induced more changes than PEG coated Au NPs over the 84 genes probed 
in human keratinocyte cells.95 When human skin fibroblasts were incubated with carbon 
nanotubes and nano-onions, the gene responses were found to be dependent on nanoparticle 
concentration.92 While these studies illustrated that nanoparticles can have a global impact on 
cells, much of this impact is still relatively unknown. 
 
1.7.  Thesis Overview 
The work described in this thesis is divided into two parts: 1) investigating the nano-bio 
interface through adsorption of biomolecules onto Au NPs, and developing methods to analyze 
biomolecule’s binding, orientation and conformation; and 2) understanding how the protein 
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corona interacts with cell media, and ultimately how Au NPs induce cellular phenotypic and 
genotypic changes. The remainder of the thesis will be structured with this outline in mind, with 
Chapter 2–4 focusing on part 1, and Chapter 5–7 focusing on part 2. 
In Chapter 2, a procedure to synthesize mixed phospholipids coated Au NPs with 
different underlying surface chemistry is described. The goal of this work is to create lipid 
vesicle mimics of tunable sizes for chemical sensing and biomedical applications. Methods to 
analyze the phospholipid composition and arrangement are discussed, and it is found that the 
phase separation of mixed phospholipids on Au NPs is dependent on nanoparticle size. In 
Chapter 3, α-synuclein’s binding, orientation and conformation on negatively charged citrate Au 
NPs is studied, while in Chapter 4, α-synuclein’s orientation and conformation on positively 
charged poly(allylamine hydrochloride) coated Au NPs is studied. The aim of this work is to 
deduce possible protein folding changes as well as orientation preferences on Au NP with 
different surface functionalities, and thus investigate the use of Au NPs as a potential therapeutic 
agent for amyloid diseases. It was found that the underlying surface chemistry controls α-
synuclein’s binding orientation and conformation, and the affinity of α-synuclein for Au NPs is a 
lot stronger than for lipid vesicles.  
Chapter 5 discusses the non-specific adsorption of serum proteins on Au NPs during in 
vitro applications. Serum protein adsorption on Au NPs was shown to be influenced by Au NP’s 
surface chemistries, and the aggregation of Au NPs can be controlled by embracing the protein 
corona formation. The cellular uptake is shown to be influenced by the surface chemistry on Au 
NPs and its aggregation state. Chapter 6 details work on Au NP’s impact on cell mobility, where 
it is found that as cells transverse across a Au NP coated surface, they ‘vacuum’ up Au NPs 
which influences their migration. In Chapter 7 the short term effect of Au NP incubation on 
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cellular global gene expression is studied, and it is shown that the surface chemistries on Au NPs 
is the driving factor that results in different cellular pathways being up or down-regulated.  
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CHAPTER 2 
Evidence for Patchy Lipid Layers on Gold Nanoparticle 
Surfaces 
 
 
2.1.  Introduction 
Much progress has been made in recent years in the synthesis and applications of gold 
nanoparticles (Au NPs). In addition to excellent control over size and shape, the ability to fine-
tune the localized surface plasmon resonance of Au NPs underlies the potential for biological 
applications in imaging, sensing, drug delivery, and photothermal therapy.1 However, one 
continuing issue for biological applications of nanomaterials is that the reagents used in their 
synthesis can induce toxicity (in addition to possible negative effects of the nanoparticles 
themselves). In the case of Au NPs, a surfactant that is commonly used in their synthesis, 
cetyltrimethylammonium bromide (CTAB), is toxic at 10−7 M concentrations.2 In order to make 
Au NPs safe for biological applications, postsynthetic modification is usually required to alter 
the surface chemistry to make the particles more biocompatible (less prone to aggregation and 
less toxic). For example, polymers such as poly(ethylene glycol) (PEG) and polyelectrolytes 
such as poly(allylamine) hydrochloride (PAH) can be used to help stabilize Au NPs in aqueous 
solutions, as well as favor their uptake into cells.2−5 While this surface functionalization might 
solve the biocompatibility issue, recent studies have shown that polyelectrolyte-coated Au NPs 
                                                            
  This chapter is reprinted with permission from: Jie An Yang and Catherine J. Murphy. Langmuir, 2012, 28(12), 
5404-5416.  (DOI: 10.1021/la300325p) Copyright 2012 American Chemical Society. 
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can attract a large array of serum proteins to their surface, changing their ζ potentials and hence 
functionality.2 This is a significant issue if single or low copies of proteins, of which each has a 
distinct biological role, are trapped in this “protein corona”.6 As a means to overcome this 
problem, inspired by lipid vesicles that stabilize drug molecules and can be used as drug delivery 
systems,7 recent investigation has focused on using biomolecules such as phospholipids to 
passivate Au NP surfaces. In making Au NPs more “cell”-like, a 2-fold advantage is achieved: 
(i) biocompatible Au NPs with possibly reduced inflammatory response are produced and (ii) 
control over protein binding is possibly enabled.  
Phospholipids are amphipathic in nature: the charge on the phosphate headgroups make 
them hydrophilic, while the acyl tail chains confer hydrophobicity. They form the major 
component of cell membranes and can generally be subdivided on the basis of their phosphate 
headgroups, of which phosphatidylcholine (PC), phosphatidylserine (PS), and 
phosphatidylethanolamine (PE) are the most abundant. For example, of the total lipid content in 
the brain, 20−30% comprises PE, 10−25% PC, and 5−10% PS, and the remainder is made up of 
sphingolipids and sterols.8 In addition to variations in the headgroups, the saturation and length 
of the acyl tail chains modulate the fluidity and transition temperature of lipid layers.9 By 
modulating the lipid’s liquid-gel state, lipid layers can be deposited on flat and/or spherical silica 
surfaces to form a supported lipid bilayer membrane.10−15 While lipid coating on flat surfaces can 
be done with relative ease, pores form in the lipid layer when coated on nanostructured surfaces 
less than 22 nm in size.16,17 Regardless, it is agreed that the deposition of lipid layers on flat 
surfaces occurs first via the attachment of the vesicles to the support; the vesicle then spreads out 
and fuse with other patches to form a continuous lipid membrane. 
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Investigations on mixed lipid membranes on flat and structured surfaces revealed that 
lipid domains can result.18−22 The phase separation of lipids is a result of the fluidity, attraction, 
and repulsion behavior of the lipids, influenced by the acyl tail chain length,23 saturation of the 
acyl tail chains,24,25 variations in phosphate headgroups,26,27 and charge as introduced by ions, 
pH, and charged proteins.19,28,29 In particular, on a curved environment, lipid mixtures also show 
a strong tendency to phase-separate as a means to reduce lateral pressure and area density 
induced by the curvature.20−22 Lipids can coat nanoscale silica particles. When a single lipid is 
used, a homogeneous lipid bilayer forms on spherical silica particles.11,14 Mixed lipids have also 
been shown to form homogeneous layers on nanoscale silica, as revealed with cryoelectron 
microscopy and NMR and IR spectroscopy.12,30,31 Mixed lipid bilayers have been shown to be 
stable on polysilicon nanowires.32 However, the formation of lipid domains on nanosized silica 
particles has been little discussed. Recent work on lipid coating of Au NPs shows great promise 
to enable biocompatibility.33−36 Several methods now exist to favor formation of the lipid bilayer 
on Au NPs, which include use of a thiolated lipid for the strong sulfur−gold bond formation and 
a mixture of single- and double-chain fatty acid-type lipids to increase the packing density on the 
curved surface.35,37 By surface ligand exchange, Orendorff et al. showed that phospholipids can 
be used to displace CTAB on Au nanorods, albeit not completely.38 These phospholipid Au 
nanorod composites can be used to sequester lipophilic drug molecules into the bilayer, acting to 
stabilize these hydrophobic molecules in an aqueous environment.37 Other cargo such as RNA, 
DNA, and protein can potentially be attached to the surface of Au nanorods, allowing their use in 
targeted delivery.39 The situation for spherical Au NPs and lipids is not so straightforward. The 
chemistry changes with respect to NP size, due to the increasingly high surface curvature as the 
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NP size decreases. For example, 60 nm Au spheres can be encapsulated with lipids, while sub-4-
nm spheres are usually found embedded in the bilayer of lipid vesicles.33−36 
Investigations of lipids with Au NPs thus far have focused on using lipids with one type 
of phosphate headgroup and do not truly mimic the highly varied lipid composition of cell 
membranes. Mixed-lipid-coated Au NPs are therefore a crucial next step in biocompatible NP 
chemistry, as they allow for the mimicry of cellular surfaces in terms of solvent-facing functional 
groups and charge density. In a broader sense, the generation of “patchy” NPs is of great 
fundamental interest for nanoscale assembly as well as in biomimetic systems.40−42 However, 
while proven to be theoretically feasible via molecular simulations,41,43,44 it has been very 
difficult to prove the existence of patches on colloidal nanoscale surfaces. Nevertheless, using 
scanning tunneling microscopy, Stellacci and co-workers have evidence that, for Au NPs of 
diameter ∼5 nm, particular pairs of thiols form organized stripes (or “ripples”) that are sub-2-nm 
in width.45 Phase segregation of mixed thiols on Au NPs can also be probed by matrix-assisted 
laser desorption/ionization coupled with ion mobility-mass spectrometry as well as 
spectrophotometric titrations with fluorescent probes.46,47 These techniques, which require strong 
gold−sulfur binding and have been shown to work only on small Au NPs, are not feasible for 
lipid adsorption on Au NPs, as electrostatic interactions are usually the main attractive force. In 
this work, we have successfully coated mixed lipid layers on a variety of highly curved Au NP 
surfaces with diameters ranging from 20 to 90 nm. Lipid bilayers were formed on 
poly(allylamine) hydrochloride (PAH) coated Au NPs and “hybrid” lipid bilayers were formed 
on octadecanethiol-coated Au NPs, taking advantage of the lipid tail association with the 
hydrophobic self-assembled monolayer of the octadecanethiol. 
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Evidence of lipid coating was obtained through various spectroscopy techniques as well 
as transmission electron microscopy (TEM) imaging, which suggests that the mixed lipid phase-
separates on nanoparticle surfaces and exists as lipid domains. Depending on the surface charge 
of the Au NP, the type of lipid that is preferentially adsorbed on the Au NP is also varied. These 
lipid-coated Au NPs showed increased stability against aggregation over a larger pH range as 
compared to their native NPs. To demonstrate the versatility of lipid-coated Au NPs, the lipid 
layer served as a base to coordinate other lipid−protein complexes. 
 
2.2.  Materials and Methods 
2.2.1  Materials   
Gold(III) chloride trihydrate (HAuCl4·3H2O, ≥99.9%), sodium citrate tribasic dihydrate 
(Na3Cit·2H2O, ≥99%), hydroquinone (≥99%), 1-octadecanethiol (98%, C18SH), poly-(allylamine 
hydrochloride) (PAH; MW 15 000 g/mol), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), monoclonal anti-biotin antibody (mouse), and OptiPrep density gradient medium were 
obtained from Sigma Aldrich and were used as received. 1-Palmitoyl-2-oleoyl-sn-glycero-3-
phospho-L-serine (sodium salt) (POPS), 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine 
(LPC), and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt) 
(biotin PE) in chloroform were obtained from Avanti Polar Lipids and were used as received. 
Osmium tetroxide (OsO4, 4%, aqueous) was obtained from EMS and diluted to 0.1% before use. 
Ultrapure deionized water (17.9 MΩ, Barnstead NANOpure II) was used for all solution 
preparations. Glassware was cleaned with aqua regia and rinsed thoroughly before use. 
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2.2.2.  Synthesis of Gold Nanoparticles  
Au NPs of diameter 12 and 20 nm were synthesized via the boiling citrate method as 
previously described.48,49 Larger NPs (50 and 90 nm) were synthesized with 12 nm particles used 
as seeds.50 Briefly, 2 mL of a 1% (w/v) HAuCl4·3H2O solution was centrifuged at 17,000 
relative centrifugal force (RCF) for 60 min after which the top 1 mL was obtained and added to 
94 or 97.25 mL of ultrapure deionized water and 4 or 0.75 mL of 12 nm NPs for the resultant 50 
or 90 nm particles, respectively. The solution was then stirred rapidly at room temperature and 
0.22 mL of 1% trisodium citrate dihydrate was added, followed immediately by 1 mL of 0.03 M 
hydroquinone. The solution was allowed to stir overnight. 
 
2.2.3.  PAH Coating of Gold Nanoparticles 
A 1 mL aliquot of as-made Au NPs was centrifuged and purified. The Au pellet was 
collected and resuspended in 1 mL of water. To this purified Au NPs pellet, 100 μL of NaCl (0.1 
M) and 200 μL of PAH (10 mg/mL) were added simultaneously, and the solution was vortexed. 
The NPs were allowed to incubate overnight before being purified by centrifugation. 
 
2.2.4.  Preparation of Lipid Vesicles 
For mixed lipids on Au NPs, a 1:1 weight ratio of POPS/LPC was used in all cases. 
Briefly, a total of 1 mg of lipid (0.5 mg of each POPS and LPC) in chloroform was dried under a 
stream of nitrogen. The lipid film was then further dried in vacuum for about 6 h, after which 20 
mM HEPES buffer was added to give a final concentration of 2 mg/mL. The mixture was briefly 
sonicated to totally suspend the lipids, affording a clear colorless solution. Dynamic light 
scattering measurements of these vesicles gave an average hydrodynamic diameter of ∼90 nm. 
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2.2.5.  Synthesis of Lipid-Coated Gold Nanoparticles 
Au NPs were centrifuged to remove the excess ligands from the synthesis and redispersed 
to 0.5 mL in 20 mM HEPES buffer. For mixed lipid bilayers on Au NPs, 0.5 mL of the 1:1 
POPS/LPC lipid solution from the above section was added to PAH coated Au NPs and mixed. 
For mixed lipid hybrid bilayer on Au NPs, 0.5 mL of the lipid solution was added to purified 
citrate capped NPs, followed by an appropriate amount of C18SH (5 μg/mL ethanol). The mixture 
was incubated overnight at room temperature. The mixture was then centrifuged and the Au 
pellet was resuspended in HEPES buffer. Analysis of these composites was performed within 24 
h. 
 
2.2.6.  Osmium Tetroxide Staining for Transmission Electron Microscopy Samples 
A small amount of concentrated sample (8 μL) was dropped onto a TEM grid and 
allowed to sit for about 1 h. Excess sample was wicked off by use of Whatman filter paper. The 
grid was then floated on top of 0.1% OsO4 stain (4% OsO4 diluted with water) for 1−1.5 h. The 
grid was wicked dry and washed three times with water for 10 min each. 
 
2.2.7.  Quantification of Bound Lipids using Mass Spectrometry 
Lipid-coated Au NPs were twice centrifuged to remove excess unbound lipids and 
concentrated down to a volume of 100 μL. The concentration of the Au NPs was determined by 
use of their known extinction coefficients from UV−visible spectroscopy. A known amount of 
either 1 M KCN or aqua regia was added to the solution to etch the Au NPs for about 2 h at room 
temperature. The colorless solution was then analyzed by HPLC/tandem mass spectrometry 
(MS/MS). The HPLC flow rate was set at 0.35 mL/min. HPLC mobile phases consisted of A (25 
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mM ammonium acetate in H2O) and B (MeOH). The gradient was: 0−0.5 min, 50% A; 5−16 
min, 0% A; 16.5− 25 min, 50% A. The autosampler was kept at 5 °C. The injection volume was 
1 μL. The mass spectrometer was operated under both positive and negative electrospray 
ionization. The electrospray voltage was set to −4500 V in negative mode and 5500 V in positive 
mode, the heater was set at 600 °C, the curtain gas was 35, and GS1 and GS2 were 50, 50, 
respectively. Quantitative analysis was performed via multiple reaction monitoring (MRM), 
where m/z 496.4 and m/z 104.1 (positive mode for LPC) and m/z 760.5 and m/z 673.5 (negative 
mode for POPS) were monitored. 
 
2.2.8. Conjugation of 12 nm Gold Nanoparticles to Larger Lipid-Coated Gold 
Nanoparticles with Protein Linkers 
A 3:1 weight ratio of either POPS or LPC/biotin PE was used for the lipid mixture. A 
1:2:1 weight ratio of POPS/LPC/biotin PE was used for the mixed lipid mixture. The lipid 
mixture was prepared following the method described above. Au NPs were incubated with the 
lipid mixture overnight and then purified. Au NPs of diameter 12 nm were centrifuged at 6,000 
rcf for 30 min, and 10 μg of anti-biotin antibody (HEPES, pH 9) was added and the mixture was 
allowed to incubate for 1 h. The conjugated Au NPs were centrifuged at 6000 rcf for 30 min and 
added to the larger lipid-coated Au NPs, followed by incubation for 2 h at room temperature. The 
complexed Au NPs were then centrifuged at 500 rcf for 15 min, redispersed in water, and coated 
with PAH as described above. To separate bound from unbound 12 nm NPs, we found it 
necessary to employ a density gradient of OptiPrep (60% w/v iodixanol in water).51 Briefly, 
0.2−1 mL solutions of varying densities (50%, 43.3%, 38.9%, 35.9%, 35.9%, 33.9%, 32.6%, 
31.7%, 31.1%, and 30% iodixanol) were made by dilution with water. These solutions were then 
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layered in a 15 mL eppendorf tube, with the most dense solution at the bottom. The Au NPs 
solution was layered on top without disturbing the density gradient, and the tube was centrifuged 
at 500 rcf for 15 min. Larger lipid-coated Au NPs complexed with 12 nm NPs would be denser 
and travel down the density gradient, appearing as a red band. These were collected and purified 
twice via centrifugation before imaging by electron microscopy. 
 
2.2.9.  Instrumentation 
Absorption spectra were taken on a Cary 500 scan UV−vis−near-IR spectrophotometer. 
Transmission electron microscopy data were obtained with a JEOL 2100 cryo electron 
microscope operating at 200 kV. Zeta potential and dynamic light scattering measurements were 
performed on a Brookhaven Zeta PALS instrument. LC/MS/MS analysis was performed in the 
Metabolomics Center at University of Illinois Urbana−Champaign (UIUC) with a 5500 QTRAP 
mass spectrometer (AB Sciex, Foster City, CA) which is equipped with a 1200 Agilent LC. 
Analyst (version 1.5.1, Applied Biosytems) was used for data acquisition and processing. A 
Phenomenex (Torrance, CA) column [Kinetex 2.6 μm pentafluoropentyl (PFP) phase, 100 × 4.6 
mm] was used for the separation. 
 
2.3.  Results and Discussion 
2.3.1.  Design and Synthesis of Lipid Bilayers or Hybrid Bilayers on Au NP Surfaces 
The amphiphilic nature of lipids is due to their polar headgroup and the nonpolar fatty 
acid tails. Association of lipids with Au NPs can thus potentially occur either via electrostatic 
interactions of the heads with charged species on the Au NP surfaces or through hydrophobic 
interactions with the tails and hydrophobic species on the Au NP surfaces. Electrostatic 
interaction of the negatively charged headgroup of a lipid with positively charged 
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poly(allylamine hydrochloride) (PAH) coated Au NPs would thus give lipid bilayers on NPs in 
water (Scheme 2.1). In this design, the polar head of one lipid layer faces the cationic particle 
surface, and in order to sequester the hydrophobic tail from water, a second lipid layer associates 
with the Au NPs. Conversely, functionalizing the Au surface with an alkanethiol, 1-
octadecanethiol (C18SH), produces a hydrophobic surface that allows for interaction with the tail 
ends of lipid, which we term “hybrid” bilayers (since the bilayer is composed of the alkanethiol 
and a lipid, not two lipids).33 In our investigations, lipids with two different phosphate 
headgroups were studied: a saturated single fatty acid chain compound, lysophosphatidylcholine 
(LPC), and a monounsaturated double fatty acid chain compound, 1-palmitoyl-2-oleoyl-sn-
glycero-3-phospho-L-serine (sodium salt) (POPS). The phosphatidylcholine (PC) and 
phosphatidylserine (PS) headgroups were chosen because they are two of the four major types of 
lipids found in the human body.9  
The choice of a 1:1 POPS/LPC lipid formulation was based on previous work with other 
types of nanomaterials. Fischlechner et al. had previously shown that a 1:1 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC)/ POPS mixture was ideal for the formation of a 
homogeneous lipid bilayer on PAH-terminated silica particles (3−8 μm).31 As expected, 
negatively charged POPS was attracted to the positively charged PAH through electrostatic 
interactions. Zwitterionic POPC was also found to associate with PAH, and it was postulated that 
hydrogen bonding occurs between the phosphate on POPC and the amine on PAH. We therefore 
surmised that a 1:1 ratio of two related lipids would be favorable for bilayer formation on Au 
NPs as well. However, to accommodate the huge increase in surface curvature for the 20−90 nm 
NPs compared to 3−8 μm silica particles, we substituted LPC for POPC, reducing the acyl tail 
chains from two to one.  The single  acyl  tail  reduces the steric hindrance of LPC,  allowing it to 
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Scheme 2.1.  Formation of Lipid Bilayers or Hybrid Bilayers on Au NP Surfacesa 
 
 
aWith PAH coated Au NPs (blue on gold), a lipid bilayer results. Addition of alkanethiol (C18SH, 
purple) to citrate-capped Au NPs results in the formation of hybrid bilayers on the Au NPs. The 
labels 1-6 refer to Au NPs with (1) a POPS bilayer, (2) a mixed POPS/LPC bilayer, (3) an LPC 
bilayer, (4) a POPS hybrid bilayer, (5) a mixed POPS/LPC hybrid bilayer, and (6) an LPC hybrid 
bilayer. 
34 
 
adopt a conical shape and conform onto a smaller NP (Scheme 2.2). The trimethylammonium 
headgroup also makes it similar to cetyltrimethylammonium bromide (CTAB), which is 
commonly used to make Au NPs.52 In fact, LPC is known to act as a detergent and forms 
micelles of size 5 nm.53 This potentially reduces the spatial requirement at the hydrophobic tail 
end, allowing for tighter packing on the highly curved surface of Au NPs. The other lipid in our 
construct, POPS, has its cylindrical shape imposed by the two acyl tail chains, which favor larger 
liposome bilayers due to its low intrinsic curvature compared to LPC (Scheme 2.2).54 In 
addition, POPS was specifically chosen for its low transition temperature (Tm) of 14 °C, allowing 
experiments to be performed at room temperature while maintaining the lipid layer in its fluid 
state. 
In order to discover which combination of lipids would provide colloidal stability to Au 
NPs in organic solvent (presumably due to lipid monolayer formation), we layered an aqueous 
phase containing PAH-coated 20 nm Au NPs on top of a chloroform layer containing various 
lipids. The mixtures were vigorously mixed and allowed to stand overnight. Results showed that 
only when a mixture of 1:1 POPS/LPC was used were Au NPs transferred cleanly into the 
organic phase (Figure 2.1). This highlights the notion that the formation of a lipid layer on a 
highly curved surface is more favored when mixtures of lipids are used, possibly as a result of 
better packing and hence passivation of Au NP surface. This is consistent with results from lipid 
coating on silica particles. We were thus motivated to explore lipid bilayer coatings on Au NPs 
composed of either POPS or LPC alone, and a mixture of 1:1 POPS/LPC. 
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Scheme 2.2.  Cartoon of a Micelle Made of LPC and a Liposome Made of POPSa  
 
 
 
 
 
 
 
 
 
 
aLPC micelle is shown in gray and POPS liposome is shown in red. The single tail of LPC makes 
it difficult for LPC to fill all the volume of a bilayer while accommodating the area of the 
headgroup, resulting in a micelle structure instead of a liposome.  
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Figure 2.1.  A photograph illustrating the distribution of Au NPs in water /chloroform mixtures 
in the presence of lipids. The top solvent layer is water; the bottom is chloroform. The red color 
indicates the phase in which the gold nanoparticles, originally coated with PAH, reside.  Lipid 
identity in 1:1 ratios or as single components is indicated under each vial. 
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2.3.2.  Characterization and Stability of Lipid Bilayers on Au NPs 
Lipid bilayer formation was achieved, in principle, by incubating PAH-coated Au NPs 
with (1) POPS, (2) a 1:1 mixture of POPS/LPC, and (3) LPC (Scheme 2.1). To form the hybrid 
lipid layer, a ratio of 1 or 2 C18SH to surface Au atoms was chosen on the basis of recent X-ray 
crystallography, which showed that thiols bind to either 1 or 2 Au atoms on the surface of small 
Au NPs.55 Incubation of citrate-capped Au NPs in the presence of octadecanethiol (C18SH) with 
(4) POPS, (5) a 1:1 mixture of POPS/LPC, and (6) LPC should result in a hybrid bilayers on the 
gold surface, using the thiol as the bridging ligand to create hybrid bilayers (Scheme 2.1). Au 
NPs of various diameters (20−90 nm) were employed as substrates. These lipid-coated Au NPs 
were characterized with UV−vis spectroscopy, dynamic light scattering (DLS), and ζ potential 
measurements. In the remainder of the section, Au NPs will be referred to by their surface (1−6, 
Scheme 2.1) and their gold core diameter in nanometers, enclosed in brackets. 
Ultraviolet−visible spectroscopy measurements of Au NPs showed a slight red shift in 
the wavelength maximum of ∼2−3 nm after functionalization with lipids for most samples, 
consistent with an increase in the refractive index, suggesting lipid attachment (Figure 2.2).35 
LPC alone on PAH-coated Au NPs that were 20 nm in diameter (Scheme 2.1; [3, 20 nm]) 
aggregated upon separation of free LPC and resuspension in HEPES buffer. Since LPC is only 
adsorbed to the PAH layer via hydrogen bonding if the results on silica surfaces apply, the lipid 
bilayer is easily desorbed, causing subsequent aggregation in water. The hybrid bilayers with 
POPS alone on 50 and 90 nm gold nanospheres (Scheme 2.1; [4, 50 nm] and [4, 90 nm]) showed 
blue shifts in the UV−vis rather than red shifts. These blue shifts were fairly reproducible and 
were observed only with POPS alone. While we are currently unsure of the significance of this 
blue shift, the shift does at least provide qualitative evidence for a new surface coating. 
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Figure 2.2. UV-vis spectra of Au NPs before (dotted lines) and after (solid lines) lipid 
functionalization, for three different gold core sizes.  (a) Au NPs coated with PAH and then 
POPS, of diameter 20 nm (black), 50 nm (red) and 90 nm (blue). (b) Au NPs coated with PAH 
and then 1:1 POPS:LPC, of diameter 20 nm (black), 50 nm (red) and 90 nm (blue). (c) Au NPs 
coated with PAH and then LPC, of diameter 20 nm (black), 50 nm (red) and 90 nm (blue). (d) 
Au NPs coated with 1-octadecanethiol and POPS, of diameter 20 nm (black), 50 nm (red) and 90 
nm (blue). (e) Au NPs coated with 1-octadecanethiol and 1:1 POPS:LPC, of diameter 20 nm 
(black), 50 nm (red) and 90 nm (blue). (f) Au NPs coated with 1-octadecanethiol and LPC, of 
diameter 20 nm (black), 50 nm (red) and 90 nm (blue).  
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An increase of about 3−20 nm in the hydrodynamic size of the Au NPs was detected after 
lipid coating via dynamic light scattering (Figure 2.3), consistent with the addition of nanoscale 
organic layers. In all cases the electrostatic PAH-enabled coating (Scheme 2.1) led to larger 
apparent particle diameters than the alkanethiol hydrophobic approach (Scheme 2.1), possibly 
suggesting the formation of lipid multilayers. No evidence for bulk Au NP aggregation was 
apparent by either UV−vis or light scattering measurements. Zeta potential measurements 
showed the change in NP surface charge after lipid coating (Figure 2.4a, b). For example, the ζ 
potential of 20 nm PAH-coated Au NPs changed from +55.92 ± 2.75 mV to −87.61 ± 4.92 mV 
after POPS coating, to −92.66 ± 1.60 mV after POPS/LPC coating, and to +20.51 ± 1.36 mV 
after LPC coating. Similar changes were seen for hybrid bilayer Au NPs: 20 nm citrate-capped 
Au NPs changed from −36.46 ± 1.36 mV to −103.8 ± 2.85, −70.99 ± 1.59, and −18.9 ± 2.74 mV 
after coating with POPS alone, POPS/LPC, and LPC alone, respectively. The presence of 
negatively charged POPS in the bilayer lowered the ζ potential to a negative value, while 
zwitterionic LPC reduced the inherent surface charge.  
As the 1:1 POPS/LPC surface coatings most closely mimic the heterogeneity found in the 
cell membrane (compared to pure POPS or LPC coatings), we examined Au NPs with these 
coatings made by the two methods (Scheme 2.1). Further evidence for a mixed lipid coating on 
Au NPs comes from the ζ potential measurements with respect to pH (Figure 2.4). Results 
showed that 1:1 POPS/LPC-coated Au NPs were more stable to aggregation and exhibited 
different ζ potential changes as a function of pH compared to native Au NPs. PAH-coated Au 
NPs maintained a positive ζ potential above pH 10 and citrate-capped Au NPs aggregated 
immediately below pH 8, limiting the range of measurements for these samples. In contrast, both 
types of mixed-lipid-coated Au NPs maintained a negative ζ potential until pH 3.9. In a mixed  
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Figure 2.3.  Dynamic light scattering data for Au NPs after 1:1 POPS:LPC lipid coating for three 
different gold core diameters (20 nm, 50 nm, 90 nm): initial citrate-capped (black), 1-
octadecanethiol plus lipid (red), PAH-coated (blue) and PAH-coated plus lipid (green). All 
measurements were made in HEPES buffer at pH 7. 
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Figure 2.4.  Zeta potential and light-scattering measurements to qualitatively establish surface 
coverage changes upon lipid functionalization. (a) Zeta potential measurements of 20 nm 
diameter Au NPs with PAH and lipid layers 1, 2 and 3 (Scheme 1). (b) Zeta potential 
measurements of 20 nm octadecanthiol-capped Au NPs with lipid layers 4, 5 and 6 (Scheme 1).  
(c) Zeta potential variations with respect to pH for 20 nm (black), 50 nm (blue) and 90 nm (red) 
Au NPs with 1:1 POPS:LPC with an initial coating of PAH. The behavior of native PAH Au NPs 
(20 nm) are given in black dotted lines. (d) Zeta potential variations with respect to pH for 20 nm 
(black), 50 nm (blue) and 90 nm (red) Au NPs with 1:1 POPS:LPC with an initial coating of 1-
octadecanethiol. The behavior of native citrate Au NPs (20 nm) are given in black dotted lines. 
(e) Hydrodynamic diameter changes with respect to pH for 20 nm (black), 50 nm (blue) and 90 
nm (red) Au NPs with 1:1 POPS:LPC with an initial coating of PAH. The data for native PAH 
Au NPs (20 nm) are given in dotted lines. (f) Hydrodynamic diameter changes with respect to 
pH for 20 nm (black), 50 nm (blue) and 90 nm (red) Au NPs with 1:1 POPS:LPC with an initial 
coating of 1-octadecanethiol. The data for native citrate Au NPs (20, 50, 90 nm) are given in 
dotted lines.  
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PC and PS vesicle, the pKa of the carboxyl group was 3.6 ± 0.1 and the pKa of the amino group 
was 9.8 ± 0.1.56 The pH change at 3.9 is very close to the carboxyl group pKa, suggesting the 
presence of a PS and PC layer. 
Mixed-lipid-coated Au NPs, for 50 and 90 nm diameters, showed increased resistance to 
aggregation with respect to pH changes as compared to the native PAH or citrate Au NPs (Figure 
2.4e,f). The native PAH-coated Au NPs were unstable at pH > 7, while native citrate-capped Au 
NPs aggregated below pH 7. Au NPs bearing the nominal 1:1 POPS/LPC, for 50 and 90 nm 
diameters, maintained their hydrodynamic sizes throughout pH changes and did not aggregate. 
The 20 nm Au NPs bearing 1:1 POPS/LPC were stable above pH 7 but tended to aggregate 
below pH 7. We postulate that the high surface curvature of these smaller particles favors the 
homogeneous distribution of the mixed lipids (vide infra). When mixed lipids distribute 
homogeneously on a curved surface, the difference in the sterics of LPC and POPS leaves much 
space in the lipid layer, decreases the packing density, allowing small ions to penetrate into the 
hydrophobic lipid layer and hence destabilize it, causing the aggregation. On larger 50 and 90 
nm NPs, lipid domain formation is favored, thus allowing better packing and conferring greater 
stability to these lipid NP composites. 
Mass spectrometry was used to quantify the number of lipid molecules associated per Au 
NP. Table 2.1 shows the number of POPS and LPC molecules per Au NP of diameters 20 and 90 
nm. While a ratio of 1:1 POPS/LPC was incubated with the Au NPs, a different adsorbed ratio 
was found for the hybrid Au NPs. For example, on 20 nm hybrid Au NPs, a 13-fold excess of 
LPC over POPS was detected. Similarly, on 90 nm hybrid Au NPs, 28 times more LPC 
molecules were associated with the gold nanoparticles as compared to POPS molecules. A 
distinctly different trend  was observed for  the  mixed lipids on PAH-coated Au NPs. For  mixed 
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Table 2.1. Number of Lipid Molecules Detected per Au NP by Use of LC/MS/MS and Their 
Respective Ratiosa 
 
Au NP POPS LPC 
Ratio 
(LPC/POPS)
 20 nm Au NPs  
hybrid (with C18SH) 36 ± 4 460 ± 190 13 
bilayer (on PAH) 8400 ± 900 8300 ± 500 0.99 
    
 90 nm Au NPs  
hybrid (with C18SH) 2600 ± 400 73000 ± 18000 28 
bilayer (on PAH) 48000 ± 7500 89000 ± 41000 1.85 
 
aThe lipids were incubated with the Au NPs at a ratio of 1:1 (POPS:LPC) before purification. For 
reference, ~1300 or 2600 total lipids would constitute a monolayer or bilayer around 20 nm Au 
NPs, respectively, and ~25,000 or 50,000 total lipids would constitute a monolayer or bilayer 
around 90 nm Au NPs, respectively.  
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lipids on 20 nm PAH Au NPs, the nominal 1:1 ratio of LPC/POPS was maintained (8400 ± 900 
POPS versus 8300 ± 500 LPC molecules), while on 90 nm PAH Au NPs, a 1.85 LPC/POPS ratio 
was measured. These results demonstrate that the surface coating on Au NPs can influence the 
adsorption of lipids, although the imbalance of POPS and LPC is surprising for the thiol-
modified, hybrid Au NPs. The zwitterionic charges as well as the single acyl tail chain of LPC 
could allow for tighter packing in hybrid Au NPs than POPS (negatively charged, more repulsion 
between POPS molecules), resulting in a higher ratio of LPC incorporated than POPS. On the 
other hand, positively charged PAH on Au NPs could strongly attract POPS molecules via 
electrostatic interactions as compared to LPC, resulting in increased POPS adsorption.  
Large differences in the total lipid content between hybrid lipid on Au NPs and lipid 
bilayer on PAH Au NPs were also measured. On 20 nm Au NP, 36 ± 4 POPS and 460 ± 190 
LPC molecules were in the hybrid lipid layer, compared to 8400 ± 900 POPS and 8300 ± 500 
LPC molecules in the bilayer on PAH-coated Au NPs. A similarly large difference was observed 
for POPS on 90 nm Au NPs (Table 2.1). The much higher lipid counts on PAH-coated Au NPs 
implies lipid multilayer formation on PAH-coated Au NP surfaces; the differences are too great 
to be attributed to tighter packing of the lipids on one type of NP versus another. Simple 
footprint estimates of 1 nm2 for each lipid suggest that 20 nm Au NPs should accommodate 1300 
lipids/Au NP if the lipids formed a monolayer, or at least 2600 lipids/Au NP if the lipids formed 
a bilayer. Clearly, the total lipid content of the hybrid bilayers is far short of this footprint 
estimate, while for the PAH-coated 20 nm Au NPs, the detected lipid content is far higher than a 
simple mono- or bilayer. For 90 nm Au NPs, similar estimates give 25 000 lipids for a 
monolayer or 50 000 for a bilayer; the experimental mass spectrometry data are within a factor of 
2 of the estimated coverage. 
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Interestingly, the hybrid-lipid-coated Au NPs using C18SH were resistant to cyanide 
etching, even though there are fewer lipid molecules per nanoparticle than the PAH-coated gold 
nanoparticles. These hybrid NPs were not etched with 1000 μL of 1 M KCN as compared to 
citrate-capped NPs, which can be etched with as little as 20 μL for the same volume and 
concentration of NPs. The hybrid NPs were stable in the presence of KCN for up to a week, 
demonstrating the extent of thiol passivation-induced protection of Au NPs surface. This is 
similar to results published by Sitaula et al.,57 who showed that a 6-fold excess of 1-decanethiol 
to surface Au atoms can be used to stabilize Au NPs synthesized with a phosphatidylcholine 
lipid against cyanide etching. It is worth pointing out that, in our case, a lower concentration of 
alkanethiol is used to yield the same results. However, we have no information about the 
distribution of C18SH and lipid in the inner and outer leaflet. 
The visualization of lipid bilayers on Au NPs was performed by TEM imaging with a 
positive stain, osmium tetroxide (OsO4). OsO4 works by reacting preferentially with cis double 
bonds in unsaturated lipids to form a cyclic compound, allowing the lipid to be visible when 
viewed under the TEM.58,59 Given enough time and at the right temperature, OsO4 can oxidize 
even alkanes in a [3 + 2] addition of a C−H bond to two oxo ligands of OsO4.60,61 By precisely 
controlling the staining time at room temperature, we were able to preferentially stain only POPS 
while LPC (saturated) remained unstained and unobservable.62 Electron micrographs of POPS-
coated Au NPs 1 and 4, stained with OsO4, are shown in Figures 2.5 and 2.6 for 20 and 90 nm 
diameter particles. The expected thickness of a lipid bilayer is about 5 nm,9 while the measured 
organic layer thickness for 1 and 4 ranges from 2.2 to 3.3 nm and 2.3 to 4.6 nm for 20 nm NPs, 
and 3.1 to 9.0 nm and 3.3 to 6.2 nm for 90 nm NPs, respectively. As the drying and processing 
steps  can  greatly alter  apparent  organic  layer  thicknesses,  we  conclude  that  the  data at the  
46 
 
 
 
Figure 2.5.  Stained TEM images of PAH-coated Au NPs with POPS ([1, 20 nm] and [1, 90
nm]). Scale bars = 20 nm.  
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Figure 2.6.  Stained TEM images of C18SH coated Au NPs with POPS (4-20nm and 4-90nm). 
Scale bars = 20 nm. 
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minimum support a continuous bilayer of POPS around these particles. In some cases, 
multilayered lipids on Au NPs were observed at a low fraction, as seen from the striation in the 
organic layer (Figure 2.7a). While variations in organic layer thickness were also seen on 20 nm 
Au NPs, this is not as obvious (Figure 2.8). The lack of a double bond in LPC renders LPC-
functionalized particles less likely to be stained with this method. In order to demonstrate 
complete passivation of LPC-coated Au NPs 3 and 6, cryo TEM was performed (Figure 2.9). 
Cryo TEM images showed a continuous layer of organic material surrounding the Au NPs, 
suggesting that a homogeneous layer of LPC exists on Au NPs 3 and 6. 
 
2.3.3.  Formation of Lipid Domains on Au NP Surfaces 
The presence of single types of lipids on Au NPs was confirmed by spectroscopy, light 
scattering, and the appropriate electron microscopic techniques. For Au NPs with the nominal 
1:1 POPS/LPC coatings, the most interesting question is, do these mixed lipids form domains on 
the NP surface? The preferential staining of OsO4 for unsaturated lipids allows for the 
visualization of POPS domains on Au NP surfaces. If the amount of surface-bound POPS is large 
enough, and its distribution about the NP surface was random, we would expect to observe a 
(faint) complete organic layer around the particle. Alternatively, if domains of POPS were 
present, NPs with patchy stained organics would be observed. The term patch, instead of domain, 
is used here to denote the distribution of lipids due to the diffusive nature of OsO4; that is, the 
stained patches might be slightly larger than the expected lipid domains. Figure 2.7 shows the 
how the outline lipid layer on 90 nm C18SH Au NPs varies when the lipids are either POPS 
alone, 1:1 POPS/LPC, and LPC alone. With POPS alone, a complete coating of organics could 
be observed around the Au NP, while with LPC alone the organic layer was not observed, as it is  
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Figure 2.7.  Preferential staining by OsO4 for POPS on 90 nm C18SH-coated Au NPs with (a) 
POPS alone [4, 90 nm], (b) 1:1 POPS/LPC [5, 90 nm], and (c) LPC alone [6, 90 nm]. Only 
POPS lipid domains are observed on Au NPs.  
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Figure 2.8.  Stained TEM images of 20 nm PAH coated Au NPs with LPC and POPS [2, 20nm]. 
The difference in organic layer thickness could possibly indicate the presence bilayer or 
multilayer lipids. The organic layer is only visible when the Au NPs are not fully on the formvar 
coating of the TEM grid. 
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Figure 2.9.  Cryo-TEM images of 20 and 90 nm Au NPs with an LPC coating ([3, 20 nm] and 
[3, 90 nm]). 
  
52 
 
not stained. A similar staining pattern was observed for both types of lipid-coated 50 and 90 nm 
Au NPs (Figure 2.10). With a nominal 1:1 POPS/LPC mixture, variations in staining patterns 
were observed. For both types of lipid-coated Au NPs of sizes 50 and 90 nm, patches of stained 
organics were observed, suggesting that domains of POPS are present on these NP surfaces as 
expected. The size of the patches is apparently, from the micrographs, a quarter to a half the 
circumference of the particles as they appear in the two dimensional images. Surprisingly, for 
mixed lipids on Au NPs of size 20 nm ([2, 20 nm] and [5, 20 nm]), a completely stained organic 
layer surrounding the NP was (faintly) observed. Mass spectrometry data supports the presence 
of LPC/POPS in ratios of 13:1 and 1:1 for hybrid and bilayer anchoring on 20 nm Au NPs 
respectively. This translates to patches with estimated coverage of 30° and 180° on these NPs, 
thus allowing us to rule out the patchy nature of lipids on 20 nm Au NPs, assuming the staining 
technique has sufficient resolution. This result then suggests that either the lipid layers are indeed 
random, not patchy, on these smaller particles or that only POPS binds significantly to the 
smaller NPs. However, the latter possibility is not likely from the mass spectrometry data; LPC 
is present at a much higher concentration than POPS for these Au NPs, thus ruling out that only 
POPS is present on the smaller Au NPs. This random distribution of POPS and LPC on smaller 
Au NPs (20 nm) and the patchy distribution on larger Au NPs (50 and 90 nm) suggests that 
surface curvature can influence the distribution and packing of lipids. A third possibility, of 
course, is that the TEM staining is insufficient to distinguish patches on 20 nm nanoparticles.  
It has been clear for many years that the mixing of two lipids with different headgroups 
or acyl chains is nonrandom.63 In general, the demixing of two lipids can be understood from the 
contributions of the headgroups and the acyl chains.23 The headgroup of LPC is zwitterionic in 
character,  with  the  negative charge  at  the phosphate  separated by several angstroms from  the 
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Figure 2.10.  OsO4-stained TEM images of PAH- and C18SH-coated Au NPs of three different 
sizes with lipids, with the lipid being POPS alone, a mixture of POPS and LPC (1:1), and LPC 
alone. Scale bars = 15 nm. Only in the cases of 1:1 POPS/LPC are asymmetric coatings 
observed. 
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choline unit that carries the positive charge ( ).28 This is in contrast to POPS, which 
has a carboxylate group attached to the amine ( ). Evidence has shown that the 
PS−PS electrostatic repulsion can be overwhelmed by other interactions and that the mixing of 
PS and PC headgroup lipids is nonideal, that is, domains will form.26,27 The single cis double 
bond on one of the acyl chain in POPS also introduces a kink, imparting partial disorder 
properties which prevent close encounter with neighboring lipid.24 This causes POPS to pack 
poorly with LPC, which has a saturated acyl chain, further favoring its domain formation to 
minimize exposure of water to the hydrophobic regions.25,64 In addition, the tendency for lipids 
to phase-separate is increased with increasing curvature due to the reduction of lateral pressure 
and area density of lipids.20−22 When all these are taken into consideration, it is not surprising 
that mixed-lipid layers on Au NP surfaces will phase-separate to form domains of POPS and 
LPC rich regions, thus resulting in patchy NPs.  
Parthasarathy et al. had previously shown a curvature of at least 0.8 ± 0.2 μm−1 can 
modulate the phase separation of lipids with the lipid domains preferred at lower curvatures.65 
Here, we propose a possible mechanism for lipid adsorption onto Au NPs: due to the faceted 
nature of the surface of 50 and 90 nm diameter Au NPs, the curvature is extremely high at acute 
edges along facets and close to zero on the facets. POPS domains thus might only occupy 
positions on the facets, with the caveat that it is already not occupied by LPC. The formation of 
POPS domains is favored as they further reduce the surface energy by allowing tighter packing 
of lipids. The stronger electrostatic interaction of the PAH underlayer with POPS, compared to 
hydrogen bonding with LPC, might result in more POPS being included in the lipid bilayer on 
PAH-coated 50 and 90 nm Au NPs, which translated to a larger domain size as observed. The 
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facets on 20 nm diameter Au NPs are smaller. While POPS domains could still form on these 
facets, it might be energetically more unfavorable for the formation and stabilization of small 
POPS domains. In this sense, an even distribution of POPS and LPC would be preferred as 
compared to POPS domains, as the surface tension could be more evenly distributed between the 
conical-shaped LPC and the cylindrical-shaped POPS. 
 
2.3.4.  Functionalization of Lipid Coated 90 nm Au NPs with Smaller Au NPs via Protein 
Bridges 
Lipid layer formation on Au NPs is not limited to POPS and LPC. Various surface 
modifications can be performed by incorporating functionalized lipids, either into the lipid layers 
of POPS or LPC alone or in the mixed lipid composition. This would ultimately improve and 
expand the functionality of Au NPs in areas such as targeting and imaging through control over 
the types of protein bound. As a proof of concept, we incorporated a biotinylated lipid, 1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-biotinyl (biotin PE), at 25% (w/w) into the 
lipid composition. The lipids were then incubated with 90 nm Au NPs as per the above-
mentioned protocol and purified. To determine the positioning of these biotin-functionalized 
lipids, anti-biotin antibodies conjugated to 12 nm Au NPs were incubated with the lipid-coated 
Au NPs and then purified by density gradient centrifugation. The spatial distribution of the small 
12 nm Au NPs about the large 90 Au NPs was then visualized by TEM.  
Our results demonstrate that biotin PE, through fingerprinting with 12 nm Au NP labels, 
is incorporated into the lipid bilayer and hybrid Au NPs (Figure 2.11). In addition, a range of 
distribution of 12 nm Au NPs for single and mixed lipids on Au NPs was seen. Figure 2.11a 
shows the change in 12 nm Au NP conjugation onto 90 nm PAH-coated Au NPs when the lipids 
were varied from POPS alone, mixed lipids, and LPC alone. In all cases, a 3:1 weight ratio was 
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Figure 2.11.  (a) Schematic and TEM images of biotinylated 90 nm NPs with anti-biotinylated 
12 nm NPs for lipid layers on PAH-coated Au NPs. Initial lipid ratios from top to bottom were 
POPS/biotin PE (3:1), POPS/LPC/biotin PE (1:2:1), and LPC/biotin PE (3:1). (b) Schematic and 
TEM images of biotin/anti-biotin conjugation of 90 and 12 nm NPs for lipid layer on C18SH-
functionalized Au NPs. Initial lipid ratios from top to bottom were POPS/biotin PE (3:1), 
POPS/LPC/biotin PE (1:2:1), and LPC/biotin PE (3:1). All scale bars are 50 nm.  
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used where biotin PE makes up 25% (w/w). In the mixed lipid case, a ratio of 1:2:1 
POPS/LPC/biotin PE was used. Likewise, the same was done for hybrid lipids on 90 nm Au NPs 
with POPS, mixed POPS/LPC, and LPC lipids (Figure 2.11b). TEM images demonstrate that at 
least two types of Au NP label distribution exists: individual 12 nm Au NPs and groups or 
patches of two or more Au NPs.  
To quantify the distribution of 12 nm Au NP labels, we performed an angle analysis 
(Scheme 2.3). In this analysis, we can describe the distribution of the particles by either the 
average angle of labels or the distribution of label angles (Scheme 2.3). Simple mathematical 
modeling shows that the theoretical angle from the center of a 90 nm sphere to the edges of a 12 
nm sphere is 13°. This allows us to identify individual particles as opposed to groups of particles 
from the angles. In addition, as a means to standardize measurements, 12 nm Au NPs separated 
by more than 1° were treated as individual particles or patches (more than 1 NP grouped 
together). The results of this analysis are shown in Table 2.2 for the data represented by Figure 
2.11; histograms of the full data set are given in Figure 2.12. To characterize the distribution and 
extent of coverage, three parameters were calculated: (1) average number of patches per Au NP 
(avg. patches/NP) to show the distribution of biotin PE; (2) the fraction of patches ≥30° (no. of 
patches ≥30°/total) as a means to quantify the number of biotin PE domains, given that two 
particles together would provide an angle of 26°; and (3) the average angle covered on each NP 
(avg. angle per NP covered) to demonstrate the extent of coverage. Lipid composition on Au 
NPs influences the distribution of Au NP labels present. For example, for PAH-coated Au NPs, 
when the lipid composition was varied from POPS/biotin PE to POPS/LPC/biotin PE to 
LPC/biotin PE, the average number of patches per NP changed from 3.72 to 3.02 to 2.13. Of 
these patches, only 15.1% and 23.1% are larger than or equal to 30° (more than two particles 
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Scheme 2.3.  Angle Analysis of Small Particle Labels around a Larger Particle to Quantify 
Distribution of the Biotinylated Lipid, Biotin PEa 
 
 
 
aA cluster of small particles define the angle ϕ, and the individual small particle defines the angle 
θ. To distinguish between these two cases, small particles separated by more than 1° are taken to 
be distinct patches. The average angle of all associated small particles can be calculated, or a 
histogram of measured angles per large particle can be calculated.  


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Table 2.2.  Distribution of Smaller Au NPs Bound to 90 nm Au NPs via Biotin/Anti-Biotin 
Interactions, for both PAH-Coated and C18SH-Functionalized Au NPsa 
 
 PAH Hybrid (C18SH) 
system POPS POPS/LPC LPC POPS POPS/LPC LPC 
total count 90 nm 
NP 107 160 108 111 102 124 
total patches 398 483 230 528 389 384 
avg. patches/NP 3.72 3.02 2.13 4.76 3.81 3.10 
no. patches ≥ 
30˚/total 0.15 0.23 0.53 0.34 0.26 0.40 
avg. angle per NP 
covered 75.2° 74.8° 83.7° 131.4° 107.3° 98.7° 
 
aAverages of 100 or more Au NPs were counted and the respective angles were measured. 
“Patch” refers to a patch of small nanoparticles in this case. All lipid layers are synthesized with 
an initial biotin PE content of 25% (w/w). 
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Figure 2.12.  Histograms of the counts of 12 nm Au NP label angles on 90 nm Au NPs with 
respect with the total angles measured. PAH coated Au NPs with a) POPS/biotin PE, b) 
POPS/LPC/biotin PE and c) LPC/biotin PE. Hybrid Au NPs with d) POPS/biotin PE, e) 
POPS/LPC/biotin PE and g) LPC/biotin PE.  
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together) on Au NPs with POPS/biotin PE and POPS/LPC/biotin PE, respectively, while for 
LPC/biotin PE the ratio stands at 52.6%. Regardless of the type of patches formed, the mean 
angle occupied by labels per NP are similar: 75.2° for POPS/biotin PE, 74.8° for 
POPS/LPC/biotin PE, and 83.7° for LPC/biotin PE. The distribution of labels on hybrid Au NPs 
are higher as compared to their PAH counterparts. The average number of patches per NP are 
higher at 4.76, 3.81, and 3.10 for POPS/biotin PE, POPS/LPC/biotin PE, and LPC/biotin PE 
respectively. In addition, the mean angle occupied by labels per NP are also larger: 131.4° for 
POPS/biotin PE, 107.3° for POPS/LPC/biotin PE, and 98.7° for LPC/biotin PE. However, the 
fraction of patches 30° or larger are similar for POPS/biotin PE and LPC/biotin PE at 33.9% and 
39.6%, respectively, and lower for POPS/LPC/biotin PE at 26.2%.  
From this evidence, no clear preference of biotin PE for either hybrid or bilayer on Au 
NPs was observed. We can postulate that biotin PE had a preference for POPS as compared to 
LPC, on the basis of the data in Table 2.2. The larger number of patches with ≥30° on LPC-alone 
NPs could reflect an increased tendency of biotin PE to form separate domains within an LPC 
surface. It is clear that these data do once again suggest that lipid domain formation of biotin PE 
might occur on Au NP surfaces, thus highlighting the notion that the underlying lipid 
composition (POPS or LPC) can influence the distribution of the functionalized lipids. By 
carefully selecting the lipid types, compositions, and ratios, we believe that it is possible to fine-
tune the distribution of functionalized lipids on Au NPs, such that the two extremes of ligand 
distribution (evenly dispersed versus Janus particles) can be achieved. Work along these lines is 
currently in progress. 
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2.4.  Conclusion 
Single and mixed lipid coating of Au NPs has been demonstrated, using two different 
means to secure the lipid onto the metal: hydrophobic interactions or electrostatics. Several lines 
of evidence, including UV−vis spectroscopy, ζ potential, and electron microscopy, support the 
formation of lipid layers on Au NPs. These lipid-coated Au NPs show remarkable stability to 
aggregation in buffers and at different pHs, which could certainly expand the possibilities for 
using Au NPs in biological applications for cellular imaging, targeting, or therapeutics. There is 
evidence for lipid domains on mixed-lipid-coated Au NPs larger than 50 nm, while evidence for 
a homogeneous mixed lipid layer was obtained for Au NPs of size 20 nm. Mass spectrometry of 
mixed-lipid-coated Au NPs reveals a large variation in lipid content that depends on initial 
surface coating of the gold and on gold core size. We have also shown that the lipid layer can be 
functionalized with biotin-conjugated lipids. The distribution of this biotin PE can be deduced 
through visualization after incubation with smaller Au NPs conjugated with anti-biotin 
antibodies. By careful selection of the types of lipids and ratios, the surface chemistry on Au NPs 
can be fine-tuned from an evenly dispersed configuration to that similar of Janus particles. 
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CHAPTER 3 
Wild-Type α-Synuclein Binding and Orientation on Anionic 
Gold Nanoparticles* 
 
 
3.1.  Introduction 
Parkinson’s disease (PD), a degenerative disorder of the central nervous system, affects 
∼2% of individuals over the age of 60.1 This translates to about one million people in the United 
States in 2011, with 50 000 new cases diagnosed every year. PD is a movement disorder 
characterized by tremor, bradykinesia, muscular rigidity, and loss of coordination. 
Pathologically, the occurrence of PD is characterized by a loss of dopamine neurons in the 
substantia nigra pars compacta, coupled with the appearance of Lewy bodies, proteinaceous 
aggregates that develop inside nerve cells.2 Studies into these Lewy bodies have indentified α-
synuclein (α-syn) as a major component of these inclusions,3 and many subsequent studies have 
shown that the overexpression of wild-type α-syn and the production of wild-type and mutant α-
syn in mice and fly models lead to a loss of dopaminergic neurons, motor deficits, and neuronal 
inclusions, all of which are hallmarks of PD.4,5 A more recent in vitro study demonstrated that α-
syn can be transmitted from α-syn-overexpressing (donor) cells to non-overexpressing (acceptor) 
cells, resulting in the formation of Lewy-like inclusions in acceptor cells.6 Although the cause of 
PD is still not known, these results show that the relationship between PD and α-syn is deeply 
                                                            
* This chapter is reprinted with permission from: Jie An Yang, Brittany J. Johnson, Sway Wu, Wendy S. Woods, 
Julia M. George and Catherine J. Murphy. Langmuir 2013, 29, 4603-4615.  (DOI: 10.1021/la400266u) Copyright 
2013 American Chemical Society. 
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intertwined and imply that the severe disruption of protein homeostasis with the accumulation of 
misfolded protein in Lewy bodies can be the cause of neuronal death.2 As such, much effort has 
been expended in the study of α-syn. 
α-Syn is a 140-amino-acid-long protein found in relatively high abundance in the brain 
(>1 μM in normal human brain and ∼70 pM in cerebrospinal fluid).7 It is present in high 
concentration at presynaptic terminals and can be broadly divided into three domains: an 
amphiphilic N-terminus region (residues 1−60) that contains four imperfect 11-residue amino 
acid repeats with a conserved motif (KTKEGV), a hydrophobic, highly amyloidogenic domain 
(residues 61−95) with three additional KTKEGV repeats, and an acidic C terminus(residues 
96−140).8 In aqueous buffers, α-syn is unstructured, but its shape can be easily modulated 
depending on the environment.9 When bound to vesicles composed of acidic lipids, α-syn adopts 
an α-helical structure. The curvature of the vesicles can influence the resultant α-helix: on small 
vesicles (20−25 nm), a horseshoe α-helix is maintained whereas on larger vesicles (∼100 nm) an 
extended α-helix configuration is observed.10 At low pH, high temperature, or in the presence of 
metal ions, the premolten globule state is predominant.11,12 At high concentrations, α-syn tends to 
aggregate into a series of morphologically different soluble oligomers, which further fold into a 
β-sheet conformation that rapidly polymerizes into fibrils.13 It is these fibrils that form the basis 
of Lewy bodies. However, growing evidence suggests that it is not the fibrils but the oligomeric 
intermediates of α-syn that are the toxic species.14 Although the exact function (and hence native 
structure) of α-syn is still not known, several hypotheses for its function have been put forward: 
regulation of synaptic vesicle release and trafficking, modulation of membrane curvature, and 
physiological regulation of enzymes and proteins.9,15 The ability to control the various folding 
pathways of α-syn would thus enable us to relate structure to function more easily.  
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Interest in gold nanoparticles (Au NPs) has been building because of their potential use in 
therapeutics and biomedical applications.16 The combination of low toxicity, nanoscale size, and 
large scattering and absorption coefficients of Au NPs enable potential applications such as 
targeted contrast agents for photothermal therapy, drug delivery agents for cancer therapy, and 
transfection agents for gene therapy.17 In the context of α-syn, Au NPs are fascinating potential 
substrates (tunable from 12 to 100 nm) in the size range of the lipid vesicles that α-syn favors. 
However, fundamental questions about the interaction between Au NPs and the biological 
medium remain to be answered. Specifically, the Au NP-protein interaction can alter the way 
cells “perceive” Au NPs or proteins. For example, it has been shown that regardless of the initial 
surface functionalization on Au NPs, when introduced into cellular growth media loaded with 
bovine serum albumin(BSA), the resultant effective charge on Au NPs is the same as for BSA, 
signifying BSA adsorption.18 Dawson et al. have gone further to show that a plethora of proteins 
bind to NPs when introduced into human plasma,19 making up a two-layer protein corona: a hard 
inner corona of strongly associated and very slowly exchanging proteins and a soft outer corona 
of weakly bound proteins in rapid exchange with free proteins insolution.20 This resultant protein 
corona is likely how cells perceive NPs.  
The formation of a protein corona on Au NPs is potentially a double-edged sword with 
regard to beneficial or detrimental effects on cells and will have to be carefully understood and 
perhaps regulated for future biomedical applications. First, low copy-number proteins, once 
trapped on the surface of Au NPs, may be rendered less bioavailable to the cell, thus throwing 
normal cellular pathways into disarray. Alternately, overexpressed proteins can be sequestered 
onto Au NPs and removed, making the cellular environment more “normal” in terms of the 
concentration of media components. Second, the adsorption of proteins onto Au NPs surfaces 
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can potentially alter the protein structure, which may result in severe consequences if such 
misfolded proteins trigger disease. Although many investigations assume that proteins (e.g., 
antibodies) maintain their tertiary structure when adsorbed onto NP surfaces, increasing 
emphasis has been placed on the changes that occur to protein structures in recent years.21,22 It 
can thus be inferred that the structural changes for natively unstructured proteins such as α-syn 
might be more extreme when they are bound to Au NPs. These two points make the study of 
protein binding and structure on a nanoscale object an important and difficult task. 
Thus far, work regarding α-syn adsorption on NPs has been limited. α-Syn has been used 
as a 1D assembly template to align Au NPs linearly or on Au NPs to use as a surface-enhanced 
Raman-scattering substrate.23,24 α-Syn-conjugated quantum dots can accelerate α-syn fibrillation 
in cells by acting as nucleating seeds.25 More work has been done on the amyloid β peptide, a 
shorter aggregation-prone peptide also found in the brain. Protein fibrillation of amyloid β can be 
controlled to a certain extent by influencing the lag phase, either by monomer or oligomer 
association to NPs.26 Amyloid fibrillation is also strongly dependent on the ratio of NP surface 
area to peptide concentration and the surface chemistry of the NPs.27,28 Molecular simulation has 
demonstrated that the shape and size of an NP can also influence amyloid fibril formation.29 
These studies illustrate strong peptide binding to NPs and also provide indirect evidence that the 
specific adsorption of the peptide onto NPs occurred, making them more/less favorable to 
fibrillation and hence conformation change. 
Here, we study the adsorption of wild-type α-syn onto 20-and 90-nm-diameter Au NPs. 
Au NPs can be considered to be protein-sized substrates, thus allowing for a better understanding 
of the folding mechanism of α-syn, or lipid vesicle mimics, allowing for an improved 
understanding of the shape control of α-syn. As expected, α-syn binds to Au NPs in multiple 
71 
 
layers via a hard and soft corona. The binding constants (overall and separate) were obtained 
using a combination of UV-vis spectroscopy, dynamic light scattering, and fluorescence 
quenching. We also demonstrate here that α-syn binds with higher affinity for 90 nm Au NPs 
than for 20 nm Au NPs that more closely match α-syn’s favored lipid vesicle substrate. In 
addition, we use a protease digestion foot printing method to deduce the structure of 
nanoparticle-bound α-syn. 
 
3.2.  Materials and Methods 
3.2.1.  Materials   
Gold(III) chloride trihydrate (HAuCl4·3H2O, ≥99.9%), sodium citrate tribasic dihydrate 
(Na3Ct·2H2O, ≥99%), hydroquinone (≥99%) and4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES, ≥99.5%) were obtained from Sigma-Aldrich and were used as received. 
Sequencing-grade trypsin (lot 082301) was obtained from GBioscience. Ultrapure deionized 
water (17.9 MΩ, Barnstead Nanopure II) was used for all solution preparations. A solution of 
HEPES buffer (20mM, pH 7) was prepared in ultrapure deionized water. Trypsin solutions were 
made by reconstituting trypsin in (NH4)2CO3 (25mM) to a final concentration of 12.5 μg/mL 
(0.54 μM). Glassware was cleaned with aqua regia and rinsed thoroughly before use. 
 
3.2.2.  Synthesis of Gold Nanoparticles  
Au NPs (diameter 20 nm) were synthesized by the boiling citrate method as previously 
described with some modifications.30 Briefly, 2.5 mL of 0.01 M HAuCl4·3H2O was added to 
97.5 mL of ultrapure water in a 200 mL Erlenmeyer flask and heated to boiling. An aqueous 
solution of sodium citrate (5% w/w, 2 mL) was then added, and the solution was allowed to boil 
for another 30 min. During this period, the color of the solution slowly changed to deep red. 
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Another portion of sodium citrate (1% w/w, 1 mL) was added, and the solution was allowed to 
boil for another 30 min. Au NPs produced by this method yielded a diameter of 17.5 ±1.3 nm 
under transmission electron microscopy (TEM). The hydrodynamic diameter measured by 
dynamic light scattering was 31.2 ± 0.4 nm. 
Au NPs (diameter 90 nm) were synthesized using 12 nm Au NPs as seeds and 
hydroquinone as the reducing agent.31 Seed Au NPs (diameter 12 nm) were synthesized using the 
boiling citrate method but with 3 mL of 1% sodium citrate. HAuCl4·3H2O solution (1% w/v, 2 
mL) was centrifuged at 17,000 rcf for 1 h, after which the top 1 mL was obtained and added to 
97.25 mL of ultrapure deionized water and 0.75 mL of the 12 nm NP solution. The solution was 
then stirred rapidly at room temperature, and 0.22 mL of 1% w/w sodium citrate was added, 
followed immediately by 1 mL of 0.03 M hydroquinone. The solution was allowed to stir 
overnight. Au NPs produced by this method yielded a diameter of 89 ± 13 nm under TEM. The 
hydrodynamic diameter measured using dynamic light scattering was 90.8 ± 0.3 nm. 
 
3.2.3.  Production of α-Synuclein 
α-Syn protein was expressed and purified as previously described.32 Briefly, the gene 
encoding wild-type human α-syn (SNCA) was cloned into the pET28 vector (Novagen). Protein 
expression was induced with 1 mM isopropyl-β-d-thiogalactopyranoside (IPTG) at 37 °C, 
followed by alkaline lysis, boiling, and precipitation with 60% ammonium sulfate. Precipitates 
were resolubilized and purified by hydrophobic interaction chromatography on a HiPrep 16/10 
butyl fast flow Sepharose column (GEBiosciences) and eluted with decreasing salt. α-Syn-
containing fractions were pooled and concentrated, subjected to size-exclusion chromatography 
on a Superdex 75 10/300 GL column (GEBiosciences), and lyophilized for storage at −80 °C. 
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The concentrations of α-syn solutions were determined by measuring the UV absorbance at 280 
nm using an extinction coefficient of 5200 M-1cm-1.33 
 
3.2.4.  Incubation of α-Synuclein with Gold Nanoparticles   
Prior to each experiment, an aliquot of α-syn was reconstituted in HEPES buffer at a 1 
mg/mL (70 μM) concentration. For dynamic light scattering (DLS) and UV−vis measurements, 
purified Au NPs (for 20 nm, 1.2 nM in particle concentration for DLS and 0.63 nM for UV−vis; 
for 90 nm, 10.5 pM for both DLS and UV-vis) were added and incubated with varying 
concentrations of α-syn (0−7 μM) at 4 °C for at least 12 h to ensure equilibrium. For 
fluorescence quenching measurements, varying concentrations of Au NPs (for 20 nm Au NPs, 
from 0 to 0.16 nM; for 90 nm Au NPs, from 0 to 5 pM) were incubated with α-syn (7 μM). All 
measurements were made at 25 °C before returning the samples to 4 °C for storage. The hard-
corona boundα-syn on Au NPs was purified from excess free α-syn and soft corona-bound α-syn 
by centrifugation at least three times and dispersed in HEPES buffer. 
 
3.2.5.  Amino Acid Analysis 
α-Syn-coated Au NPs were purified a minimum of three times via centrifugation. An 
aliquot of a protein−nanoparticle complex of known concentration was digested with either 1 M 
KCN or aqua regia. The sample was then dried down and resuspended in constant-boiling HCl (6 
N) in a sealed ampule at 110°C for 12−24 h. The sample was again dried down in a speed 
vacuum prior to derivatization, and amino acids were quantified by gas chromatography−mass 
spectrometry (GC-MS). Because the amino acid sequence of α-syn is known, the α-syn per Au 
NP can be deduced. 
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3.2.6.  Trypsin Digestion of α-Synuclein on Au NPs 
α-Syn-coated Au NPs were purified a minimum of three times via centrifugation. Fixed 
volumes of trypsin solution were added to known number of α-syn coated Au NPs such that the 
ratio of trypsin/α-syn ranged from 1:5 to1:160. The samples were microwave digested for 15 min 
at 55 °C (70 W), following which separation was achieved using Amicon filters(MWCO = 30 
000 Da) with centrifugation at 14,000 rcf for 5 min. The supernatant was collected, dried down, 
and analyzed using nanoliquid chromatography mass spectrometry/mass spectrometry(LC 
MS/MS). The Au pellet was further purified twice before the digestion of the Au NPs with 1 M 
KCN, lyophilized to dryness, and analyzed. The mass spectrometry data was processed using 
Waters Protein Lyns Global Server 2.2.5, Mascot (Matrix Sciences) and blasted against the 
NCBI-NR protein database for wild-type human α-syn (gi|4507109). 
 
3.2.7.  Instrumentation 
A microcentrifuge (Eppendorf model 5418, Fisher-Thermo Electron) was used in various 
steps of synthesis and purification as detailed above. Standard absorption spectra were taken on a 
Cary 500 Scan UV−vis−NIR spectrophotometer at a scan rate of 30 nm/s. More accurate scans 
were performed at a 1 nm/s scan rate from wavelengths 450 to 550 nm for 20 nm Au NPs and 
from 530 to 595 nm for 90 nm Au NPs. Zeta potential and dynamic light scattering 
measurements were performed on a Brookhaven Zeta PALS instrument. Fluorescence quenching 
data were obtained on a Jobin Yvon FluoroMax-3 fluorometer. The excitation wavelength was 
set at 270 nm, and the emission was scanned from 275 to 400 nm at a scan rate of 1 nm/s and an 
integration time of 0.1 s. All spectra were corrected with HEPES buffer as the baseline. Areas 
under the emission peak were used to quantify the fluorescence. All measurements were made in 
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triplicate. Amino acid analysis was performed on an Agilent 6890 gas chromatograph (with an 
Agilent 7683B autosampler) coupled to an Agilent 5973 mass-selective detector. The column 
used was a 30 m DB5 column, and the helium gas was set at a constant flow rate of 3 mL/min. 
The mass spectrometer was operated in positive electron impact mode (EI) at a 69.9 eV 
ionization energy in the m/z 50−800 scan range. The spectra of all chromatogram peaks were 
evaluated using AMDIS (NIST, Gaithersburg, MD, USA).Protein digestion was performed on a 
CEM Discover microwave digestor (Mathews, NC). The mass spectrometer used for peptide 
analysis was a Waters quadrupole time-of-flight mass spectrometer (QToF) connected to a 
Waters Nano Acquity UPLC. A Waters AtlantisC-18 (0.03 mm particle, 0.075 mm × 150 mm) 
column was used, with the flow rate set to 250 nL/min. Peptides were eluted using a linear 
gradient of water/acetonitrile containing 0.1% formic acid 0−60% B in 60 min. The mass 
spectrometer was set for data-dependent acquisition; ms/ms was performed on the most abundant 
four peaks at any given time. 
 
3.3.  Results and Discussion 
3.3.1.  General Binding of α-Syn to Au NPs 
The hydrodynamic diameter of α-syn is 5.3 ± 1.0 nm,34 and the two sizes of Au NPs used 
as its substrates were 20 nm (with a surface coating of citrate ions) and 90 nm Au NPs (made in 
the presence of sodium citrate and hydroquinone). One method to monitor protein adsorption 
was dynamic light scattering (DLS). The incubation of citrate-capped 20 nm Au NPs (original 
DLS diameter 31.2 ± 0.4 nm) with excess α-syn showed a Gaussian distribution of 
hydrodynamic sizes with a huge increase in mean diameter to 52.4 ± 1.6 nm before 
centrifugation (Figure 3.1a). The distribution shifted to a smaller mean of 46.4 ± 0.5nm after 
centrifugation, which led to a decrease in diameter of about 6.0 nm. The incubation of 90 nm Au 
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Figure 3.1.  Dynamic light scattering (DLS) plots of α-syn-coated Au NPs with initial diameters 
of 20 and 90 nm under transmission electron microscopy. The hydrodynamic diameter as 
measured by DLS of the 20 nm Au NPs was 31.2 ± 0.4 nm, and that for 90 nm Au NPs was 90.8 
± 0.3 nm. All distributions were fitted with Gaussian curves. (a) DLS plots of α-syn-coated 20 
nm Au NPs before (black) and after (red) centrifugation. (b) DLS plots of α-syn-coated 90 nm 
Au NPs before (black) and after (red) centrifugation. (c) DLS plots of α-syn-coated Au NPs 
(black) after a series of dilutions with HEPES buffer (red, green, and blue) at 1.5-, 2.0-, and 2.5-
fold dilution, respectively. The mean size decreased as more HEPES buffer was added. 
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NPs (original DLS diameter 90.8 ± 0.3 nm) with excess α-syn demonstrated a similar increase in 
hydrodynamic diameter to 105.9 ± 1.0 nm before centrifugation (Figure 3.1b). With 
centrifugation, a decrease of 5 nm to 100.9 ± 0.6 nm was observed. This suggests that α-syn on 
Au NPs adsorbs in multiple layers: a strongly bound inner (hard) layer (15 nm thick on 20 nm 
Au NPs and 10 nm thick on 90 nm Au NPs) and a relatively weakly adsorbed outer (soft) layer 
(6 nm thick on 20 nm Au NPs and 5 nm thick on 90 nm Au NPs). The outer “soft” α-syn corona 
is weakly bound and labile and strongly depends on the concentration of free α-syn: when 20 nm 
Au NPs incubated with excess α-syn were slowly diluted with HEPES buffer, these α-syn-coated 
Au NPs, having a mean diameter of 56.1 ± 1.0 nm before dilution, were reduced to a minimum 
of 48.1 ± 0.7 nm after three dilution steps at 0.5× dilution each step (Figure 3.1c). By titrating α-
syn into Au NP solutions and monitoring the adsorption of α-syn to 20 and 90 nm Au NPs using 
DLS and, independently, UV−vis spectroscopy to monitor plasmon bandshifts of the Au NPs, we 
can determine the overall binding constant of α-syn to Au NPs as well as estimate the total 
number of α-syn bound per Au NP. 
Increasing amounts of α-syn increased the initial hydrodynamic diameter of the 20 nm 
Au NPs from 31.2 ± 0.4 nm to a maximum of 55.5 ± 0.3 nm (Figure 3.2a). Further addition of α-
syn did not significantly increase the overall particle size, signifying the total saturation of the 
Au NP surface by α-syn. No breaks in the data were observed as a function of protein 
concentration, suggesting that the formation of the hard and soft coronas of α-syn onto Au NPs is 
not a simple two-step process. The point of saturation obtained from the plateau of the DLS plot 
was about 460 α-syn adsorbed per Au NP total in both the hard and soft coronas. An overall 
binding constant was estimated from the DLS data by fitting it to a Langmuir adsorption 
isotherm model 
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Figure 3.2.  Titration of α-syn into Au NP solutions. (a) Hydrodynamic diameter changes of 20 
nm Au NPs with an increasing α-syn/Au NP ratio. α-Syn (0−7 μM) was added to 1.2 nM of a 20 
nm Au NP solution. (b) UV−vis spectral changes with increasing amounts of α-syn (0−7 μM) 
added to a 0.63 nM 20 nm Au NP solution. (Inset) Change in absorption peak maxima with 
increasing α-syn/NP ratio. (c) Hydrodynamic diameter changes of 90 nm Au NPs with an 
increasing α-syn/Au NP ratio. α-Syn (0−7 μM) was added to 10.5 pmoles of 90 nm Au NP 
solution. (d) UV−vis spectral changes with increasing α-syn (0−7 μM) added to a 10.5 pM 90 nm 
Au NP solution. (Inset) Change in absorption peak maxima with increasing α-syn/NP ratio. The 
error bars in the DLS data represent one standard deviation from the mean of at least three 
independent experiments.  
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where ΔD and ΔDmax are the change and maximum change in NP diameter, Ka is the association 
constant, and [α-syn] is the concentration of α-syn for each DLS measurement point. If we 
assume that the increase in hydrodynamic diameter is attributed only to the adsorption of α-syn 
alone, an overall binding constant of (2.0 ± 0.4) × 107 M-1 was obtained. Here, because the 
Langmuir model assumes a homogeneous single layer α-syn adsorption onto Au NPs, no 
distinction between the hard and soft coronas is made.  
The plasmon band maxima in the UV-vis spectra of 20 nm Au NPs shifted gradually 
from 522 nm to a maximum of 527 nm with the gradual addition of α-syn (Figure 3.2b). The 
shift in the peak maximum of the plasmon band of Au NPs is due to the local refractive index 
change by the adsorption of α-syn.35 Assuming that the shift was due to only the α-syn-induced 
refractive index change and each α-syn binds to only one type of surface site on Au NPs, this 
shift was fitted into a Langmuir isotherm 
 ∆஛∆஛ౣ౗౮ ൌ
୏౗ሾ஑ିୱ୷୬ሿ
ଵା୏౗ሾ஑ିୱ୷୬ሿ  (2) 
where shifts in the plasmon peak position are used instead of the DLS data from eq 1. From this 
spectroscopic data, a Ka of (1.2 ± 0.3) × 107 M-1 was obtained. When the plasmon band maxima 
were plotted with respect to α-syn/Au NP ratio, a saturation ratio of 380 α-syn/Au NP was 
obtained, similar to that obtained using DLS.  
A similar trend was observed on 90 nm Au NPs (Figure 3.2c,d). The titration of α-syn to 
10.5 pM 90 nm Au NPs increases the hydrodynamic diameter from 90.8 ± 0.3 nm in the absence 
of α-syn to a maximum of about 110.4 ± 1.0 nm. The binding constant was estimated to be (1.8 ± 
0.2) × 108 M-1, with 40 000 α-syn/NP at saturation. In UV−vis spectroscopy, a gradual plasmon 
band shift from an initial 561.3 nm to a final 564.5 nm was observed, which correlated to a 
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binding constant of (2.0 ± 0.2) × 108 M-1. A saturation point of 60 000 α-syn/Au NP was 
obtained from the peak maxima change. Previous work has shown that α-syn can bind to silica 
and polymeric NPs; however, most examples use antibodies to capture and sequester α-syn.36,37 
α-Syn has also been mutated with a cysteine residue to exploit the strong gold-sulfur bond for its 
covalent attachment to Au NPs.23 Our results showed that the adsorption of WT α-syn to citrate-
capped 20 nm Au NPs and citrate-/hydroquinone-coated 90 nm Au NPs occurred in a 
multilayered fashion: a strongly bound hard α-syn corona followed by a weaker bound soft 
corona. Two independent methods, UV−vis spectrometry and DLS measurements, yielded very 
similar overall binding constants for both 20 and 90 nm Au NPs, respectively (Table 3.1). 
Wavelength shifts from UV−vis spectra have been shown to be a reliable indicator of physical 
and chemical changes at the NP surface.35,38 Such shifts can be converted to binding constants 
with the use of the Langmuir isotherm and have been widely used to quantify protein binding on 
Au NPs: bovine serum albumin absorption affinity onto 15 nm Au NPs was determined to be 
between 1 × 106 and 5 × 107 M-1.39 Similarly, DLS measurements have also been used to 
quantify the extent of binding.40,41 It should be noted that the Langmuir model is the simplest 
possible model for obtaining binding constants for the adsorption of molecules to a surface and 
does not take into account multilayered adsorption. However, the more complex adsorption 
isotherms that we have examined introduce more fitting parameters and therefore more 
uncertainty in comparing the overall binding constants without any improvement in the degree of 
fit. On the basis of previous work for DNA-quantum dot adsorption using various binding 
constant models, the Langmuir model should still provide a good estimate of the binding strength 
of α-syn on Au NPs within an order of magnitude of the “true” value.42 
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Table 3.1.  Binding of α-Syn onto Au NPs or Lipid Vesiclesa 
 
Summary of Binding of α-Syn on Au NPs (20 mM HEPES) 
 
Au NP 
Total Corona Hard Corona Soft Corona 
binding constant 
(M-1) 
α-syn/Au 
NP 
binding constant 
(M-1)  
binding constant 
(M-1) 
20 nm 
UV-vis Fluorescence AAA  
(1.2 ± 0.3) x 107 380 (2.9 ± 1.1) x 109 360 ± 70 
(7.9 ± 5.0) x 10-3 DLS Fluorescence (Hill) 
(2.0 ± 0.4) x 107 460 (2.3 ± 1.4) x 109 n = 0.79 ± 0.04 
90 nm 
UV-vis Fluorescence AAA  
(2.0 ± 0.2) x 108 60 000 (9.5 ± 0.8) x 1010 5300 ± 700 
(2.1 ± 0.4) x 10-3 DLS Fluorescence (Hill). 
(1.8 ± 0.2) x 108 40 000 (3.5 ± 0.5) x 1010 n = 0.52 ± 0.1 
 
 
 
Summary of Binding of α-Syn on Lipid Vesicles 
 
lipid vesicle size (nm) lipid type binding constant (M-1) 
30–50b DPPC 2.6 x 107 
 POPC/POPG (1:1) 3.5 x 107 
46c POPC/POPS (1:1) 1.8 x 105 
93c POPC/POPS (1:1) 1.0 x 104 
162c POPC/POPS (1:1) 7.4 x 103 
 
a1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG), and 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (POPS). bReference 48. cReference 49. 
  
82 
 
The multilayered binding of α-syn to Au NPs is in contrast to other protein binding 
reported in the literature. Although multilayered adsorption is observed when a plethora of 
proteins is present (such as in cell culture media),19 most work on single protein adsorption on 
nanoparticles demonstrated only the presence of a monolayer. For example, human serum 
albumin (HSA) was shown to exist as a monolayer on FePt nanoparticles.43 However, it should 
be pointed out that unlike HSA, which has a well-defined secondary and tertiary structure, native 
α-syn is unstructured and is known to aggregate. Small changes in α-syn structure, a result of 
electrostatic interactions between the Au NP and α-syn in the hard corona, can potentially 
influence its protein-protein interaction, thus forming a soft corona. 
 
3.3.2.  Quantification of the Hard α-Syn Corona on Au NPs 
The DLS results suggested that two types of α-syn adsorption exist: a hard corona that 
binds directly and tightly to the nanoparticle surface and a soft corona that is loosely bound and 
is likely in rapid equilibrium with free protein. This implies that there should be two average 
equilibrium binding constants for each corresponding hard and soft layer. The hard α-syn corona 
on Au NPs can be separated from the soft corona via centrifugation, and the hard corona remains 
tightly bound on the Au NP surface even after multiple centrifugation cycles. This fact can be 
exploited and used to purify Au NPs coated with a hard corona of α-syn. This α-syn in the hard 
corona was collected after selective Au dissolution and quantified more precisely using mass 
spectrometry, affording a value of 360 ±70 α-syn per 20 nm Au NP and 5300 ± 700 α-syn per 90 
nm Au NP in the hard corona, within the combined total of α-syn estimated from DLS and 
UV−vis spectroscopy.  
In comparison to the DLS data, the difference in the α-syn corona for 20 and 90 nm Au 
NPs is further highlighted (Table 3.1). The hard corona on 20 nm Au NPs is thicker (15 nm) than 
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that on the 90 nm Au NPs (10 nm). Simple calculations, assuming α-syn as spheres with a 5.3 
nm diameter, suggest an estimate of about 60 and 1200 α-syn molecules for a monolayer of 
coverage on 20 and 90 nm Au NPs, respectively. The 6- and 4.4-fold excesses of α-syn in the 
hard corona on 20 and 90 nm Au NPs, respectively, possibly imply either multilayered 
adsorption of α-syn in the hard corona or a significant rearrangement of α-syn 
structure/orientation such that tighter packing is ensured. This result is similar to that of β2-
microglobulin, a fibrillation-prone protein, on polymeric nanoparticles that shows that 
multilayers of protein can form on nanoparticle surfaces.44  
DLS measurements suggest that the soft corona is similar in thickness (5 to 6 nm) for 20 
and 90 nm Au NPs. Interestingly, a comparison of total and hard coronas suggests that about 
30−100 α-syn are in the soft corona for 20 nm Au NPs and about 35 000−55 000 α-syn for 90 
nm Au NPs, translating to about 14 and 85% of the total α-syn in the soft corona, respectively. 
An approximate of 90 and 1280 α-syn was estimated for the soft corona on 20 and 90 nm Au 
NPs for a thickness of 5 to 6nm. This value is similar to that found in the soft corona for 20 nm 
Au NPs; however, for 90 nm Au NPs, a 35-fold excess of α-syn was found compared to the 
calculated value. The difference between found and expected α-syn in the soft corona of 20 and 
90 nm Au NPs suggests that the Au NP size can influence the dynamics of protein−protein 
interaction even when not directly absorbed onto the Au NP surface. Such effects are important 
and should be considered when studying the impact of Au NPs on protein expression in cells. 
 
3.3.3.  Fluorescence Quenching Study of the Hard α-Syn Corona on Au NPs 
To quantify the binding affinity of the hard corona for Au NPs, a two-step fluorescence 
quenching experiment was performed (Scheme 3.1). In the first step, varying concentrations of 
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Scheme 3.1.  Cartoon of Au NPs with Hard (Blue) and Soft (Pink) Coronas and the 
Techniques Used to Deduce α-Syn Binding Constants and Structure/Orientationa 
 
 
 
aNote that the horseshoe structure of α-syn shown here is not representative of its actual 
conformation on Au NPs. 
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Au NPs were titrated against 7 μM α-syn such that the final concentration of the Au NPs ranged 
from 0 to 0.16 nM for 20 nm Au NPs and 0 to 5 pM for 90 nm Au NPs. As expected, increasing 
concentrations of Au NPs resulted in decreasing protein fluorescence intensities (Figure 3.3a). 
Plotting F0/F, the ratio of initial protein fluorescence to protein fluorescence at a given NP 
concentration, against [Au NP] yielded a curved plot that can be attributed to the strong 
absorption of Au NPs at the excitation and emission wavelengths in addition to quenching due to 
protein−nanoparticle binding, greatly reducing the fluorescence of unbound α-syn even when α-
syn is present in very large excess. To account for this inner-filter effect by the Au NPs, the α-
syn-coated Au NPs used in this first titration were collected, purified, and used in the second 
titration set against the same amount of α-syn at 7 μM (second step). Because this titration set 
consist of Au NPs precoated with a hard corona of α-syn, the fluorescence quenching obtained 
was assumed to be due to a combination of the Au NPs’ light absorption, again, and the soft 
corona (Figure 3.3a). The difference between the first and second florescence plots is then due 
solely to the hard corona of α-syn on Au NPs. The calculation of the hard corona binding 
constant was achieved by using the second plot to derive a correction factor (θ) for each Au NP 
concentration 
 θ ൌ ୊୊బ  (3) 
where F is the protein fluorescence intensity at the respective Au NP concentration and F0 is the 
initial protein fluorescence intensity. The θ factor ranges from 0.76 to 1 and from 0.45 to 1 for 
the range of 20 and 90 nm Au NP concentrations used, respectively, reflecting the larger self-
absorption of fluorescence (and hence smaller θ value) by 90 nm Au NP due to its extremely 
large extinction coefficient. The influence of the soft corona and Au absorption can then be 
factored and removed from the first fluorescence plot by dividing the florescence intensities by 
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Figure 3.3.  (a) Fluorescence quenching of 7 μM α-syn by 20 nm Au NPs (black) and α-syn-
coated 20 nm Au NPs (red). (b) Fluorescence quenching plot of 20 nm Au NPs before (black) 
and after (red) correction (i.e., the removal of Au absorption and soft corona fluorescence 
quenching). (c) Fluorescence quenching of 7 μM α-syn by 90 nm Au NPs (black) and α-syn-
coated 90 nm Au NPs (red). (d) Fluorescence quenching plot of 90 nm Au NPs before (black) 
and after (red) correction. The fluorescence intensity was taken as the area under the curve of the 
protein’s emission spectrum from 275 to 400 nm upon excitation at 270 nm.  
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their respective θ such that a “corrected” plot of fluorescence quenching due to the formation of 
a hard corona remains (Figure 3.3b).45 This plot is in turn used to estimate the binding constant 
for the hard corona. Assuming static quenching, the fluorescence quenching plot of α-syn hard 
corona can be fitted into a static quenching equation 
 ୊బ୊ౙ ൌ 1 ൅ KୱሾAu	NPሿ  (4) 
where Fc is the corrected fluorescence intensity at the respective Au NP concentration. This 
yielded a straight line plot with Ks values of (2.9 ± 1.1) × 109 M−1 and (9.5 ± 0.8) × 1010 M−1 for 
20 and 90 nm Au NPs, respectively.  
Alternatively, the Hill equation is frequently used as a measure of the binding 
cooperativity of ligands onto the same macromolecule and is given as 
 ሺ୊బି୊cሻሺ୊బି୊ಮሻ ൌ
ሾ୅୳	୒୔ሿ౤
୏ీ౤ାሾ୅୳	୒୔ሿ౤   (5) 
where Fc is the corrected fluorescence intensity of the protein, F0 is the initial protein 
fluorescence intensity, F∞ is the fluorescence intensity at saturation, n is the Hill coefficient, and 
KD is the equilibrium constant. The association binding constant Ka is the reciprocal of KD. The 
Hill coefficient, n, can be regarded as an “interaction” coefficient that reflects the extent of 
cooperativity among binding sites, with n > 1 signifying positive cooperativity, n < 1 signifying 
negative cooperativity, and n = 1 signifying noncooperativity. Fitting the corrected fluorescence 
quenching data into a Hill plot revealed Ka = (2.3 ± 1.4) × 109 M−1 and n = 0.79 ± 0.04 for 20 nm 
Au NPs and Ka = (3.5 ± 0.5) × 1010 M−1 and n = 0.5 ± 0.1 for 90 nm Au NPs, signifying that α-
syn binds strongly to both 20 and 90 nm Au NPs and this binding affinity decreases as further 
proteins adsorb onto the surface.  
Interestingly, our results show that α-syn in the hard corona adsorbs more strongly onto 
Au NPs as the NP size increases. A similar trend was observed with the overall binding constant: 
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an increase from (1.2 − 2.3) × 107 M−1 for 20 nm Au NPs to (1.8− 2.0) × 108 M−1 for 90 nm Au 
NPs. These numbers are large compared to α-syn binding to small lipid vesicles, composed of 
either a combination of phosphocholine and phosphoglycerol or phosphocholine alone at 25 or 
37 °C, with Ka values of 2.6 ×107 and 3.5 × 107 M−1, respectively (ionic strength, I = 120 mM).46 
Giant unilamellar vesicles of diameter 93 and 162 nm have Ka values of 1 × 104 and 7.4 × 103 
M−1, respectively, for α-syn (I = 160 mM).47 In our experiments, the salt strength was maintained 
at 20 mM. Although it is known that the ionic strength can influence the binding affinity of α-syn 
to nanoscale objects,48 we believe that ionic strength changes cannot solely account for 
differences in Ka values of about 5 orders of magnitude for 90 nm particles. This highlights that 
other factors are involved in the enhanced absorption of α-syn to 90nm Au NPs.  
Quantification of the binding constant of the soft protein corona to NPs, is, however, 
nontrivial. Because of the highly dynamic nature of the soft corona, the soft corona cannot be 
explicitly separated from the unbound free α-syn. In addition, fluorescence inner-filter effects by 
Au NPs cannot be separated from the fluorescence quenching effect of the weakly bound α-syn 
in the soft corona. The nonlinear effect of fluorescence quenching by Au NPs also falls off 
exponentially with respect to distance (unless one is in the regime where surface-enhanced 
fluorescence can take place, approximately 10−20 nm away from the metal surface). All of these 
factors make the determination of the soft corona binding using UV−vis, DLS, and fluorescence 
measurements complicated. However, an estimate of the soft corona binding constants can be 
obtained from the comparison of the combined adsorption constants (Langmuir isotherm) and 
hard corona adsorption constants (static quenching model). Here, the combined adsorption 
constant is taken to be a product of the hard and soft adsorption constants (Koverall = Khard × Ksoft). 
This gives Ksoft values of (7.9 ± 5.0) × 10−3 M−1 for 20 nm Au NPs and (2.1 ±0.4) × 10−3 M−1 for 
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90 nm Au NPs (Table 3.1). These numbers suggest that the binding of the soft corona is 
thermodynamically unfavorable by ∼2 kJ/mol and therefore that soft corona binding is 
kinetically driven, highly dynamic, and in constant exchange with “free” α-syn in solution.49 
 
3.3.4.  Structure of Bound α-Syn in the Hard Corona 
Currently, numerous methods for studying the protein conformation on curved Au NP 
surfaces are available. Circular dichroism (CD) can be used to detect proteins on Au NPs, 
although the background from free protein can render the data difficult to interpret; therefore, the 
best use of CD seems to be if the free protein has no CD signal but the bound protein has a 
strong one.50 We performed double-cuvette experiments where two cuvettes are stacked together 
and the samples are added to either of the cuvettes (Figure 3.4a). This setup allows us to isolate 
the structural change in α-syn when it is adsorbed onto Au NPs as opposed to the light absorption 
of Au NPs. However, apparent CD changes in α-syn signals in the presence of Au NPs were 
found to be trivial (Figure 3.4b). The high absorbance of metallic NPs can be overcome with the 
use of more exact but less accessible techniques such as synchrotron radiation circular 
dichroism.51 More conventional spectroscopy experiments have provided some insight into the 
protein structure on colloidal nanoparticle surfaces; for example, infrared spectra of the amide I 
band have been used to probe the secondary structure of hemoglobin on Au NPs.52 NMR had 
been used to study the ubiquitin interaction on 12 nm Au NPs.53 More recently, MALDI-MS was 
used to study the orientation of proteins on silica NPs.22 Here, we introduce a footprinting 
method to study the protein orientation on NPs that involves the use of an enzymatic digestion 
step to probe solvent-accessible portions of the bound protein. While our studies were in 
progress, related work by Shrivastava et al. concurs that enzymatic digestion followed by a mass 
90 
 
 
 
Figure 3.4.  (a) Setup for the circular dichroism (CD) experiments. Two cuvettes (1 mm) are 
stacked together, and the samples are placed in cuvette A or B. (b) CD spectra of α-syn alone 
(black, 10 μM), α-syn and Au NPs (20 nm, 5.6 nM) in separate cuvettes (red), and α-syn 
absorbed onto Au NPs (blue). MES buffer (10 mM, pH 6.5) was used, and the average of 10 
scans was taken (1 nm bandwidth, 12 nm/min). On the basis of the 1:360 Au NP/α-syn binding 
ratio, 20% of α-syn would be bound.  
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spectrometry analysis of nanoparticle-bound protein can give insight into protein orientation on 
nanoparticle surfaces.22 Here we show that this method is especially useful for strongly colored 
NPs such as Au NPs. 
To deduce the structure of α-syn on Au NPs, we performed in situ protein digestion of α-
syn on Au NPs. For the case of α-syn, although the lipid-bound α-helical horseshoe structure of 
α-syn was deduced using NMR, its native and β-sheet structures are relatively unknown.54 We 
hypothesized that proteases would attack a protein differently when on Au NP surfaces as 
compared to its unbound free form in solution. This difference in digestion can then be utilized 
to study the structure of the protein on Au NPs as a footprinting assay and thus deduce its 
orientation. In our study, we used trypsin to cleave α-syn at its lysine positions (there are no 
arginine residues, another site of trypsin attack, in α-syn; Figure 3.5a). A total of 15 lysines are 
on α-syn at positions 6, 10, 12, 21, 23, 32, 34, 43, 45, 58, 60, 80, 96, 97, and 101. The peptide 
fragments that were liberated in solution were collected separately from those bound to the Au 
NPs, and both samples were quantified using LCMS. When compared against the free α-syn 
digestion with trypsin, these differences would then yield (1) the section of α-syn that was bound 
to the Au NP surface, (2) lysine positions that were not cleaved in the same time frame, 
signifying a more “protected” region, and (3) the ratio of peptide fragments that reveal the extent 
of protection. By varying the trypsin/α-syn ratio, a clearer picture of the extent of protection can 
be obtained, which can be reconstructed to deduce the structure and orientation of α-syn on Au 
NPs in the hard corona. However, because of the random nature of protease digestion, multiple 
experiments must be done to ensure reproducibility (Figure 3.6). Nevertheless, in all cases, 
although the absolute number of peptides detected varied, the ratio and peptide sequences were 
very similar under each experimental condition. Figure 3.7a shows the digestion patterns of free  
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Figure 3.5.  α-Synuclein amino acid sequence and the preferred digestion sites of trypsin on (a) 
free α-synuclein, (b) α-synuclein adsorbed on 20 nm Au NPs, and (c) α-synuclein adsorbed on 90 
nm Au NPs. The trypsin/α-synuclein ratio shown here is 1:160. Lysine positions are highlighted 
in red, and sites susceptible to trypsin digestion are shown by the arrows. The frequency of 
trypsin attack is shown as a color scale, with black being the easiest for trypsin to attack and light 
gray being the least digested. 
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Figure 3.6.  Replicates of trypsin digestion of α-syn bound on 20 nm Au NPs at trypsin:α-syn 
ratios of (a) 1:160, (b) 1:100 and (c) 1:5. This demonstrates the reproducibility of trypsin 
digestion of α-syn on Au NPs. 
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Figure 3.7.  (a) Digestion pattern of free α-syn with trypsin at various trypsin/α-syn ratios. 
Digestion pattern of α-syn adsorbed on 20 nm Au NPs at trypsin/α-syn ratios of (b) 1:160, (c) 
1:100, and (d) 1:5. The peptide fragments in the supernatant are separated from those on the Au 
NP surface and are shown separately. The horizontal axis denotes the amino acids in α-syn from 
the N to C terminus. The vertical axis denotes the different types of peptide fragments obtained, 
which is further separated into those in the supernatant and on the Au NP surface. The color 
scale (normalized) denotes the number of peptides found. The scale on the z axis is the same for 
all plots. 
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α-syn at trypsin/α-syn ratios of 1:160, 1:100, and 1:5. The number of peptides was normalized 
with respect to the highest peptide count for ease of comparison. The peptide fragments are 
arranged according to their amino acid positions. These results show that increasing the ratio of 
trypsin/α-syn did not change the digestion pattern of free α-syn significantly, suggesting that 
under our experimental conditions the digestion of free α-syn was almost always complete. 
Peptide fragments from all cleavable lysine positions were detected. Peptide fragments after 
amino acid position 97 were most often not detected by mass spectrometry. Interestingly, under 
the same digestion conditions, the digestion of α-syn adsorbed on 20 nm Au NPs depends 
strongly on the trypsin/α-syn ratios. Decreasing the trypsin/α-syn ratio increased the number of 
peptides detected (Figure 3.7). These peptide fragments were also longer, an indication that some 
lysine positions were not as accessible and hence not cleaved. With a trypsin/α-syn ratio of 1:160 
(low trypsin ratio), most lysine positions at 21, 23, 32,34, 79, 96, and 97 were already cleaved, 
implying that these positions were most possibly freely accessible to trypsin. Increasing the 
amount of trypsin (trypsin/α-syn 1:100) resulted in additional lysine positions at 43, 45, 58, and 
60 being cleaved, as observed by the shorter and fewer peptide fragments on the Au NP surface, 
an indication of an increased rate of digestion with increasing amounts of trypsin. Further 
increases in the amount of trypsin (trypsin/α-syn 1:5) resulted in fewer and shorter peptide 
fragments on the Au NP surface. A comparison of the peptide fragments (in all three cases) 
detected in the supernatant and on Au NPs consistently showed the N-terminus (from amino acid 
1 to 12) on the Au NP surface while being absent in the supernatant. Peptide fragments from 
amino acids 12 to 60 were also associated with the Au NP surface, whereas peptide fragments 
from amino acid positions larger than 60 were more often located in the supernatant. 
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Interestingly, changing the trypsin/α-syn ratio did little to vary the digestion pattern of α-
syn on 90 nm Au NPs. A very similar pattern was observed for all three trypsin/α-syn ratios 
where short peptide fragments ranging from amino acids 11 to58 were found in the supernatant 
(Figure 3.8). Peptide fragments at amino acid positions larger than 60 were not detected in the 
supernatant. Similar to 20 nm Au NPs, the N-terminus was consistently found only on the 90 nm 
Au NP surface and was absent in the supernatant. However, unlike α-syn on 20 nm Au NPs, only 
peptide fragments with an amino acid position not exceeding 21 were found on the 90 nm Au NP 
surface.  
A comparison of digestion patterns of free α-syn with bound α-syn on 20 nm citrate-
capped Au NPs reveals the following: (1) The first 12 amino acids of the N-terminus bind 
consistently to the Au NP surface, as denoted by the high proportion of the N-terminus peptides 
on the Au NP surface (and lack thereof in the supernatant). (2) Some regions of α-syn are more 
accessible to trypsin than others, as shown by the longer peptide fragments on the Au NP surface 
with decreasing trypsin/α-syn ratios. Varying the trypsin/α-syn ratio altered the fragmentation 
pattern, indicating that certain parts of α-syn are more protected than others. When the 
accessibility of trypsin to the lysine sites was plotted, a radical shift in the frequency of digestion 
sites was seen (Figure 3.5). On free α-syn, the most digested lysine site is at position 80 whereas 
on 20 nm Au NP, positions 10, 21, and 23 are more heavily digested. (3) Peptide fragments on 
the Au NP surface, although less digested, follow a similar pattern to that of free α-syn, 
signifying that the native unstructured morphology is maintained when absorbed onto Au NPs. In 
fact, it had been shown that for α-syn fibrils the amino acid sequence from 32 to 102 is protected 
from trypsin digestion.55 It should be pointed out that because of the lack of lysines in the C-
terminus, the fragment from amino acids 101 to 140 remains as a single peptide fragment and  
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Figure 3.8.  Digestion pattern of α-syn adsorbed on 90 nm Au NPs at trypsin/α-syn ratios of (a) 
1:160, (b) 1:100, and (c) 1:5. The peptide fragments in the supernatant are separated from those 
on the Au NP surface and are shown separately. Color scale (normalized) is the same for all 
plots. 
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was sometimes seen on the Au NP surface. However, because of limitations to the upper mass 
range on the mass spectrometer, such information remains inconclusive. In fact, when free α-syn 
was digested, the C-terminus fragment was not detected in all three ratios.  
On the 90 nm Au NPs, similar to 20 nm Au NPs, the N-terminus was bound consistently 
to the Au NP surface. However, a more extensive digestion pattern was observed on 90 nm Au 
NPs, with few changes when the trypsin/α-syn ratio was changed. This high rate of digestion, 
coupled with the lack of changes, signifies that α-syn on 90 nm Au NPs was more susceptible to 
trypsin and thus more loosely packed and hence more exposed than on 20 nm Au NPs. This is 
reiterated by α-syn surface density analysis, where the surface density of 0.28 α-syn/nm2 was 
obtained for 20 nm Au NPs and 0.21 α-syn/nm2 on 90 nm Au NPs. These results are in line with 
DLS measurements that show that the hard corona on 90 nm Au NP is not as thick as on 20 nm 
Au NP (10 nm versus 15 nm) and hence is more amenable to trypsin digestion, which further 
signifies that some differences exist in the α-syn structure and orientation between 20 and 90 nm 
Au NPs. 
On the basis of the amino acid sequence and structure of native α-syn, negatively 
charged, citrate-capped Au NPs would have a strong affinity for the N-terminus, in accordance 
with our digestion data and overall binding constants. The absence of N-terminus peptide 
fragments in the supernatant reflects the strong binding constants of α-syn bound to Au NPs, 
consistent with our data that suggests that the hard corona binds much more strongly to the gold 
surface than does the soft corona. However, the binding of α-syn to Au NPs is significantly 
different from that of lipid vesicles (Table 3.1). Au NP surfaces with citrate ion ligands present a 
relatively hard platform compared to lipid vesicles, which favor the formation of the α-helix at 
the N-terminus because the hydrophobic face of the α-helix can penetrate the lipid bilayer. (The 
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α-helical structure of α-syn is amphoteric; the hydrophilic and hydrophobic halves are separated 
by lysine residues.56) This also further suggests that it is the combination of electrostatic 
attraction and lipid ordering that is necessary for the formation of the α-helical structure of α-syn 
on lipid vesicles. The fibrillar structure (β-sheet) form of α-syn is also highly unlikely because of 
the lack of differences in the digestion pattern from free and bound protein (lysine positions 58 
and 60 are always placed in a loop region, as opposed to lysine positions 43, 45, 80 and 96, 
which would lie in the plane of the β-sheet).57,58 
Overall, the current data suggest that α-syn maintains its native unstructured 
conformation when bound on Au NPs, with the N-terminus strongly adsorbed onto the Au NP 
surface. In its natively unstructured globular state, long-range intramolecular contacts are 
believed to exist, which makes α-syn more compact that a random coil.59 The NAC region 
(amino acids 85−95) is shielded by the C-terminus (amino acids 110−130), and C-terminus 
residues 120−130 interact with residues 105−115 as well as the region about amino acid 20 on 
the N-terminus.60 These interactions, hydrophobic between the C-terminus and NAC region as 
well as electrostatic with the N-terminus, protect α-syn from aggregation. The digestion of α-syn 
on Au NPs reflects a similar orientation: the binding of α-syn via the N-terminus also means that 
the C-terminus is projected outward from the Au NP. The C-terminus is thus the first to be 
cleaved and released into the supernatant. The NAC region (amino acids 61−95), shielded by the 
C-terminus and lying just above the N-terminus, was seen to be attached to the Au NP surface 
only through uncleaved lysine position 60. However, once cleaved, it is removed from the Au 
NP surface and into the supernatant. 
The interaction of proteins with protein-sized nanoparticlesis of fundamental importance 
as the number of potential uses of nanoparticles for in vivo applications increases. It is expected 
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that Au NPs in aqueous solution can physisorb biomolecules from a rich biological medium.18 
We show here that a similar process also occurs when Au NPs are incubated with only one type 
of protein, α-syn. It can thus be inferred that this multilayered adsorption is not a result of 
localized protein adsorption but is due to the nature of the protein (i.e., charge separation and 
structure). The separation of charges at the N-terminus (slight positive) and C-terminus 
(negative) and the propensity of α-syn to acquire secondary α or β structures from its natively 
unfolded form could contribute to the multilayered adsorption. The physisorption of wild-type 
(WT) α-syn to Au NPs is thus a good starting point as a model system for understanding α-syn 
(or other protein) affinities and interaction with protein-sized substrates such as NPs. The 
potential for nanoparticle-enabled therapy is also high, should protein adsorption to nanoparticles 
decrease the α-syn’s propensity to misfold and accumulate as potentially toxic protofibrillar or 
fibrillar species. 
The data suggest that the physicochemical nature of a nanoscale surface (lipid vesicles, 
small or larger gold nanoparticles) can tune the particle−protein binding constants and adsorbed 
structure and orientation of α-syn. How nanoparticle-bound protein responds to an event that 
would initiate aggregation, compared to free protein, is a fascinating question that is under active 
investigation in our laboratory. 
 
3.4.  Conclusion 
We have shown that α-syn binding to 20 and 90 nm Au NPs occurs via at least a two-step 
absorption: a hard α-syn corona with a strong binding constant (Ka = (2.9 ± 1.1) × 109 M−1 for 20 
nm Au NPs, Ka = (9.5 ± 0.8) × 1010 M−1 for 90 nm Au NPs) followed by a softer, 
thermodynamically unfavorable and kinetically driven corona, which is in constant exchange 
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with free α-syn in solution. Quantitative analysis of α-syn in the hard corona puts 360 ± 70 α-syn 
on 20 nm Au NPs and 5300 ± 700 α-syn on 90 nm Au NPs. The orientation of α-syn was also 
deduced using a protease digestion method in which α-syn was determined to adsorb onto Au 
NPs via the N-terminus, possibly in its native conformation. A slightly different α-syn 
conformation was adopted on 90 nm Au NPs as compared to 20 nm Au NPs, which might be 
significant in future applications of nanoparticle-enabled therapy considering α-syn’s high 
propensity to misfold. 
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CHAPTER 4 
Adsorption, Conformation and Orientation of α-Synuclein 
on Cationic Gold Nanoparticles 
 
 
4.1.  Introduction 
α-Synuclein (α-syn) belongs to the synuclein family which also consists of β- and γ-syn.1 
α-Syn is a small presynaptic protein that is found in relatively high abundance in the brain.2 
While its function is still not fully understood, it is believed to play a regulatory role in 
modulating synaptic plasticity,3 controlling presynaptic vesicle pool size,4 releasing of 
neurotransmitter and recycling of vesicles.5 α-Syn is a natively unstructured protein but can also 
form aggregates of β-sheet fibrils called amyloids. These protein aggregates form the main 
component of Lewy bodies, a class of intracellular inclusions that is highly characteristic of 
Parkinson’s disease.6 Recent studies have also demonstrated α-syn involvement in Alzheimer’s 
disease, dementia with Lewy bodies and multiple system atrophy.7 This closely interwined 
relationship between neurodegenerative diseases and α-syn implies that the disruption of protein 
homeostasis through its misfolding can be the cause of neuronal death.6 There is thus much 
motivation to study the function, folding kinetics and aggregation pathways of α-syn. More 
specifically, the ability to control the conformation of α-syn would allow relationships between 
structure and function to be deduced. 
 The 140-amino-acid-long α-syn can be broadly divided into three regions: an 
amphiphilic N-terminus region (residues 1–60) with four imperfect 11-residue amino acid 
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repeats, each containing a conserved sequence (KTKEGV); a hydrophobic and highly 
amyloidogenic central domain (residues 61–95), also known as the non-amyloid component 
(NAC) region, which contain an additional three KTKEGV motifs; and an acidic C-terminus 
(residues 96–140) which is rich in proline residues and has no structural propensity.8 α-Syn has a 
natively unstructured conformation in aqueous buffer, but can fold into various conformations 
depending on the environment and conditions.7 The N-terminus 11-mer repeat units can fold into 
an apoplipoprotein-like class-A2 helix that mediates its binding to phospholipid vesicles, which 
increases α-syn’s α-helical content from ~3% to over 70%.9,10 The curvature of vesicles can 
influence the resultant α-helix that forms: a horseshoe α-helix is maintained on 20–25 nm 
vesicles while on ~100 nm vesicles an extended α-helix is formed.11 In contrast, the hydrophobic 
NAC region is essential for α-syn aggregation and β-sheet fibril formation. Studies have shown 
that free NAC peptide can seed amyloid formation, which forms the basis of Lewy bodies.12 In 
fact, comparison with β-syn shows that the lack of the middle section of the NAC region 
(residues 73–83) of α-syn results in a lower propensity to form fibrils, and the removal of 
residues 71–82 abolish fibril assembly in α-syn.13  
Protein adsorption onto nanoparticles (NPs) can alter the proteins’ conformation and 
influence its binding orientation. For example, fluorescence and FTIR results indicate that β-
lactoglobulin’s tertiary structure changes over time when adsorbed on 90 nm silica NPs, while 
the secondary structure remained unchanged.14 In addition, the NP size and the protein’s size and 
stability also influence the proteins’ resultant conformational change when adsorbed onto silica 
NPs.15–17 Circular dichroism studies have shown that proteins in the soft corona (non-covalent, 
reversible interactions) of silica NPs are also conformational altered, which in turn alters their 
enzymatic activity.18 The orientation of adsorbed proteins onto NPs can be deduced from 
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protease digestion, and this method has been used to analyze the orientation of cytochrome c, 
RNase A, lysozyme and human carbonic anhydrase on 4–15 nm silica NPs.19,20  
Gold nanoparticles (Au NPs) have interesting physical and electronic properties, which 
allows for exciting potential therapeutics and biomedical applications such as drug delivery 
agents and gene transfection agents.21–24 However, to truly understand and take the potential uses 
of Au NPs to the next level, fundamental questions about their interactions with biological 
entities needs to be first answered. It has previously been shown that when silica NPs are 
introduced into biological medium, proteins bind non-specifically onto the silica NP surface, 
resulting in the formation of a protein corona.25 This can afford further complications as proteins 
trapped maybe less available to cells and can adversely affect cellular pathways. The influence of 
the protein corona does not just end with its adsorption: protein-protein interaction is also 
increased due to the high density of proteins on the NPs, forming a soft corona around the NP. 
The formation of this protein corona (hard and soft) also alters the surface properties of the NPs26 
and it is this layer that interacts with cells.27,28 
The surface charge and chemistry of NPs can influence protein behavior. The diversity of 
protein size, structure and charge anisotropy profoundly influence their interaction with charged 
Au NPs.29–31 For example, bovine serum albumin (BSA, 66.5 kDa) is a negatively charged 
protein at pH 7 with an isoelectric point of 4.7.32 BSA can adsorb onto both anionic and cationic 
Au NPs;26 however the adsorption of BSA onto citrate Au NPs (anionic) at room temperature is 
enthalpy driven, while the adsorption of BSA onto cetyltrimethylammonium bromide Au NPs 
(cationic) is entropically favored.33 Upon adsorption to Au NPs, the secondary structure of BSA 
changes more significantly when positively charged Au NPs are used.33–35 In contrast, 
cytochrome C (CytC, ~12 kDa) is a positively charged protein at pH 7 with an isoelectric point 
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of ~10.36 The adsorption of CytC onto anionic Au NPs is an entropy controlled process, and 
involved CytC reorientation on Au NP surface at high concentrations.36 The binding orientation 
of CtyC depends on the surface charge (anionic vs. cationic) as well as the degree of 
hydrophilicity (anionic) and hydrophobicity.37,38 
We have previously studied the interaction of α-syn with 20 and 90 nm anionic citrate-
capped Au NPs.39 Our results showed that on negatively charged Au NPs, α-syn preferentially 
adsorbs via its N-terminus while retaining its natively unstructured conformation. In this chapter, 
we varied the surface charge of Au NPs using poly(allylamine hydrochloride) (PAH). Instead of 
forming a hard and soft corona, it was found that α-synuclein agglomerates on PAH Au NP and 
subsequently causes the Au NPs to flocculate out of solution. Using circular dichroism and in 
situ trypsin digestion, we investigate how the positively charged PAH Au NPs would influence 
α-syn’s conformation and orientation upon adsorption. Our results show that upon adsorption 
onto PAH Au NPs, α-syn’s conformation is altered but a preferred orientation cannot be 
distinguished. This work has great implications for the understanding of amyloid protein 
aggregation and potential avenues to control it. 
 
4.2.  Materials and Methods 
4.2.1.  Materials   
Gold(III) chloride trihydrate (HAuCl4·3H2O, ≥99.9%), sodium citrate tribasic dihydrate 
(Na3Ct·2H2O, ≥99%), poly(allylamine hydrochloride) (PAH, M.W. 15 000 g/mol) and 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, ≥99.5%) were obtained from Sigma-
Aldrich and were used as received. Sequencing-grade trypsin (lot 082301) and trypsin beads was 
obtained from GBioscience. Ultrapure deionized water (17.9 MΩ, Barnstead Nanopure II) was 
used for all solution preparations. A solution of HEPES buffer (20 mM, pH 7) was prepared in 
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ultrapure deionized water. Trypsin solutions were made by reconstituting trypsin in (NH4)2CO3 
(25 mM) to a final concentration of 12.5 μg/mL (0.54 μM). Glassware was cleaned with aqua 
regia and rinsed thoroughly before use. 
 
4.2.2.  Synthesis and Coating of Gold Nanoparticles  
Au NPs (diameter 20 nm) were synthesized by the boiling citrate method as previously 
described with some modifications.33 Briefly, 2.5 mL of 0.01 M HAuCl4·3H2O was added to 
97.5 mL of ultrapure water in a 200 mL Erlenmeyer flask and heated to boiling. An aqueous 
solution of sodium citrate (5% w/w, 2 mL) was then added, and the solution was allowed to boil 
for another 30 min. During this period, the color of the solution slowly changed to deep red. 
Another portion of sodium citrate (1% w/w, 1 mL) was added, and the solution was allowed to 
boil for another 30 min. Au NPs produced by this method yielded a diameter of 17.5 ±1.3 nm 
under transmission electron microscopy (TEM). The hydrodynamic diameter measured by 
dynamic light scattering was 31.2 ± 0.4 nm. 
Poly(allylamine hydrochloride) (PAH) Au NPs were made by first purifying 1 mL of 
citrate Au NPs by centrifugation. The Au pellet was collected and resuspended in 1 mL of water. 
To this purified Au NPs pellet, 100 μL of NaCl (0.1 M) and 200 μL of PAH (10 mg/mL) were 
added simultaneously, and the solution was vortexed. The NPs were allowed to incubate 
overnight before being purified by centrifugation. 
 
4.2.3.  Production of α-Synuclein 
α-Syn protein was expressed and purified as previously described.34 Briefly, the gene 
encoding wild-type human α-syn (SNCA) was cloned into the pET28 vector (Novagen). Protein 
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expression was induced with 1 mM isopropyl-β-d-thiogalactopyranoside (IPTG) at 37 °C, 
followed by alkaline lysis, boiling, and precipitation with 60% ammonium sulfate. Precipitates 
were resolubilized and purified by hydrophobic interaction chromatography on a HiPrep 16/10 
butyl fast flow Sepharose column (GEBiosciences) and eluted with decreasing salt. α-Syn-
containing fractions were pooled and concentrated, subjected to size-exclusion chromatography 
on a Superdex 75 10/300 GL column (GEBiosciences), and lyophilized for storage at −80 °C. 
The concentrations of α-syn solutions were determined by measuring the UV absorbance at 280 
nm using an extinction coefficient of 5200 M-1cm-1.35 
 
4.2.4.  Incubation of α-Synuclein with Gold Nanoparticles   
Prior to each experiment, an aliquot of α-syn was reconstituted in HEPES buffer at a 1 
mg/mL (70 μM) concentration. Various amounts of α-syn was then added to a concentrated 
volume of Au NPs such that α-syn had either saturated the Au NP surface or at a 100:1 α-syn:Au 
NP ratio. The α-syn bound Au NPs were incubated at 4 °C and allowed to equilibrate overnight. 
α-Syn saturated Au NPs was purified from excess free α-syn by centrifugation at least three 
times and dispersed in HEPES buffer. 
 
4.2.5.  Trypsin Digestion of α-Synuclein on Au NPs 
To investigate the extend of protection on α-syn by Au NPs, fixed volumes of trypsin 
solution were added to known number of α-syn coated Au NPs such that the ratio of trypsin/α-
syn ranged from 1:20 to 1:200. The samples were microwave digested for 15 min at 55 °C (70 
W), following which separation was achieved using Amicon filters (MWCO = 30 000 Da) with 
centrifugation at 14,000 rcf for 5 min. The supernatant was collected, dried down, and analyzed 
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using nanoliquid chromatography mass spectrometry/mass spectrometry (LC MS/MS). The Au 
pellet was further purified twice before the digestion of the Au NPs with 1 M KCN, lyophilized 
to dryness, and analyzed.  
For timed studies, α-syn bound Au NPs (α-syn:Au NP ratio 100:1, final Au NP 
concentration 20 nM) were heated in a heat block at 37 °C. Trypsin was added such that the 
resultant trypsin:α-syn ratio was 1:187. The reaction was quenched using formic acid (2%) at 
various time points. Separation was achieved using Amicon filters (MWCO = 30 000 Da) with 
centrifugation at 14,000 rcf for 5 min. The supernatant was collected, dried down, and analyzed 
using nanoliquid chromatography mass spectrometry/mass spectrometry (LC MS/MS). The Au 
pellet was further purified twice before the digestion of the Au NPs with 1 M KCN, lyophilized 
to dryness, and analyzed. 
For reactions using trypsin beads, 50 µL of purified trypsin beads were added to α-syn 
bound Au NPs (50 nM, 600 µL). The sample was placed on a shaker at 37 °C and the reaction 
quenched with formic acid (2%) at various time points. Separation was achieved using Amicon 
filters (MWCO = 30 000 Da) with centrifugation at 14,000 rcf for 5 min. The supernatant was 
collected, dried down, and analyzed using nanoliquid chromatography mass spectrometry/mass 
spectrometry (LC MS/MS). The Au pellet was further purified twice before the digestion of the 
Au NPs with 1 M KCN, lyophilized to dryness, and analyzed. 
The mass spectrometry data was processed using Waters Protein Lyns Global Server 
2.2.5, Mascot (Matrix Sciences) and blasted against the NCBI-NR protein database for wild-type 
human α-syn (gi|4507109). 
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4.2.6.  Circular Dichroism Measurement of α-Syn on PAH Au NPs 
To prepare samples for circular dichroism measurements, solutions of 4 µM of α-syn 
were incubated overnight at 4 °C with 0, 1, 2, and 4 nM of 20 nm PAH-coated Au NPs in 10 mM 
MOPS buffer (pH 7). The sample housing in the CD was adjusted to 4 °C to maintain the 
incubation temperature. Samples were placed inside 1 mm quartz cuvettes (Starna Cells, Inc.). 
Each trace was an average of 10 scans, with integration time set as a function of photomultiplier 
voltage. The bandwidth was set at 8 nm. After collection, the data was processed with the Olis 
digital filter (size #11). Cuvettes were cleaned with aqua regia and rinsed thoroughly with water 
prior to each measurement. Secondary structure content was calculated through the SELCON3 
fitting algorithm, reference set SP43.43 
 
4.2.7.  Instrumentation 
A microcentrifuge (Eppendorf model 5418, Fisher-Thermo Electron) was used in various 
steps of synthesis and purification as detailed above. Protein digestion was performed on a CEM 
Discover microwave digestor (Mathews, NC). The mass spectrometer used for peptide analysis 
was a Waters quadrupole time-of-flight mass spectrometer (QToF) connected to a Waters Nano 
Acquity UPLC. A Waters Atlantis C-18 (0.03 mm particle, 0.075 mm × 150 mm) column was 
used, with the flow rate set to 250 nL/min. Peptides were eluted using a linear gradient of 
water/acetonitrile containing 0.1% formic acid 0−60% B in 60 min. The mass spectrometer was 
set for data-dependent acquisition; ms/ms was performed on the most abundant four peaks at any 
given time. 
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4.3.  Results 
4.3.1.  Binding of α-Syn to Cationic PAH Au NPs 
α-Syn is an amyloid protein which is prone to aggregation. To probe the propensity of α-
syn to flocculate in the presence of PAH Au NPs, the overall binding of α-syn to PAH coated Au 
NPs was investigated using UV-vis spectroscopy and dynamic light scattering (DLS) (Figure 
4.1). In UV-vis spectra, the plasmon band maxima is very sensitive to local refractive index 
changes around the Au NP,44 which can be induced by α-syn adsorption. When α-syn (0–14 µM) 
was titrated into 1 nM PAH Au NPs, the peak maxima was observed to shift a total of 18.3 nm 
(Figure 4.1a). This large shift in UV-vis maxima can be broadly characterized into two regions: a 
shift in peak maxima from 522.0 nm (0 µM α-syn) to 526.3 nm (2 µM α-syn) at lower α-syn/Au 
NP ratios (<2000:1), and a second increase in UV-vis spectra to a maximum of 540.3 nm (14 µM 
α-syn) at higher α-syn/Au NP ratios (>2000:1). While the peak maxima maintained its FWHM at 
lower α-syn/Au NP ratios, a significant broadening was observed at higher α-syn/Au NP ratios. 
Hydrodynamic diameter results from DLS measurements reflected similar trends (Figure 4.1b). 
At lower α-syn/Au NP ratios (<2000:1), hydrodynamic diameter increased from an initial of 31.2 
± 7.0 nm (0 µM α-syn) to 45.7 ± 10.5 nm (2 µM α-syn). Increasing α-syn/Au NP ratio further 
resulted in a bimodal Gaussian distribution of a smaller and larger Au NP population: the smaller 
population continued to increase slowly in hydrodynamic diameter from 83.3 ± 9.5 nm (3 µM α-
syn) to 214.1 ± 78.1 nm (14 µM α-syn) while the hydrodynamic diameter in larger population 
increased exponentially from 191.3 ± 11.0 nm (4 µM α-syn) to 4860.8 ± 661.6 nm (14 µM α-
syn).  
The plasmon band shift of 4.3 nm from an initial 522.0 nm suggest suggests a significant 
change  in  the refractive  index of  20 nm  PAH Au NPs, and  can be due to a very large  α-syn 
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Figure 4.1.  Titration of α-syn into PAH Au NP solutions. a) UV-vis spectral changes with 
increasing amounts of α-syn (0 –14 µM) added to 1 nM 20 nm PAH Au NPs. b) Change in 
absorption peak maxima of Au NPs as a function of α-syn concentration, as derived from (a). 
Gray region signifies α-syn/PAH Au NP ratio of >2000:1. c) Hydrodynamic diameter changes of 
20 nm PAH Au NPs with increasing amounts of α-syn (0 –14 µM) added to 1 nM 20 nm PAH 
Au NPs. A bimodal distribution of sizes (red and blue) is observed after α-syn/Au NP >2000. d) 
Hydrodynamic diameter changes of PAH Au NPs as a function of α-syn concentration, as 
derived from (c). Gray region signifies α-syn/PAH Au NP ratio of >2000:1. 
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corona. The hydrodynamic diameter increase of 14 nm signifies that a multilayered adsorption of 
α-syn occurred (α-syn hydrodynamic diameter is 5.3 ± 1.0 nm45), as this increase is not large 
enough to account for nanoparticle dimers or trimers. In addition, visual observations of the 
flocculates showed that the sediments still retain their bright red color, characteristic of single Au 
NPs and not black aggregates, usually seen when Au NPs aggregate (Figure 4.2). The collective 
results suggested a very thick and possible multilayered α-syn corona formation on PAH Au NPs 
which subsequently cause the assemblies to agglomerate and fall out of solution (Scheme 4.1). 
The tendency of α-syn coated PAH Au NPs to form bigger clumps and flocculate out of solution 
also suggested that α-syn is more ‘sticky’ and implies a conformational change (vide infra). 
Due to the sensitivity of the plasmons in Au NPs to local refractive index change, the 
shift in UV-vis peak maxima and hydrodynamic diameter has often been used to deduce the 
binding affinity of proteins to Au NPs. Plotting the peak maxima shifts with respect to α-syn 
concentration showed a gradual shift in peak maxima (<2 µM), followed by an exponential 
increase (Figure 4.1b). Similarly, for the changes in hydrodynamic diameter, a gradual increase 
in hydrodynamic diameter (up to ~14.5 nm) was observed below 2 µM. At α-syn concentrations 
above 2 µM, both the small and larger flocculates were observed to continuously increase in size 
as α-syn concentration increases, with the larger flocculate size increasing at an exponential rate. 
Because the data do not show surface saturation of the protein (similar to α-syn adsorption on 
anionic Au NPs39), we were unable to calculate equilibrium binding constants.  
We probed the extend of the dissociation of the outer layers by diluting PAH Au NPs 
sequentially after incubation with excess α-syn (α-syn/Au NP ratio 7000:1). Samples were 
diluted with buffer such that the final concentration of α-syn was reduced from 7 µM to 4.6, 3.5  
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Figure 4.2.  Flocculation of Au NPs. (Left) Agglomeration of α-syn coated PAH Au NPs (α-
syn/PAH Au NP 4000:1). The agglomerate remained red in color and can be resuspended by 
pipetting. (Right) Aggregation of citrate Au NPs in a high salt environment. The aggregates are 
black in color and cannot be resuspended as a red suspension again. 
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Scheme 4.1.  The Proposed Adsorption of α-Syn onto PAH Au NPs.a  
 
 
 
aAt low α-syn/PAH Au NP ratio, α-syn adsorb as multilayers while at high ratio, the α-syn 
coated PAH Au NPs agglomerates. The different colors of free and bound α-syn suggest a 
possible conformation change. 
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and 2.3 µM (Figure 4.3a). However, even after 3x dilution to 2.3 µM α-syn, no significant 
change in the hydrodynamic diameter was observed. A bimodal distribution at around 212.3 
±24.3 nm and 841.8 ± 101.0 nm was still seen, similar to the undiluted sample (7 µM α-syn) at 
around 309.8 ± 48.8 nm and 1011.6 ± 148.8 nm. A shift to larger hydrodynamic diameter for 
both small and large flocculate populations was instead observed even when α-syn coated PAH 
Au NPs were incubated at 4 °C for longer time periods (Figure 4.3b). At 4000:1 α-syn/Au NP 
ratio, the hydrodynamic diameter obtained after 1 day was 84.1 ± 4.5 nm and 191.3 ± 11.0 nm, 
which increased to 100.7 ± 10.0 nm and 409.8 ± 42.6 nm after 2 days.  The hydrodynamic 
diameter further increased to 129.0 ± 18.6 nm and 1307.6 ± 201.7 nm after 7 days incubation.  
 
4.3.2.  Conformation and Orientation of α-Syn on a Saturated PAH Au NP Surface 
Circular dichroism (CD) is commonly used to detect changes in protein conformation as 
a function of an external factor,46 and has been used to detect protein conformation changes on 
Au NPs.47,48 Here, we use CD to observe changes in the secondary structure of α-syn upon 
interaction with PAH coated Au NPs after an overnight incubation at 4 °C. The molar ratio of α-
syn to PAH Au NPs in this experiment was maintained such that α-syn was always in excess to 
Au NPs (1000–4000 α-syn/Au NP). The CD spectrum of native α-syn is characterized by its 
unstructured conformation (Figure 4.4). Addition of Au NPs caused a decrease in signal at 
around 200 nm, from -14.1 m° for α-syn without Au NPs, to -11.2, -11.1 and -11.5 m° when 
PAH Au NPs was added at 1, 2 and 4 nM respectively. Quantitative analysis of the spectrum 
shift was performed from 200 - 250 nm using a SELCON3 fitting algorithm (Table 4.1).43 The 
CD spectrum of free α-syn was fitted to 14% α helical, 7% β sheet, and 37% unstructured 
conformation. Upon addition of PAH Au NPs, regardless of PAH Au NP concentration, α helical  
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Figure 4.3.  a) Dynamic light scattering (DLS) plots showing bimodal size distribution of α-syn 
coated PAH Au NPs after a series of dilutions with HEPES buffer from an initial α-syn 
concentration of 7 µM (black), to 4.6 µM (red), 3.5 µM (green) and 2.3 µM (blue). The 
concentration of PAH Au NP is 1 nM. b) DLS plots showing the aggregation of α-syn coated 
PAH Au NPs after 1 day (black), 2 days (red) and 6 days (green) of incubation at 4 °C. α-
Syn/PAH Au NP ratio is 4000:1. DLS data is fitted to Gaussian distributions and are plotted as 
the mean ± one standard deviation. 
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Figure 4.4.  Circular dichroism spectra of α-syn adsorbed on PAH Au NPs. The concentration of 
native α-syn (MOPS buffer, 10 mM, pH 7) was kept at 4 µM (black). Au NPs was added for a 
final concentration of 1 nM (red), 2 nM (green), 4 nM (blue) (α-syn/Au NP ratio of 4000:1, 
2000:1 and 1000:1 respectively).  
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Table 4.1.  Percent of Secondary Structures as Deduced from the Circular Dichroism 
Spectrum of α-Syn Incubated With and Without PAH Au NPs.a  
 
[AuNP] (nM) α-helix (%) disordered α-helix (%)
β-sheet 
(%) 
disordered 
β-sheet 
(%) 
turn (%) unordered (%) 
0 14 13 7 7 16 37 
1.0 6 11 29 12 22 20 
2.0 6 12 28 12 21 20 
4.0 6 11 28 12 22 20 
 
 
aSecondary structure content was calculated using SELCON3 fitting algorithm. α-Syn = 4 µM.  
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and unstructured content was decreased from 14% to 6%, and 37% to 20%, respectively, while β 
sheet conformation was  increased from  7% to 29%.  The lack of a concentration dependent 
change in CD spectra suggests that PAH Au NPs can induce a change in conformation of bound 
α-syn, which is then propagated to α-syn not in direct contact with PAH Au NP surface (vide 
intra). 
To deduce the orientation of α-syn on PAH Au NPs, an in situ trypsin digestion method 
was used (Scheme 4.2). Excess α-syn was adsorbed onto PAH Au NPs and allowed to incubate 
overnight at 4 °C. After purification via centrifugation to remove unbound α-syn, trypsin was 
added to α-syn coated PAH Au NPs and microwave digested. Trypsin digests α-syn at lysine 
positions (α-syn does not have arginine, another site of trypsin digestion). A total of 15 lysine 
positions in α-syn are available for cleavage: at positions 6, 10, 12, 21, 23, 32, 34, 43, 45, 58, 60, 
80, 96, 97 and 101. The released peptide fragments were then separated from the peptide 
fragments still bound on Au NPs and quantified using mass spectrometry (MS), from which the 
orientation of α-syn can be deduced. First, by comparing the peptide fragments released into 
solution with that still bound on PAH Au NPs, it is possible to draw conclusions about the 
peptides which had a higher affinity for PAH Au NPs, hence deduce α-syn orientation. Secondly, 
compared to the free α-syn digestion pattern, lysine positions that were not as readily cleaved are 
more protected, suggesting limited trypsin accessibility. This is reflected by the larger number of 
longer, overlapping peptide fragments with missed cleavages. Thirdly, the relative proportions of 
peptide fragments on changing the trypsin/α-syn ratio reveal the extent of protection. 
Figure 4.5 shows the digestion pattern for free α-syn, α-syn in the presence of PAH 
polymer and α-syn adsorbed on PAH Au NPs. The number of peptides was normalized with 
respect to the highest peptide count in each experiment for ease of comparison and is shown as a 
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Scheme 4.2.  Cartoon of Au NP Coating with PAH and the In Situ Trypsin Digestion 
Method Used to Deduce α-Syn Orientationa  
 
 
 
 
aNote that the horseshoe structure of α-syn shown here is not representative of its actual 
conformation on PAH Au NPs.  
125 
 
 
 
Figure 4.5.  Digestion pattern of a) free α-syn, b) α-syn incubated with PAH polymer and α-syn 
incubated with PAH Au NPs (8.3 pmoles) at trypsin/α-syn ratios of (c) 1:200, (d) 1:100, and (e) 
1:20. The peptide fragments in the supernatant are separated from those on the Au NP surface 
and are shown separately. The horizontal axis denotes the amino acids in α-syn from the N to C 
terminus. The vertical axis denotes the different peptide fragments obtained, which is further 
separated into those in the supernatant and on the Au NP surface. The color scale (normalized) 
denotes the number of peptides found. The scale on the z axis is the same for all plots. 
   
126 
 
color scale in the z-axis. The peptide fragments are arranged according to their amino acid 
positions on the x-axis and the y-axis tabulates the all the peptide fragments detected. Results 
showed that for α-syn adsorbed on PAH Au NPs, peptide fragments found on Au NP surface 
were very similar to those in the supernatant; peptide fragments from the full α-syn sequence was 
detected in both solutions. Similar to free α-syn and α-syn in the presence of PAH polymer, 
peptide fragments 1–6, 61–79 and 80–96 were present in high proportions. However, it should be 
noted that while peptide fragment 81–96 was of the highest frequency in free α-syn, the peptide 
fragment with highest frequency on PAH Au NP is 1–6. Comparison of α-syn incubated with 
PAH polymer showed a similar trend: peptide fragment 1–6 was of the highest frequency, 
implying that the change in frequency can be due to the interaction of α-syn with PAH polymer. 
The number of missed cleavages (which translates to longer peptide fragments) at lysine 
positions 23, 34 and 60 were less often observed when α-syn was absorbed onto PAH Au NPs. In 
contrast, longer peptide fragments at these locations can be seen from the digest of α-syn with 
and without PAH polymer.  
The extent of protection of α-syn on PAH Au NPs was studied by varying the trypsin/α-
syn ratio at 1:200, 1:100 and 1:20 (Figure 4.5). Results showed that the digestion pattern was not 
altered significantly on varying trypsin/α-syn ratio. In particular, the number of peptide 
fragments in all three ratios and their frequencies of detected were similar. All peptide fragments 
were detected in both the supernatant as well as on Au NP surface.  
 
4.3.3.  Digestion of α-Syn on a Non-Saturated Au NP Surface 
The propensity of α-syn-coated-PAH Au NPs to aggregate made quantification of 
peptides after trypsin digestion extremely challenging. To overcome this problem, a reduced α-
syn coverage of 100:1 (α-syn/Au NP) was used instead of saturation conditions. This 
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circumvents the problem in two ways: 1) flocculation is avoided and 2) the need to separate out 
free (unbound) α-syn is eliminated. For comparison, α-syn was incubated on both citrate 
(anionic) and PAH (cationic) Au NPs. 
Trypsin was added to α-syn samples to achieve a resultant 1:187 ratio and digested at 37 
°C for 8–16 h. Figure 4.6a and b shows the peptide fragments obtained in the supernatants and 
on citrate Au NPs or PAH Au NP surfaces. When α-syn on citrate Au NPs was digested, very 
few of the peptide fragments were released into the supernatant. In addition, only the N-terminus 
was found on the Au NP surface and a large fraction of the peptide fragments had an uncleaved 
lysine position 6 (peptide fragment 1–10). In comparison, when α-syn was absorbed on PAH Au 
NPs, the number of peptide fragments in the supernatant was similar to that found on the PAH 
Au NP surface. However, the respective ratio of peptide fragments is drastically different in the 
supernatant or on the Au NP surface. Peptide fragment 1–10 was more commonly found on PAH 
Au NP surface while peptide fragment 35–43 was more often in the supernatant.  
The number of peptide fragments was tabulated to provide a more representative picture 
of the digestion pattern (Figure 4.6c). For ease of comparison, peptide fragments were grouped 
according to α-syn’s amino acid sequence: residues 1–23, 24–43, 44–58 and 59–97, where the 
first 3 groups reflects the N-terminus and the last group the non-amyloid component (NAC) 
region. The C-terminus residues 98–140 was excluded due to limitations on the detection limit of 
the mass spectrometer. We find that digestion of free α-syn resulted in the release of peptides 
from 1–23 and 59–97 at (35.2 ± 5.8) % and (36.5 ± 5.2) % of the total peptides detected 
respectively, while peptides with amino acids from 24–43 and 44–58 were found at lower ratios 
((13.7 ± 1.0) % and (14.6 ± 1.6) % respectively). When α-syn was bound to citrate Au NPs, a 
significant increase in the fraction of peptides from 1–23 was observed at (76.4 ± 3.2) %, while  
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Figure 4.6.  Digestion pattern of α-syn using trypsin when absorbed onto a) citrate Au NPs and 
b) PAH Au NPs. A α-syn/Au NP ratio of 100:1 was used. The peptide fragments in the 
supernatant are separated from those on the Au NP surface and are shown separately. Color scale 
(normalized) is the same for all plots. c) Fraction of peptide fragments from α-syn digestion 
when free in solution (black), absorbed on citrate Au NPs (red) and absorbed on PAH Au NPs 
(blue). Peptides were grouped into 4 groups according to their amino acid positions: 1–23, 24–
43, 44–58 and 59–97. d) α-Syn lysine susceptibility to trypsin digestion when free in solution 
(black), absorbed on citrate Au NPs (red) and absorbed on PAH Au NPs (blue).  
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peptides from 24–43, 44–58 and 59–97 adds up to only about 23 % of the total peptides detected. 
Similarly, the fraction of peptides from 1–23 for α-syn on PAH Au NPs was high at (56.4 ± 7.0) 
%. However, the fraction of peptides from 24–43 and 44–58 of α-syn on PAH Au NPs were 
more similar to free α-syn, at (19.4 ± 4.2) % and (17.6 ± 3.3) % respectively, while peptide from 
59–97 only made up (6.6 ± 1.9) % of the total peptide fragments. 
The susceptibility of α-syn to trypsin digestion was mapped by illustrating the lysine 
positions which are susceptible to trypsin attack (Figure 4.6d). It is assumed that every peptide 
fragment is independent of each other: every peptide fragment is counted with two lysine 
cleavages (except terminal peptides) and tabulated. Since there are no lysine positions in the C-
terminus, only the N-terminus and NAC region is considered (amino acids 1–101). Results show 
that after 2 h digestion, lysine at position 10 is more digested on both citrate and PAH Au NPs as 
compared to free α-syn while the accessibility at lysine position 6 is relatively similar. In 
contrast, lysine at position 80 is more digested with free α-syn than when absorbed on citrate or 
PAH Au NPs. Differences in the digestion of α-syn was detected between lysine positions 32 and 
60, specifically at positions 34, 43 and 58. In this region, digestion on citrate Au NPs is 
suppressed, while on PAH Au NPs the rate of digestion is higher than free α-syn at lysine 
positions 34 and 43 and similar at position 58. 
 
4.4.  Discussion 
While many studies have focused on investigating the adsorption, orientation and 
conformation of proteins with known tertiary structure on surfaces,15,16,19,49,50 the natively 
unstructured conformation of α-syn and its potential to aggregate implies a different adsorption 
kinetics when bound onto nanoscale surfaces. Indeed, α-syn coated Au NPs have been used to 
align Au NPs in amyloid fibrils, suggesting conformational changes of bound α-syn.51 In 
130 
 
addition, while the influence of NPs on the aggregation kinetics of amyloid proteins has been 
studied,52–55 this complicated process is still little understood. The study of α-syn adsorption onto 
Au NPs is thus a good case study which can be extended to other unstructured and aggregation 
prone proteins. 
We would like to highlight that while we used the more general term ‘flocculation’ to 
describe the instability of the α-syn coated PAH Au NPs, in actual fact, these Au NPs 
agglomerate rather than aggregate. To allow readers a better understand the chemistry behind α-
syn coated PAH Au NPs, we paraphrase the definitions from Ross and Morrison, as well as from 
Weisbecker et al..56,57 A ‘floc’ is defined as any close association of primary particles, aggregates 
and agglomerates, and ‘flocculation’ is the process of forming them. ‘Aggregates’ are more 
closely associated particles and cannot be separated once they are formed, while ‘agglomerates’ 
are loose, reversible association of particles. Visually, α-syn coated PAH Au NPs form red 
agglomerates which settled to the bottom of the suspension over time, and can be resuspended by 
pipetting (Figure 4.2). In contrast, citrate Au NPs aggregates when placed in a high salt 
environment to a purple/black suspension and will not revert to a red suspension even with 
sonication. For subsequent discussion, we will use ‘agglomerate’ to describe the instability of α-
syn coated PAH Au NPs. 
At <2000 α-syn/PAH Au NP ratio, a steady red shift in UV-vis (522.0 nm to 526.3 nm) 
and an increase of hydrodynamic diameter was observed (31.2 ± 7.0 nm to 45.7 ± 10.5 nm). This 
change in UV-vis and hydrodynamic diameter is characteristic of protein adsorption onto Au 
NPs. Given the hydrodynamic diameter of α-syn is 5.3 ± 1.0 nm,45 DLS data suggest that the 
protein layer is about 1.5 times α-syn’s hydrodynamic size. At >2000 α-syn/PAH Au NP, α-syn 
coated PAH Au NPs continue to agglomerate and grow in size even when not agitated and 
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placed in 4 °C. At 3000 α-syn/PAH Au NP ratio, the UV-vis peak maxima of 527.3 nm suggest a 
NP diameter of ~40 nm. A doubling of the hydrodynamic diameter was also seen on transiting 
from 2000 to 3000 α-syn/PAH Au NP ratio: 45.7 ± 10.5 nm to 83.3 ± 9.5 nm. These 
agglomerates, once formed, did not decrease in size when diluted. In addition, the agglomerates 
were observed to grow in size over time, suggesting that α-syn coated PAH Au NPs are 
extremely ‘sticky’.  
The results suggest that the multilayered adsorption of α-syn onto PAH Au NPs does not 
make up the soft corona. The soft corona is usually defined as a labile, weakly interacting protein 
layer that is in constant exchange with proteins in solution,58 which can be further weakened by 
decreasing the probability of proteins colliding with NPs, i.e. dilution. However dilution does not 
cause the hydrodynamic diameter to decrease, indicating that the multilayered adsorption of α-
syn is strong.  
The increased tendency of α-syn adsorbed onto PAH Au NPs to agglomerate suggest a 
possible α-syn conformation change. The aggregation of free α-syn can be induced with agitation 
and heating to 37 °C.59,60 Under these conditions, aggregation is only often seen after 8 days (21 
µM, 0.025 M Tris-HCL, pH 7.5, 37 °C).59 In the presence of spermine, a positively charged 
polyamine, aggregation kinetics is increased to a aggregation half-time of ~17 h (10 µM 
spermine, 1.75 µM α-syn, 25 mM Tris-HCL, pH 7.5, 37 °C).61 Previous studies have showed that 
positively charged polyamine such as spermine can bind to the C-terminus of α-syn, releasing the 
long range interactions with the N-terminus and opening up the compact α-syn structure.62,63 In 
our experiments, incubation of α-syn (< 14 µM) with PAH Au NPs at 4 °C without agitation 
induced agglomeration of PAH Au NPs, while with anionic citrate Au NPs, such agglomerations 
are not seen.39  The positively charged PAH Au NPs could have a similar interaction with α-syn: 
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binding of α-syn onto PAH Au NPs weakened the long range interactions such that α-syn has an 
increase affinity to aggregate, thus implying a conformational change of bound α-syn. 
The agglomeration of α-syn coated PAH Au NPs made fitting of UV-vis and DLS data to 
a BET adsorption isotherm (or any isotherms) unreliable: the sensitivity of the UV-vis plasmon 
peak of Au NPs to protein adsorption is only accurate if the Au NPs are well separated from each 
other. In this case, it is usually assumed that the plasmon peak shift is due to the change in 
refractive index around the Au NP, which is caused only by protein binding. However, when α-
syn coated Au NPs agglomerates, the UV-vis plasmon band shift is also now partially attributed 
to the inter-NP interactions. Similarly for DLS data, the increase in hydrodynamic diameter due 
to PAH Au NP agglomerates cannot be isolated from the increase due to α-syn adsorption. 
To probe the orientation and potential long range interaction changes of α-syn on PAH 
Au NPs, we performed in situ trypsin digestion of α-syn when absorbed onto either citrate or 
PAH Au NPs. We have previously studied the binding of α-syn onto negatively charged citrate 
Au NPs.39 A hard α-syn corona comprising of strong electrostatic interactions and a soft corona 
of weaker noncovalent protein-protein interactions of α-syn on citrate Au NPs was observed.39 In 
addition, the orientation of α-syn binding onto citrate Au NPs was determined to be via the N-
terminus, while the conformation remained unchanged. Digestion of α-syn on a saturated PAH 
Au NP surface showed that the full range of peptide fragments can be found in both the 
supernatant and Au NP surface, with the relative ratio of peptide fragments similar in each 
section. This further confirms the presence of multilayered α-syn adsorption on PAH Au NPs. 
The reduced number of missed cleavages implied that the peptide fragments were more readily 
digested; α-syn on PAH Au NPs were more accessible to trypsin attack than free α-syn, 
suggesting that some of the long range interactions were disrupted and hence α-syn is more 
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‘accessible’ to trypsin. Qin et al. had previously shown that when α-syn fibrils were subjected to 
trypsin digestion, residues 32–102 were protected from digestion.64 The possible on-particle 
formation of α-helical structure is unlikely: the hydrophobic side of the amphiphilic α-helix is 
unlikely to be stabilized on the hard PAH Au NP surface.65 Taken together, this suggest that 
while α-syn maintained its native unstructured conformation when binding to PAH Au NPs, this 
conformation is slightly altered such that it is more accessible to trypsin attack.  
Further confirmation was provided by CD measurements: incubation of α-syn with PAH 
Au NPs increased the percentage of β-sheet structures and decreased the α-helical content, 
suggesting that PAH Au NPs can result in a change of secondary conformation in α-syn when 
adsorbed onto PAH Au NPs. It should be highlighted that this change in conformation is similar 
regardless of PAH Au NP concentration. In most cases, protein’s conformation changes are Au 
NP concentration dependent; increasing Au NP concentration decreases the α-helical content of 
bovine serum albumin.35 In our case, the lack of a concentration dependent change suggests that 
PAH Au NPs exert a global influence on α-syn; all (or almost all) of α-syn’s conformation was 
altered. In light of UV-vis and DLS data, which showed that α-syn coated PAH Au NPs 
agglomerate at high α-syn/PAH Au NP ratio, it is possible that the adsorption of the first α-syn 
layer on PAH Au NPs resulted in some conformational change, which as a result made bound α-
syn more ‘sticky’, hence can attract more α-syn to bind which are also induced conformational to 
change. In contrast, α-syn adsorption onto negatively charged citrate Au NPs did not induce any 
observable conformational change in CD spectra39, highlighting that α-syn maintained its 
compact, unstructured nature when adsorbed (long range interactions not disrupted). While 
changes in conformation has been shown to be inducible by nanoparticle size16,18,19,66, we show 
134 
 
here that α-syn’s conformation on nanoparticles also depend on the nanoparticles’ surface charge 
and the change is propagated throughout the solution. 
The multilayered adsorption of α-syn onto PAH Au NPs made it difficult to deduce the 
orientation of the bound α-syn. We thus studied the trypsin digestion of α-syn on a non-saturated 
Au NP surface. Since the conformation of α-syn remained in its unstructured conformation under 
saturated conditions for citrate Au NPs and consistently changed for PAH Au NPs, we believe 
that at unsaturated conditions, the conformation and orientation of α-syn on citrate and PAH Au 
NP remained similar to saturated conditions. We chose here to use a 100:1 α-syn/Au NP ratio 
based on previous experiments which showed that 360 ± 70 α-syn absorbs per citrate Au NP in 
the hard corona.39  
Results showed that peptide fragments from the N-terminus are only found on the citrate 
Au NP surface, confirming that α-syn binds via the N-terminus on citrate Au NPs. In contrast, 
the digestion pattern of α-syn on PAH Au NPs once again displayed all peptide fragments in 
both supernatant and Au NP surface, suggesting that α-syn is randomly absorbed onto PAH Au 
NPs, i.e. there is no specific orientation. This can be explained by examining the conformation of 
the native unstructured α-syn: it is believed that the NAC region is shielded by the N- and C-
terminus, with long range interactions between amino acid 120 on the C-terminus and amino 
acid 20 on the N-terminus.62 The N- and C-terminus are thus outward facing and can interact 
with Au NPs. The C-terminus (residues 96–140) is high in acidic amino acids, which can be 
strongly attracted to the positively charged PAH Au NP surface. The hydrophilic portion of the 
amphiphilic N-terminus (residues 1–65) is made up of both acidic and basic amino acids, and 
thus is not immune to absorption onto PAH Au NPs, although its interaction might be weaker. 
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By grouping peptide fragments according to their amino acid sequence, the section of α-
syn which is more accessible to trypsin can be mapped. The lysine susceptibility plots also 
provided an idea of the ‘activity’ at a particular lysine site, which suggests that the adsorption of 
α-syn onto Au NPs increases its susceptibility to trypsin at the N-terminus (amino acid 1–23) 
while at the same time decreasing digestion at the NAC region (amino acid 59–97). These results 
can be explained by taking into considerations the long range interactions within α-syn, possibly 
additional binding sites to Au NPs as well as the close proximity of bound α-syn to each other on 
Au NPs. The intra-protein interactions are sufficiently strong, such that α-syn is composed of a 
more compact ensemble than would be expected of a random coil.67 Atomic force measurements 
demonstrated that the intra-protein interactions have an average of 64 ± 30 pN (10 mM Tris-HCl, 
pH 7.5)68, while inter-protein interactions between α-syn dimers required 43.1 ± 1.8 pN for 
separation.69 It is thus highly likely that when α-syn is bound on Au NPs, after trypsin digestion, 
peptide fragments are still held in close proximity to each other by the intra-protein and inter-
protein interactions. These peptide fragments would still prevent trypsin from penetrating the 
inner core region of α-syn (lysine position 80). With free α-syn, trypsin digestion cleaves α-syn 
and the peptide fragment is able to move/diffuse away, allowing trypsin to further attack 
‘protected’ sites. The increased accessibility of α-syn on PAH Au NPs at lysine positions 34, 43 
and 58 might be due to α-syn’s random orientation on PAH Au NPs: when bound via the C-
terminus, the change in conformation as a result of weakened intra-protein interactions might 
open up α-syn structure, allowing trypsin attack. 
The lysine accessibility plot also highlights the differences at lysine position 10. On free 
α-syn, peptide fragments 1–10 can be further digested by trypsin to peptide fragments 1–6. 
Peptide fragment 7 –10 is not detected as the peptide mass is not above the detection threshold. 
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Since it has been established that the absorption of α-syn on citrate Au NPs occurs via the N-
terminus while on PAH Au NP it is randomly orientated, the increase digestion at lysine position 
10 only serves to reinforce the idea that α-syn remains in its native conformation when bound. 
Assuming that α-syn is 4 nm in diameter and maintains a spherical shape67, about 10 amino acids 
would be in contact with the Au NP surface.70 This estimate suggests that lysine at position 10 
would be more exposed to trypsin than at position 6 when α-syn is absorbed on citrate Au NPs 
and for some of the α-syn on PAH Au NPs. Since the N-terminus peptides are bound onto Au NP 
surface, they cannot be further digested to the shorter peptide fragment (1–6), resulting in the 
larger amount of peptide fragments with amino acids 1–10.  
Comparison of the digestion pattern of α-syn on both saturated and non-saturated citrate 
and PAH Au NP revealed differences in the accessibility of α-syn to trypsin (Figure 4.7). On the 
saturated citrate Au NP surface, the most preferred lysine digestion site was at position 21, with 
positions 10, 12, 43, 58 and 80 less preferred. However, on the non-saturated citrate Au NP 
surface, the most preferred digestion site was position 10. This difference in digestion pattern 
reflects the change in packing density of α-syn on either saturated or non-saturated citrate Au NP 
surface; the tighter packing on a saturated surface would limit trypsin accessibility to the N-
terminus and hence position 10. On saturated PAH Au NP surface, α-syn is more digested at 
position 6 and 80, and less digested at positions 10, 43, 58 and 60, while on non-saturated PAH 
Au NP surface the preferred digestion site is at position 10. By taking into account the random 
orientation and the multilayered adsorption of α-syn on transiting from non-saturated to saturated 
PAH Au NP conditions, it can be observed that the digestion pattern of α-syn on saturated PAH 
Au NPs is a combination of α-syn on non-saturated PAH Au NPs and free α-syn in solution. 
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Figure 4.7.  α-Syn amino acid sequence and the preferred digestion sites of a) free α-syn, b) α-
syn on citrate Au NPs (saturated), c) α-syn on PAH Au NPs by trypsin (saturated), d) α-syn on 
citrate Au NPs (non-saturated), e) α-syn on PAH Au NPs by trypsin (non-saturated). On 
saturated Au NP surface, the trypsin/α-syn ratio is 1:100. On non-saturated Au NP surface, the α-
syn/Au NP ratio used is 100:1 and the trypsin/α-syn ratio is 1:187. Lysine positions are 
highlighted in red and the frequency of trypsin attack is shown as arrows with a color scale, with 
black being the easiest for trypsin to attack and light gray being the least digested. Data from α-
syn on citrate Au NPs (saturated) was obtained from Ref 39.  
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4.5.  Conclusion 
In conclusion, our results highlights that the surface chemistry of Au NPs is crucial in 
influencing α-syn binding. By titrating α-syn to positively charged PAH Au NPs, it was found 
that α-syn adsorbed in a multilayered fashion. The adsorption of α-syn onto PAH Au NPs altered 
its conformation, resulting in a consistent decrease in α-helix and an increase in β-sheet 
regardless of PAH Au NP concentration. The resultant α-syn coated PAH Au NPs are more 
‘sticky’, and above 2000:1 α-syn/PAH Au NP ratio, tend to agglomerate into large flocculates 
and crash out of solution. Trypsin digestions illustrated the difference in α-syn orientation on 
either citrate or PAH Au NPs: on citrate Au NPs, α-syn adsorbed via the N-terminus while on 
PAH Au NPs, α-syn binds in a random orientation. Digestions obtained using non-saturated α-
syn conditions showed similar trends. In addition, it was found that the fraction of peptides from 
amino acid 1–23 increased while that of 59–97 decreases upon adsorption to either citrate or 
PAH Au NPs when compared to free α-syn. By tabulating the ‘activity’ at each lysine position of 
α-syn, position 10 was more digested and 80 less digested when on either citrate or PAH Au NPs 
when compared to free α-syn. These results highlight that the accessibility of α-syn to trypsin is 
altered when adsorbed onto Au NPs. Our work on α-syn binding onto PAH Au NPs contributes 
to better understanding of nanoparticle mediated therapy for amyloid diseases. 
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CHAPTER 5 
Tuning Cellular Response to Nanoparticles via Surface 
Chemistry and Aggregation* 
 
 
5.1.  Introduction 
The excellent synthetic size and shape control of gold nanoparticles (Au NPs) allows for 
the localized surface plasmon resonance (LSPR) of Au NPs to be easily fine-tuned. Coupled with 
the ease of surface functionalization of Au NPs, the use of Au NPs is very popular in biological 
applications.1–4 For example, the sensitivity of the LSPR to changes in the Au NPs’ immediate 
environment as well as the high scattering coefficient of metallic Au NPS allows them to be used 
as sensing and imaging probes.5–7 The conversion of absorbed light into heat by Au NPs shows 
potential in photothermal therapy.8,9 Small molecules can also be attached via various means 
(electrostatic, covalent, hydrophobic) to Au NPs in order to enable applications in gene/drug 
delivery.10,11 However, while Au NPs have the potential to revolutionize nanotechnology based 
biomedical applications, in order to predict their biological interactions in detail, a more holistic 
understanding of the particle physiochemical properties after immersion in biological media is 
required. 
In a usual in vitro cell-nanoparticle experiment, cells are first plated on a hard substrate 
such as a culture dish. The Au NPs are then dispersed in cell media, which is added as a 
suspension to the cells. In such a scenario, the Au NPs are often assumed to be well-dispersed. 
                                                            
* This chapter has been submitted to Small as: Jie An Yang, Samuel E. Lohse, Catherine J. Murphy. ‘Tuning 
Cellular Response to Nanoparticles via Surface Chemistry and Aggregation.’ 
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However, Au NPs are commonly observed to aggregate when introduced into a high protein, 
high salt environment.12 Au NPs aggregation is also observed as a function of pH and results 
from the presence of cross linking species (e.g., divalent cations or polyelectrolytes) in solution, 
which implies that NPs in cellular or environmental media are primarily stabilized 
electrostatically.13 Accordingly, NP aggregation complicates in vitro studies of NP bio-
interactions. For instance, in vitro uptake of aggregated Au NPs has been shown to occur at 
different rates than well-dispersed Au NPs (although the precise uptake rate also depends on the 
initial Au NP size and the cell type).14,15 In addition, metallic Au NPs are dense and can settle to 
the bottom of the culture plates over time, and such phenomena has been observed for Au NPs 
larger than 90 nm in diameter as well as long gold nanorods (Au NRs).16,17 This poses another 
challenge as NP uptake by cells is directly related to NP concentration, and cells plated at the 
bottom or top of the culture plate will have different cellular uptake of NPs as the cells 
experience a different effective NP dose.12,17,18  
Even before introduction of NPs to cells, evidence points towards the formation of a 
protein corona around NPs when incubated with cell media or blood plasma.19,20 The adsorption 
of proteins occurs regardless of initial surface chemistry on NPs (although surface chemistry 
may influence the composition of the corona). Au NPs with different initial surface charges have 
been shown to develop similar ζ-potentials after incubation in cell media loaded with bovine 
serum albumin (BSA), signifying BSA adsorption.21 The adsorption of proteins onto NPs is non-
specific: a plethora of proteins bind onto the NP surface when introduced into blood plasma.22 
Further analysis of the protein adsorption onto NPs showed that protein adsorption can be 
resolved into two layers: a hard inner corona of strongly associating proteins and a soft outer 
corona comprised of weakly bound, highly labile proteins in constant exchange with free 
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proteins in solution, which ultimately influences how cells “perceive” NPs. 23,24 While this 
protein corona had been shown to mitigate and reduce NP’s capabilities and functions25, effects 
from NP incubation is still felt by cells. For example, cetyltrimethylammonium bromide 
(CTAB), a surfactant that is commonly used in the synthesis of Au NPs and is toxic to certain 
culture cells at 10-7 M concentrations21 , can induce toxicity from the incomplete removal of free 
CTAB from the CTAB-Au NPs.26,27 Au NPs can also cause cells to undergo potentially 
damaging morphological changes. The actin fibers of human dermal fibroblasts (HDF) cells had 
been shown to be disrupted when incubated with citrate capped Au NPs.28 The cellular uptake 
via endocytosis of Au NPs resulted in the enlargement of lysosomes and reduced the lysosome 
degradation capacity by increasing its pH.29 Au NPs can also alter cellular migration, and 
depending on the cell type can either slow down or speed up migration.16  
To be able to analyze and study NP-cell interactions more reproducibly, it is thus crucial 
to have methods to 1) avoid the aggregation of NPs in cell media, and 2) understand both the 
acute and sub-lethal toxicity of NPs on cells. The Derjaguin-Landau-Verwey-Overbeek (DLVO) 
theory, which proposed that the stability of a suspension is determined by the interaction of two 
opposing electrostatic and van der Waals interactions30–32, suggests that aggregation of NPs can 
be prevented by electrostatic and/or steric repulsive forces. It thus implies that by carefully 
controlling the pH, ionic strength and protein concentration, it is possible to prevent NP 
aggregation. In order to develop a more global picture of in vitro AuNP toxicity, the impact of 
NPs on acute cellular mortality should be supplemented by studies of how cell morphology, 
metabolism, and gene expression change following NP exposure. 
The protein corona formation on Au NPs can be embraced and used as an additional 
electrostatic/steric stabilizer to prevent the aggregation of Au NPs in cell media. Previously, Kah 
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et al. showed that the protein corona can be exploited to trap DNA or drugs for triggered release, 
and the sequential addition of first serum protein in PBS followed by the payload resulted in 
smaller Au NP clusters than when added simultaneously.33 In this paper, we show that by 
incubating Au NPs sequentially first with serum proteins in nanopure deionized water, and then 
dispersing the protein-Au NP complexes in buffer (containing amino acids, salts and nutrients) to 
make up the complete cell media, aggregation can be prevented. The cellular uptake of Au NPs 
as well as their toxicity was shown to be significantly different depending if Au NPs are 
aggregated or not. We also show that the use of other biomolecules such as phospholipids to 
overcoat Au NPs can prevent their aggregation in cell media. Cell viability assays were 
supplemented with fluorescent confocal images which showed that while cells are still viable, 
cell morphology is changed. Overall, our results highlight that the aggregation of Au NPs in cell 
media can be prevented, and should be factored in as a major component of NP-cell interaction 
in in vitro uptake and toxicity assays. 
 
5.2.  Materials and Methods 
5.2.1.  Materials   
Gold(III) chloride trihydrate (HAuCl4·3H2O, ≥99.9%), sodium citrate tribasic dihydrate 
(Na3Ct·2H2O, ≥99%), poly(allylamine hydrochloride) (PAH, M.W. 15 000 g/mol) and 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, ≥99.5%) were obtained from Sigma-
Aldrich and were used as received. 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (sodium 
salt) (POPS), 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (LPC) and L-α-
phosphatidylethanolamine-N-(4-nitrobenzo-2-oxa-1,3-diazole) (ammonium salt) (F-lipid) in 
chloroform were obtained from Avanti Polar Lipids and were used as received. Fetal bovine 
serum (lot #: A45D03D) was obtained from Gemini Bio-products. Fluorescein phalloidin and 
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DAPI was obtained from Invitrogen and used as suggested. Coomassie (Bradford) protein assay 
was obtained from Thermo Scientific. Ultrapure deionized water (17.9 MΩ, Barnstead Nanopure 
II) was used for all solution preparations, which was further sterile filtered as needed. A solution 
of HEPES buffer (20 mM, pH 7) was prepared in ultrapure deionized water. Glassware was 
cleaned with aqua regia and rinsed thoroughly before use. 
 
5.2.2.  Synthesis and Coating of Gold Nanoparticles  
Au NPs (diameter 20 nm) were synthesized by the boiling citrate method as previously 
described with modifications.34 Briefly, 2.5 mL of 0.01 M HAuCl4·3H2O was added to 97.5 mL 
of ultrapure water in a 200 mL Erlenmeyer flask and heated to a gentle boil with stirring. An 
aqueous solution of sodium citrate (5% w/w, 2 mL) was added and the solution was allowed to 
boil for another 30 min. During this period, the color of the solution changed slowly to a deep 
red. Another portion of sodium citrate (5% w/w, 0.2 mL) was added and the solution was 
allowed to boil for another 20 min, following which the solution was allowed to cool slowly to 
room temperature while stirring. The hydrodynamic diameter measured by dynamic light 
scattering was 32.3 ± 0.2 nm. 
Poly(allylamine hydrochloride) (PAH) Au NPs were made by first purifying 1 mL of 
citrate Au NPs by centrifugation. The Au pellet was collected and resuspended in 1 mL of water. 
To this purified Au NPs pellet, 100 μL of NaCl (0.1 M) and 200 μL of PAH (10 mg/mL) were 
added simultaneously, and the solution vortexed for 10 s. The NPs were allowed to incubate 
overnight or longer before being purified by centrifugation. 
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5.2.3.  Lipid Coating of Gold Nanoparticles 
A 1:1 weight ratio of POPS:LPC was used to coat Au NPs. F-lipid was doped at 10% of 
the total lipid mass. Briefly, a total of 1 mg of lipid (0.5 mg of each POPS and LPC) in 
chloroform was dried under a stream of nitrogen. The lipid film was then further dried under 
vacuum for about 6 h, after which 2 mL HEPES buffer was added to give a final concentration of 
0.5 mg/mL. The mixture was sonicated for about 60 min to totally suspend the lipids, affording a 
clear colorless solution. To make lipid coated PAH (L-PAH) Au NPs, purified PAH Au NPs was 
added directly to the lipid mixture and mixed (1 pmole PAH Au NPs in 0.5 mg lipids). The 
mixture was allowed to incubate overnight before purification by centrifugation at 600 rcf for 30 
min. The supernatant was again centrifuged at 3000 rcf for 20 min. For hybrid lipid coated (HL) 
Au NPs, purified citrate-capped NPs was first added to lipid mixture (1 pmole citrate Au NPs in 
0.5 mg lipids), followed by 2 µL C18SH (0.5 mg/mL ethanol). The mixture was mixed and 
incubated overnight at room temperature, then centrifuged at 4000 rcf for 25 min.  
 
5.2.4.  Cell Media 
Cell media for growth of HDF cells and Au NP studies was made in house. Regular cell 
media was made from high glucose Dulbecco’s Modified Eagle Medium (DMEM) containing 4 
mM L-glutamine, 1 mM sodium pyruvate, 3.7 g/L sodium bicarbonate and supplemented with 
10% FBS and 1% pen-strep. For the two steps addition of cell media, serum free 2x high glucose 
DMEM was supplemented with 8 mM L-glutamine, 2 mM sodium pyruvate and 3.0 g/L sodium 
bicarbonate. FBS was diluted to 20% with sterile water and when needed, added to 2x DMEM in 
a 1:1 ratio. 
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5.2.5.  Incubation of Gold Nanoparticles in Cell Media 
Au NPs were added to cell media in 2 ways. Au NPs were centrifuged, purified, pelleted 
and the concentration measured. For Au NPs added directly to cell media, an aliquot of Au NPs 
was taken and added to a 15 mL tube. Cell media was then added to the tube and pipetted up and 
down several times to disperse the Au NPs. For sequential addition of Au NPs to cell media, an 
aliquot of Au NPs was first added to a 15 mL tube, followed by the addition of 20% FBS and 
mixed. An equal volume of buffer (with other amino acids, salts and nutrients) was then added to 
the Au NP solution and mixed thoroughly by pipetting. 
 
5.2.6.  Bradford Assay 
Au NPs, after incubation with serum proteins, were centrifuged 3 times with 1x 
phosphate buffer saline (PBS) to remove excess unbound proteins. The Au NP pellet was 
incubated with 5 µL KCN (1 mM) until all the Au NP had dissolved. The protein sample was 
then made up to 150 µL in 1x PBS. Samples (150 µL) were first added to 96 well plates, 
followed by 150 µL of Bradford assay reagent and mixed well. The mixture was allowed to 
incubate for about 10 min before analyzing the absorbance at 590 nm using a plate reader. 
Standard curves were made using albumin standards in 1x PBS from 0–200 µg/mL.  
 
5.2.7. Staining of HDF Cells for Confocal Imaging 
HDF cells were plated at a density of 20,000 cells/dish in 35 mm MatTek dishes and 
allowed to grow overnight. Au NPs (1 nM) were added and the cells incubated again overnight. 
After incubation, HDF cells were washed 2 times with 1x PBS and fixed with 4% 
paraformaldehyde (in 1x PBS) for 30 min. HDF cells were then washed 3 times with 1x PBS 
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with 5 min incubation each. The cells were permeabilized with 0.5% Triton X-100 for 10 min 
and washed 3 times with 1x PBS for 5 min each. HDF cells were then incubated with 10% goat 
serum (in 1x PBS, 0.1% NaN3) for 1 h before washing again 3 times with 1x PBS. Fluorescein 
phalloidin was added and HDF cells incubated for 30 min, following a 3 times wash with 1x 
PBS. DAPI was then added to the cells for 10 min and washed 3 times with 1x PBS before 
imaging under confocal microscope. 
 
5.2.8.  Instrumentation 
A microcentrifuge (Eppendorf model 5418, Fisher-Thermo Electron) was used in various 
steps of synthesis and purification as detailed above. Standard absorption spectra were taken on a 
Cary 500 Scan UV-vis-NIR spectrophotometer at a scan rate of 30 nm/sec. Dynamic light 
scattering and zeta potential measurements were performed on a Brookhaven Zeta PALS 
instrument. Absorbance from 96 well plates was measured at 590 nm on a SpectraMax 
absorbance plate reader. Fluorescence confocal images were taken on a Zeiss LSM 710. 
 
5.3.  Results 
5.3.1.  Addition of Au NPs to Cell Media 
Four types of 20 nm spherical Au NPs were investigated: anionic citrate-capped Au NPs, 
cationic poly(allylamine hydrochloride) (PAH) coated Au NPs, and two types of lipid coated Au 
NPs (Scheme 5.1). A 1:1 lipid mixture of 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine 
(anionic, POPS)/1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (zwitterionic, LPC) was 
used to coat Au NPs. These lipids, which we have used before, were conjugated onto Au NPs in 
two ways.35  By utilizing  the hydrophobic interactions of  the acyl tails with  octadecanethiol  
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Scheme 5.1.  Types of Au NPs Used and Surface Ligands.a  
 
 
 
 
aNote: ligands are not drawn to scale. PAH coating is shown as a blue layer on top of the citrate 
Au NPs. Subsequent AuNP lipid coatings are shown in a cutaway view. 
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(C18SH)-functionalized Au NPs, a hybrid lipid layer on Au NPs with the inner leaflet comprising 
of C18SH and the outer leaflet comprising of lipids can be made (HL Au NPs). Alternatively, by 
using electrostatic attractions between the polar headgroup of lipids with positively-charged 
PAH Au NPs, lipids can be coated onto PAH Au NPs (L-PAH Au NPs). UV-vis spectra of these 
Au NPs in water showed that after lipid coating, red shifts in the plasmon peak maxima of ~1-3 
nm was seen, signifying a change in the refractive index around the Au NP after 
functionalization (dotted spectra, Figure 5.1a, b). Dynamic light scattering (DLS) data showed an 
increase in the hydrodynamic diameter after lipid functionalization: ~6 nm for HL Au NPs and a 
larger increase of ~128 nm for L-PAH Au NPs, possibly suggesting multilayered lipid formation 
on PAH Au NPs (Table 5.1). Upon lipid coating, the zeta potential became more negative (-51.9 
± 1.3 mV for HL Au NP and -48.7 ± 1.3 mV for L-PAH Au NP), reflecting the presence of 
POPS (negatively charged lipid) in the lipids on Au NPs.  
The four types of Au NPs were incubated with cell media in the following two ways: 1) 
direct incubation with the full cell media (10% fetal bovine serum (FBS) in buffer with amino 
acids, salts and nutrients), or 2) sequential addition by first incubating Au NPs with 20% FBS in 
water, followed by the addition of 2x buffer (containing amino acids, salts and nutrients) in a 1:1 
ratio (Scheme 5.2). As compared to incubation with just bovine serum albumin (BSA) alone, 
these methods mimic the complexity of the environment. When Au NPs were incubated directly 
in cell media, aggregation was observed for citrate and PAH Au NPs (Figure 5.1). The UV-vis 
plasmon band red shifted and broadened, signifying the presence of larger aggregates as 
compared to their respective Au NP suspensions in water. Visually, a red to purple color 
transition of the Au NP suspension was observed. However, when first incubated with 20% FBS, 
and subsequently added to an equal volume of 2x buffer, no aggregation was observed even after  
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Figure 5.1.  UV vis spectra of 20 nm Au NPs from a) the direct addition to cell media and b) the 
sequential addition first to 20% FBS followed by 2x buffer. Black = citrate Au NPs; red = PAH 
Au NPs; blue = L-PAH Au NPs; green = HL Au NPs. The corresponding Au NPs in water is 
shown as the dotted spectra. Inserts: Photographs showing Au NP color after addition to bio-
fluids. 
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Table 5.1.  Hydrodynamic Diameter from Dynamic Light Scattering (DLS), ζ-Potential Changes and Protein Adsorbed per 20 
nm Au NP (protein/NP) When in Water, When Added Directly to Cell Media and When Added Sequentially to Cell Media. 
 
Au NP 
surface 
Water Direct Addition Sequential Addition 
DLS (nm) ζ-potential 
(mV) 
DLS (nm) ζ-potential 
(mV) 
protein/NPa DLS (nm) ζ-potential 
(mV) 
protein/NPa 
citrate 32.3 ± 0.2 -19.2 ± 1.2 83.2 ± 1.1 -22.7 ± 0.4 22 ± 1 36.8 ± 0.3 -14.0 ± 1.2 47 ± 3 
PAH 34.7 ± 0.3 +16.6 ± 1.6 169.1 ± 7.2 -18.8 ± 0.6 43 ± 4 66.8 ± 1.1 -18.7 ± 0.8 45 ± 1 
L-PAH 163.2 ± 1.6 -48.7 ± 1.3 150.2 ± 1.2 -27.4 ± 0.8 69 ± 4 315.0 ± 5.7 -30.9 ± 0.3 85 ± 2 
HL 38.4 ± 0.3 -51.9 ± 1.3 43.1 ± 2.0 -10.8 ± 2.2 36 ± 2 35.8 ± 0.4 -17.5 ± 1.4 44 ± 1 
 
a) Measured using Bradford assay with bovine serum albumin as calibration. 
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Scheme 5.2.  Addition of Au NPs to Cell Media via Direct or Sequential Methods.a  
 
 
 
aFBS = fetal bovine serum. 
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an overnight incubation. In this case, no peak broadening was observed in the UV-vis spectra 
and the Au NP suspensions remained red in color. Lipid coated Au NPs (HL and L-PAH) were 
stable in both methods, suggesting that the lipid layer can effectively reduce Au NP aggregation.  
DLS data showed increase in hydrodynamic diameter on going from water, to direct or 
sequential addition of cell media for most Au NPs (Table 5.1). An increase in the hydrodynamic 
diameter of citrate Au NPs was seen when directly added to cell media (from 32.3 ± 0.2 nm to 
83.2 ± 1.1 nm), but when sequentially added to cell media, only a small increase was observed 
(from 32.3 ± 0.2 nm to 36.8 ± 0.3 nm). The diameter of PAH Au NPs increased from 34.7 ± 0.3 
nm in water to 169.1 ±7.2 nm in direct addition to cell media, but only to 66.8 ± 1.1 nm in the 
sequential addition method. HL Au NPs maintained their hydrodynamic diameters in all 3 types 
of solutions, at 38.4 ± 0.3 nm in water, 43.1 ± 2.0 nm in direct addition to cell media and 35.8 ± 
0.4 nm in sequential addition. Interestingly, sequential addition of L-PAH Au NPs to cell media 
showed a larger hydrodynamic size increase of 315.0 ± 5.7 nm than when directly added to cell 
media (150.2 ± 1.2 nm).  
The amount of protein adsorbed from the media per Au NP was quantified using the 
Bradford assay (Table 5.1). With the exception of L-PAH Au NPs, when sequentially added to 
cell media, citrate, PAH and HL Au NPs had similar amounts of protein adsorbed on the 20 nm 
Au NPs (47 ± 3, 45 ± 1 and 44 ± 1 protein/NP respectively). Approximately twice as much 
protein was adsorbed onto L-PAH Au NPs (85 ± 2 protein/NP), probably due to the larger size 
after multilayered adsorption of lipids onto PAH Au NPs. When Au NPs were incubated directly 
in cell media, more variation was observed. The amount of protein adsorbed per Au NP for 
citrate, PAH, L-PAH and HL Au NPs was 22 ± 1, 43 ± 4, 69 ± 4 and 36 ± 2 respectively.  
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5.3.2.  Interaction of Au NPs with HDF Cells 
Au NPs from both addition methods were incubated with human dermal fibroblast (HDF) 
cells to study the impact of surface chemistry and sequence of addition on cell viability. Au NPs 
were incubated with HDF cells for at least 24 h and the relative cell viability was quantified 
(Figure 5.2a, b). When Au NPs were added directly in cell media, incubation of HDF cells with 
citrate, L-PAH and HL Au NPs did not result in significant decrease of cell viability at up to 1 
nM Au NP concentration. In the presence of PAH Au NPs, the relative cell viability decreased to 
close to 0 % at the 1 nM PAH Au NP concentration. In comparison, when Au NPs were 
sequentially added to cell media, relative cell viability remained high at about 100 % for citrate 
and HL Au NPs. These Au NP types did not significantly reduce HDF cells cell viability at up to 
4 nM Au NP concentration. With L-PAH Au NPs, a slight decrease in relative cell viability to 
(78 ± 27) % was observed at 4 nM Au NP. HDF cells incubated with PAH Au NPs after 
sequential addition to cell media had a relative cell viability of (102 ± 4) % at 1 nM PAH Au NP 
concentration; HDF cells relative cell viability only decreases to (12 ± 4) % at 4 nM PAH Au NP 
concentration, four-fold the concentration as compared to PAH Au NPs in cell media.  
The uptake of Au NP by HDF cells was quantified using ICP-MS (Figure 5.2c). Au NP 
uptake by HDF cells was largest for Au NPs that had been directly added to cell media. 2.3–4.8 x 
105 Au NPs were detected per HDF cell when incubated with citrate, PAH or L-PAH Au NPs. 
With HL Au NPs, (3.2 ± 2.5) x 104 Au NP were found per HDF cell. In contrast, sequential 
addition of Au NPs to cell media resulted in a smaller Au NP uptake by HDF cells. With citrate 
Au NPs, a significant decrease in uptake was observed: only (250 ± 130) Au NP/cell was 
detected, a thousand-fold decrease. Uptake of PAH, L-PAH and HL Au NPs by HDF cells were 
decreased but less drastically; PAH and L-PAH Au NPs uptake was decreased by half to about 
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Figure 5.2.  Cell viability assay of HDF cells in a) direct addition to cell media and b) sequential 
addition to cell media. Citrate Au NPs (black), L-PAH Au NPs (blue) and HL Au NPs (green) do 
not cause significant decrease in HDF cell viability in both conditions. PAH Au NPs (red) cause 
significant decrease in cell viability at 1 nM when directly added to cell media, but only at 4 nM 
when sequentially added. c) ICP-MS results quantifying Au NP uptake per HDF cell in direct 
addition (black) or sequential addition to cell media (red). Au NP concentration used is 0.1 nM.  
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(1.2–2.3) x 105 Au NP/cell, while with HL Au NPs, a 20-fold decrease was observed ((1.6 ± 0.3) 
x 103 Au NP/cell). 
While Au NPs are non-toxic to HDF cells at low concentrations, cell morphology has 
been shown to be influenced by the uptake of Au NPs.28 In particular, actin fibers were observed 
to be disrupted when incubated with citrate Au NPs.28 To further explore the effect of Au NPs on 
cells, HDF cells incubated with Au NPs (1 nM) using both addition methods were stained for F-
actin fibers using fluorescent phalloidin and imaged using fluorescence confocal microscopy. 
HDF cells incubated with Au NPs using the direct method is shown in Figure 5.3. Control HDF 
cells (without Au NPs) had well defined F-actin fibers. Incubation of HDF cells with citrate Au 
NPs disrupted the F-actin fibers, as judged by many globular fluorescent dots within the cell. In 
comparison, F-actin fibers were still prominent when incubated with HL Au NPs, although some 
fluorescent dots can be seen, signifying that some disruption still occurred.  At 1 nM PAH Au 
NP concentration, HDF cells were not viable: all observed HDF cells were shrunk, lost their 
multipolar nature and the F-actin fibers were not clearly defined. At the same concentration, L-
PAH Au NPs did not totally disrupt F-actin fibers of HDF cells; while the fibers can still be seen, 
they were not as well defined as control cells. In contrast, incubation of HDF cells with Au NPs 
in using the sequential method at the same concentration disrupted F-actin fibers of HDF cells to 
a lesser extent for all types of Au NPs (Figure 5.4).  
The high scattering cross section of Au NPs allows them to be easily located under the 
reflectance mode of confocal microscopy. Large scattering was observed from HDF cells when 
incubated with citrate and L-PAH Au NPs, and to a lesser extent HL Au NPs, suggesting large 
uptake of Au NPs by HDF cells (Figure 5.3). In contrast, much less scattering was observed for 
HDF  cells incubated with citrate Au NPs with sequential addition to cell  media  (Figure 5.4a).  
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Figure 5.3.  Representative confocal images of control HDF cells and HDF cells exposed to 
citrate, PAH, L-PAH and HL Au NPs (1 nM) directly added to cell media for 24 h. Actin was 
stained with fluorescein phalloidin, nucleus was stained with DAPI and Au NPs was detected 
using reflectance mode at 633 nm.  
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Figure 5.4.  Representative confocal images of HDF cells exposed to citrate, PAH, L-PAH and 
HL Au NPs (1 nM) sequentially added to cell media for 24 h. Actin was stained with fluorescein 
phalloidin, nucleus was stained with DAPI and Au NPs was detected using reflectance mode at 
633 nm.   
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HDF cells incubated with PAH and L-PAH Au NPs showed large scattering from Au NPs, 
reflecting the large uptake of Au NPs. 
A critical question regarding intracellular Au NPs is if the surface chemistry is changing 
on entering the cell. To understand if the lipids are displaced from Au NPs when they are 
uptaken into HDF cells, the lipid layer on HL and L-PAH Au NPs were doped with a fluorescent 
lipid (F-lipid) and incubated with HDF cells. In the absence of Au NPs, fluorescence from the F-
lipid was not detected, signifying that uptake of lipid vesicles alone by HDF cells is not 
favorable (Figure 5.5). With L-PAH Au NPs carrying F-lipid, fluorescent vesicles (~0.8 µm) 
could be detected inside HDF cells. In addition, a weaker fluorescence was observed to be 
diffused all over the cell membrane, even after multiple washing steps. F-lipid on any of the Au 
NPs did not produce any fluorescence, as judged by confocal microscopy. Therefore the 
observation of F-lipid in HDF cells suggests that PAH Au NPs aid in the uptake of biomolecules 
into cells and this layer can be stripped from Au NPs after cellular entry with a 16 h incubation. 
Fluorescence from F-lipid was not observed when HDF cells were incubated with HL Au NPs. 
This can be due to either the lipids remained trapped on the Au NP surface or the fluorescence is 
too weak to be detected due to the lower uptake of HL Au NPs. 
 
5.4.  Discussion 
A previous study have shown that the protein corona formation on Au NPs is dependent 
on the type of cell culture media and time, and that the nanoparticle-protein interaction can be 
mediated by the different components of cell media.36 In our investigations, we have further 
broken down the cell media into its buffer and FBS components, such that their respective 
impact on Au NPs can be studied. 
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Figure 5.5.  Representative confocal images of control HDF cells and HDF cells exposed to HL 
and L-PAH Au NPs (1 nM) doped with fluorescent lipids. Nucleus was stained with DAPI and 
Au NPs was detected using reflectance mode at 633 nm. Control cells were treated with F-lipids 
only.  
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The initial surface chemistry of the AuNP strongly influences its tendency to aggregate in 
cell media. When citrate and PAH Au NPs were added to cell media using the sequential 
method, no significant aggregation of Au NPs was observed. The addition of FBS alone to Au 
NPs allowed for the complete formation of a protein corona, which potentially stabilizes Au NPs 
to the harsh conditions of ionic strength changes introduced by the salts added subsequently. On 
the other hand, while the protein corona can still form on citrate and PAH Au NPs when 
introduced directly to cell media, the concurrent, and possibly faster kinetics of aggregation of 
Au NPs due to the salts prevents complete passivation of Au NP surface before aggregation 
occurs. This suggests that aggregation of Au NPs in cell media is due to the exposure of Au NPs 
to salts prior to the formation of a well-developed protein corona. Multilayers of lipids on L-
PAH Au NPs (but not HL Au NPs) also seem to influence protein binding and aggregation; DLS 
data showed larger increase from sequential addition compared to direct addition. 
It was observed that lipid coated Au NPs (HL and L-PAH Au NPs) did not aggregate 
when introduced directly into a high-salt cell media. These results suggest that biomolecules 
such as proteins and lipids can be used to mitigate Au NP aggregation. Based on the DLVO 
theory, the attractive van der Waals interaction must be counter balanced by a potential barrier 
introduced by repulsive electrostatic interactions from the electric double layer of NPs for them 
to be well dispersed in solution.30–32  For NPs, this potential barrier is small and can be easily 
overcome by a change in the ionic strength of solution. However, unlike Au NPs, due to the 
shape and the non-uniform distribution of charges in proteins, the electrostatic interactions 
between proteins can have both attractive and repulsive interactions and cannot be fully 
described by DLVO theory.37 In a high salt medium such as cell media, proteins were shown to 
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stabilize NPs through solvation forces.38 It is this energy penalty that increases the intermolecular 
repulsion and hence stabilizes protein and lipid coated Au NPs from aggregation.39 
Under our experimental conditions, fewer proteins adsorb onto citrate Au NPs when they 
are aggregated compared to when they are well-dispersed, while similar amounts of proteins 
adsorb onto PAH Au NPs regardless of their aggregation state. PAH Au NPs had 43 ± 4 
protein/NP from direct addition to cell media (aggregated) and 45 ± 1 protein/NP from sequential 
addition to cell media (not aggregated), while citrate Au NPs in direct addition (aggregated) had 
22 ± 1 protein/NP and 47 ± 3 in sequential addition (not aggregated). At equilibrium, the size 
and surface curvature of NPs may influence the extent of protein corona formation. Given that 
the total surface area exposed is smaller for aggregated Au NPs than for non-aggregated Au NPs, 
fewer proteins would be able to adsorb on aggregated Au NPs. 
 Interestingly, lipids did not reduce protein corona formation on Au NPs. In fact, even 
more proteins bound onto L-PAH Au NPs than the other types of Au NPs. It is possible that 
lipids can trap lipohilic proteins in the media. This has been shown for lipid coated Au NRs, 
where lipophilic analytes can be trapped on the Au NR surface for enhanced detection.40 
In our study, we limited the sedimentation of Au NPs by using smaller 20 nm Au NPs. 
Previously, we have shown that larger 90 nm Au NPs as well as Au NRs, because of their mass, 
can sediment in a relatively short amount of time (~3.5 h for 90 nm Au NPs and ~14.1 h for Au 
NRs to fall 1 mm).16 Similarly, using Stokes’ law, the settling velocity for 20 nm Au NPs 
(assuming the Au NPs remain well-dispersed) is 3.9 x 10-3 nm/s, which translates to ~7.1 x 104 h 
or ~3000 days to fall a distance of 1 mm. Such a time frame is much longer than a typical Au 
NP-cell incubation study (~1-2 days), and the effects from sedimentation should be negligible. 
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Indeed, for the duration of our experiments (~1-2 days), non-aggregated Au NPs were observed 
to remain in suspension. 
When aggregated (direct addition) citrate and PAH Au NP were added to HDF cells, 
more Au NP were taken up by cells. This is not surprising as aggregated Au NPs are denser and 
settle to the bottom of the plate much faster (where the cells are). The sedimented Au NPs, either 
on the plate surface or on HDF cells, increased the local Au NP concentration at the substrate 
interface, resulting in a larger cellular uptake. However, by ensuring that the Au NPs are well 
dispersed, a much lower Au NP uptake was observed. In fact, for well-dispersed Au NPs, 
completely different trends in the relative Au NP uptake were observed. In the absence of 
aggregation, the uptake of the citrate Au NPs was almost negligible compared to the other 
AuNPs tested. The toxicity of PAH Au NPs was also found to be dramatically altered when 
using either aggregated (direct addition) or non-aggregated (sequential addition) samples. 
However, the aggregation of citrate Au NP did not affect the relative cell viability of HDF cells. 
Similar results have been observed in other studies and are found to be dependent on various 
factors such as cell type and NP surface: transferrin-coated Au NPs (aggregated) are non-toxic to 
HeLa, A549 cells and MDA-MB-435 cells14 while single walled carbon nanotubes were shown 
to be toxic to mice only when aggregated.41 The toxicity of cationic NPs is possibly due to strong 
interactions with cell membranes, and resulted in the disruption of membrane integrity.42 In our 
work, the aggregation of cationic PAH Au NPs increased its concentration at the bottom of the 
dish (where the cells are), and hence possibly enhanced its toxicity. Given that proteins adsorbed 
onto Au NPs, it is highly likely that the underlying coating layers on the Au NPs can influence 
cellular response, and also implies that the protein corona is evolving as it enters the cell.  
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A total of (4.8 ± 0.3) x 105 PAH Au NP/cell was found in HDF cells using the direct 
addition method (aggregated PAH Au NPs, 0.1 nM), while when added sequentially (non-
aggregated PAH Au NPs, 0.1 nM), (2.3 ±0.4) x 105 PAH Au NP/cell was seen. At the same dose, 
the uptake of PAH Au NPs was twice as much when aggregated as compared to non-aggregated. 
The relative cell viability of HDF cells in well dispersed PAH Au NPs only decreases to ~10 % 
at 4 nM, while in aggregated PAH Au NPs the relative cell viability decreases to ~0 % at 1 nM, 
indicating that the effective toxic dosage of PAH Au NPs is four-fold higher when non-
aggregated. While these results suggest that aggregated PAH Au NPs are uptaken at a higher rate 
and are more toxic, it is not possible to deduce correlation from causation; the uptake of PAH Au 
NPs may not be linearly related to PAH Au NP concentration and toxicity can be due to either an 
increased uptake of PAH Au NPs or the disruptive process of PAH Au NP size and accumulation 
in HDF cells. In addition, since a fraction of ICP-MS results may be due to Au NPs on the cell 
surfaces that are not washed away (in addition to internalized Au NPs), this fraction might be 
larger with aggregated PAH Au NPS, and hence cannot be correlated to toxicity. 
Confocal imaging showed that F-actin fibers were disrupted to a various extents 
depending on Au NP type. Compared to control HDF cells, incubation of all Au NPs types to 
HDF cells resulted in varying decrease in F-actin fiber intensity and thickness, with the 
appearance of actin dots. Similar to results reported by Pernodet et al., incubation of citrate Au 
NPs to HDF cells showed F-actin fiber disruption.28 The F-actin disruption was more obvious 
and pronounced with aggregated (direct addition) citrate and PAH Au NPs and suggest either F-
actin de-polymerization or a lack of F-actin polymerization and formation. Since HDF cells are 
exposed to a higher relative concentration of Au NPs when aggregated, it suggests that the F-
actin disruption is Au NP concentration dependent. Indeed, when non-aggregated citrate and 
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PAH Au NPs are used, F-actin disruption occurred to a lesser extent. The incubation of lipid Au 
NPs with HDF cells helped reduced but did not eliminate F-actin fibers disruption, as judged by 
the appearance of actin dots. Since phalloidin stains specifically for F-actin, the actin dots 
observed are unlikely to be due to G-actin (monomer) accumulation. Increasing evidence showed 
that in addition to its cytoskeletal role, actin also plays an essential role in the endocytotic 
process.43,44 It is thus possible that the presence of actin dots in HDF cells is due to an increase in 
endocytotic events that occur at the cell surface due to Au NP uptake.  Our interpretation of actin 
dots formation is in line with previous results, which showed that actin dots only form at the 
‘top’ surface of HDF cells.28 
To investigate the lability of surface ligands on Au NPs, lipid coated Au NPs were doped 
with F-lipid and incubated with HDF cells. It was observed that only when exposed to L-PAH 
Au NPs did HDF cells show fluorescence due to F-lipid. Since the lipid vesicles (POPS/LPC/F-
lipid) was shown to not be actively taken up by HDF cells, it can be concluded that the uptake 
and presence of F-lipid was aided by the endocytosis of L-PAH Au NPs. The bright fluorescence 
from F-lipid in HDF cells is believed to be due to 1) L-PAH Au NPs uptaken in extremely large 
quantities and 2) the multilayered lipid adsorption allowed for more F-lipid to be adsorbed per 
PAH Au NP. While bright fluorescent spots can be detected on HDF cells, probably due to 
endocytosized L-PAH Au NPs, fluorescence can also be detected throughout the cell surface. 
The delocalization of F-lipid from endocytotic vesicles implies that surface ligands on PAH Au 
NPs can be stripped from the surface. It also further implies that the underlying surface 
chemistry is equally important in facilitating the dissociation of the lipid layer, i.e. the 
electrostatic interaction between the lipid layer and PAH layer can be disrupted upon entering the 
cell. In addition, coupled with the relative cell viability of HDF cells when incubated with L-
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PAH Au NPs, the data further showed that the toxicity of the underlying layer cannot be 
discounted. 
 
5.5.  Conclusion 
In conclusion, we have demonstrated how the formation of the protein corona can be used 
as a method to prevent Au NP aggregation in cell media. We show that the surface chemistry of 
Au NPs and its sequence of addition to cell media can elicit differential cellular response. Even 
before endocytosis into HDF cells, the surface chemistry affects Au NP aggregation in cell 
media. However, by first adding Au NPs to FBS and then subsequently to the buffer, aggregation 
can be avoided. Aggregation of Au NPs can also be avoided by over-coating Au NPs with other 
biomolecules such as lipids. The aggregation state of the AuNPs is shown to strongly influence 
both cellular toxicity and Au NP uptake: non-aggregated PAH Au NPs are four-fold less toxic to 
HDF cells than aggregated PAH Au NPs and the uptake of non-aggregated citrate Au NPs is a 
thousand-fold less than aggregated citrate Au NPs. The aggregation state of the AuNPs can also 
influence the sub-lethal toxicity of AuNPs in vitro, specifically their effect on cell morphology. 
Upon uptake of Au NPs, the F-actin formation is disrupted and actin dots are predominant, 
possibly a response to the increase in endocytotic processes. The actin fiber disruption is more 
pronounced when aggregated AuNPs enter the cells. The lipid layer on L-PAH Au NPs was also 
seen to dissociate from PAH Au NP on entering the cell. In light of our findings, we suggest that 
future experiments regarding NP-cell interaction should be carefully regulated for NP 
aggregation and that the literature should be perused with this in mind. 
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CHAPTER 6 
Nanovacuums: Nanoparticle Uptake and Differential 
Cellular Migration on a Carpet of Nanoparticles 
 
 
6.1.  Introduction 
Gold nanoparticles (Au NPs) are excellent model NP systems for biological studies 
because of their low cytotoxicity and large absorption and scattering coefficients.1 These 
properties have enabled biomedical applications of Au NPs in areas such as chemical sensing, 
imaging, drug delivery and targeting.2−7 While the promise of nano/biotechnology is great, the 
understanding of nanoparticle mechanisms of interaction with biological entities has only been in 
recent years probed and questioned. For example, gold nanospheres (Au NSs) are preferentially 
taken up by HeLa cells as compared to gold nanorods of similar sizes.8 Au NSs of 40−50 nm 
diameter showed the largest uptake by human breast cancer cells as compared to other sizes.9 A 
net negative surface charge on the Au NPs was also shown to be preferred for Au NP uptake into 
human keratinocyte cells.10 Albanese and Chan showed that the degree of Au NP aggregation, a 
common but unavoidable occurrence when Au NPs are added to cell media, can influence 
cellular uptake.11 Recently, a study showed that the inherent density of Au NPs created a 
concentration gradient within the cell chamber, and cells at the bottom of the chamber were 
exposed to larger amounts of Au NPs as compared to the top.12 Most work on Au NPs has 
                                                            
  This chapter is reprinted with permission from: Jie An Yang, Hoa Tri Phan, Shruti Vaidya and Catherine J. 
Murphy. Nano Lett. 2013, 13, 2295-2302.  (DOI: 10.1021/nl400972r) Copyright 2013 American Chemical Society. 
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focused on their cytotoxicity.4,13 However, the changes in cellular behavior in the presence of Au 
NPs is potentially more interesting. For example, the study of cell migration is an area of active 
research as it has implications in wound healing, remodeling, and cancer metastasis.14,15 Cells 
undergoing repeated polarized extension-contraction cycles, which when coupled with adhesion 
and de-adhesion to the substrate, causes cell migration.16 In particular, for single cell migration, a 
5 step process has been identified: (1) leading edge formation, (2) adhesion and traction force 
generation, (3) focalized proteolysis, (4) actomyosin contraction, and (5) rear-end retraction.17 
This model is active in both normal and neoplastic single cell migration, the rate of which is 
influenced by the cell type and cellular environment. As long ago as 1977, Au NPs with 
diameters of 200−400 nm were used to visualize cell migration through the formation of tracks 
under darkfield illumination.18 This assay was used to track 3T3 fibroblast cells and human 
keratinocytes after fixation.19,20 However, because the Au NPs were plated on the substrate 
before the cells, cell adhesion to the substrate could be compromised. More recently, it had been 
shown that the uptake of Au NPs by human dermal fibroblast (HDF) cells can influence the 
formation of intracellular actin fibers, thus can indirectly affect cell adhesion and spreading.21 
Taken together, previous work suggests that with improvements in Au NP size, shape, and 
surface control, the time is ripe to study cellular function such as cell migration with well-
defined nanostructures. 
Here, we study the effect of sedimented Au NPs on cell migration. In a typical setup, 
prostate carcinoma (PC3) or HDF cells were first plated to about 60−70% confluency. The cells 
were plated such that cell−cell interactions were minimized and cells were allowed to freely 
diffuse. The Au NPs then added to the cell media were allowed to sediment slowly based on their 
intrinsic density onto the glass substrate, and the cellular behavior was observed over a period of 
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at least 8 h (Scheme 6.1). The media was left intact during the experiments. We show that cells 
in vitro, using their leading edge, can “clean” a surface deposited with gold nanospheres (Au 
NSs) and long gold nanorods (Au NRs). The measured mean square displacement (MSD) and 
mean cumulative square distance (MCSD) values of the cell show that the “vacuuming” of Au 
NPs by cells is deeply intertwined with cellular migration and may relate to the known 
differences in migration mechanisms of PC3 and HDF cells. 
 
6.2.  Materials and Methods 
6.2.1.  Materials   
Gold(III) chloride trihydrate (HAuCl4·3H2O, ≥99.9%), sodium citrate tribasic dehydrate 
(Na3Ct・2H2O, ≥99%), hydroquinone (≥99%), sodium borohydride (>98%) 
hexadecyltrimethylammonium bromide (CTAB, >99%), poly(allylamine hydrochloride), (PAH, 
M.W. ~15,000), poly(acrylic acid, sodium salt) solution (PAA, M.W. ~15,000, 35 wt. % in 
H2O), poly(sodium 4-styrenesulfonate) (PSS, M.W. ~70,000), poly(diallyldimethylammonium 
chloride) solution (PDADMAC, M.W. <100,000, 35 wt. % in H2O), filipin III (≥85%) and 
chlorpromazine hydrochloride were obtained from Sigma Aldrich and were used as received. 
Ascorbic acid (>99%) was obtained from Acros Organics. Phosphate buffer saline without Ca2+ 
and Mg2+ (PBS, 10X) was obtained from Lonza and diluted to 1X before use. 
Methoxy(polyethylene glycol) thiol (mPEG, M.W. 5,000) was obtained from Nanocs. Calcein 
AM, ethidium homodimer-1, Hoechst 33342 and Cellmask Orange plasma membrane stain were 
obtained from Invitrogen and used as per staining protocol. Polydimethylsiloxane (PDMS, 
Slygard 184) was obtained from Dow Corning. Prostate carcinoma (PC3) and human dermal 
fibroblast (HDF) cells were obtained  from  ATCC.  All cell media were prepared in house (PC3  
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Scheme 6.1.  Experimental Setup and Uptake of Au NPsa 
 
 
 
a(a) Schematics of experimental setup. Cells were first plated at low densities. Au NPs added 
were allowed to sediment (1−2 h) and cell migration observed. (b) Cartoon of the uptake of Au 
NPs on a substrate by a generic cell. The cell probes the surface for Au NPs. As the cell 
migrates, Au NPs are taken up via the leading edge and subsequently endocytosized at the cell 
body.  
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medium: Ham's F-12K (kaighns modification, Sigma N3520) with 1.5g/L sodium bicarbonate 
supplemented with 10% FBS and 1% pen-strep. HDF medium: high glucose DMEM with 1mM 
sodium pyruvate (Mediatech 50003) and 3.7g/L sodium bicarbonate supplemented with 10% 
FBS and 1% pen-strep). Ultrapure deionized water with 17.9 M_ (Barnstead Nanopure II) was 
used for all solution preparations. CTAB solution was made to 0.1 M in deionized water. PAH, 
PAA, PSS and PDADMAC solutions were made to 10 mg/mL in 1 mM NaCl solution. mPEG 
solution was made to 1mM in deionized water. Glassware were cleaned with aqua regia and 
rinsed thoroughly before use. 
 
6.2.2.  Synthesis of Gold Nanoparticles  
Gold nanospheres (Au NSs) (diameter 90 nm) were synthesized using 12 nm Au NPs as 
seeds and hydroquinone as the reducing agent.22 Seed Au NPs (diameter 12 nm) were 
synthesized using the boiling citrate method but with 3 mL of 1% sodium citrate. HAuCl4·3H2O 
solution (1% w/v, 2 mL) was centrifuged at 17,000 rcf for 1 hr after which the top 1 mL was 
obtained and added to 97.25 mL ultrapure deionized water and 0.75 mL of the 12 nm NP 
solution. The solution was then stirred rapidly at room temperature and 0.22 mL of 1% w/w 
sodium citrate was added, followed immediately by 1 mL of 0.03 M hydroquinone. The solution 
was allowed to stir overnight. Au NSs produced by this method yielded a diameter of 89 ± 13 nm 
under TEM. The hydrodynamic diameter measured using dynamic light scattering was 90.8 ± 0.3 
nm. 
Long gold nanorods (Au NRs) were synthesized using the three step synthesis, starting 
from gold seeds.23 The seeds were made by adding HAuCl4·3H2O solution (0.01 M, 0.25 mL) to 
CTAB solution (0.1 M, 9.75 mL). Ice cold NaBH4 solution (0.01 M, 0.6 mL) was added and the 
mixture stirred vigorously for 10 min. The brown solution was allowed to sit for about 1 h before 
180 
 
use. Two ependorff tubes (labeled A and B) containing HAuCl4 solution (0.01 M, 0.25 mL) and 
CTAB solution (0.1 M, 8.75 mL) and a flask (labeled C) containing HAuCl4 solution (0.01 M, 
2.5 mL) and CTAB solution (0.1 M, 90 mL) were made up. Ascorbic acid (0.1 M, 0.05 mL in A 
and B, 0.5 mL in C) was added and mixed until the solutions turned colorless. Seed solution (1 
mL) was added to A and mixed. After 15 sec, 1 mL of A was added to B and mixed. After 30 
sec, the entire solution of B was added to C and mixed. The solution was stored overnight for the 
gold nanorods to fully grow before purification. Au NRs made by this method had an aspect ratio 
of 14 (294 ± 112 nm by 21.1 ± 3.6 nm). 
 
6.2.3.  Polymer Coating on Gold Nanoparticles 
Au NSs (0.01 nM, 1 mL) were purified once and Au NRs (0.1 nM, 1 mL) were purified 
twice via centrifugation. The gold pellet was resuspended in 1 mL deionized water, following 
which NaCl solution (10 mM, 0.1 mL) and polyelectrolyte solution (10 mg/mL, 0.2 mL) was 
added simultaneously. The solution was vortexed and allowed to incubate overnight before 
purification via centrifugation. Au NSs and NRs were at least triple coated in this study (Au NS: 
PAH/PAA/PAH (positive) or PAH/PAA/PAH/PAA (negative); Au NR: PSS/PDADMAC/PSS 
(negative) or PSS/PADADMAC/PSS/PDADMAC (positive)). For mPEG coating on Au NPs, 
mPEG (1 mM, 10 μL each addition) was added to the purified Au NPs in a three step addition 
with a 1 h interval. 
 
6.2.4.  Fabrication of Cell Chamber   
The cell chamber is a simple setup made of a glass slide, PDMS and a cover slip. A 10 
mm diameter hole was first drilled into the glass slide. PDMS of 18 mm by 18 mm by 1 mm and 
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18 mm by 18 mm by 9 mm were made and a hole with a 10 mm diameter punched out. It is 
crucial to wash the PDMS multiple times at this point to remove excess unreacted monomers and 
initiator.24 This was performed by continuously stirring the PDMS in the following solvent: 
pentane for 24 h, pentane 24 h, xylene 2 h, xylene 24 h, xylene 24 h, xylene 24 h, 200 proof 
EtOH 2 h, EtOH 24 h, EtOH 12 h, and DI water 24 h. The PDMS was then dried overnight in an 
oven at 70 °C. The glass slide and cover slip (thickness = 1.5) were cleaned in piranha solution 
(3:1 H2SO4:30% H2O2) for 1 h, washed thoroughly with DI water and dried under a stream of 
nitrogen. (Caution: Piranha solution is extremely reactive with organic matter.) To assembly the 
cell chamber, the glass slide and PDMS (18 x 18 x 1 mm) was first placed in an UV ozone 
cleaner for 3 mins and both exposed sides placed in contact. The PDMS side of the glass slide 
was again place face up in the UV ozone cleaner with a cover slip for 3 mins and both exposed 
side placed in contact. The cell chamber was then placed in an oven at 70 °C overnight to 
facilitate bonding of PDMS to glass. This gives a cell chamber with a thickness of 2 mm (glass 
slide thickness plus PDMS). The cell chamber was pre-coated with poly-lysine (0.3 mL, 
1mg/mL) for 2 h before the cells were plated. To increase the volume of the cell chamber, the 
thicker PDMS (18 x 18 x 9 mm) can be placed in contact with the glass slide. The total volume 
of media that can be added to this setup is 1 mL. Before imaging, the top PDMS was removed 
and the glass slide covered with another cover slip on top to reduce evaporation. 
 
6.2.5.  Incubation of Cells with Au NPs 
PC3 cells (plating density 80,000) and HDF cells (plating density 20,000) were plated 
and allowed to adhere to the surface overnight. Au NPs (0.005 or 0.02 nM) in media was added 
and further incubated as required. The cell chambers were always sealed with a cover slip prior 
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to imaging. For experiments with filipin (2.5 μg/mL) and chlorpromazine (5μg/mL), cells were 
treated with the compounds and incubated for 15 mins at 37 °C before washing with 1x PBS. Au 
NPs in media was then added. 
 
6.2.6.  Cell Viability Assays 
A Live/Dead stain kit was used to visualize the cells under fluorescence microscopy. 
Following washing with PBS, 0.2 mL of the stain (2.5 μL calcein AM and 8 μL ethidium 
homodimer-1 in 10 mL PBS) was added and allowed to incubate for 45 min before imaging. 
Live cells will fluoresce green while dead cells will give a red fluorescence. 
 
6.2.7.  Instrumentation 
A microcentrifuge (Eppendorf model 5418, Fisher-Thermo Electron) was used in various 
steps of synthesis and purification as detailed above. Standard absorption spectra were taken on a 
Cary 500 Scan UV-vis-NIR spectrophotometer at a scan rate of 30 nm/sec. Zeta potential and 
dynamic light scattering measurements were performed on a Brookhaven Zeta PALS instrument. 
All spectra were corrected with HEPES buffer as baseline. Darkfield imaging was performed on 
a Zeiss Observer.Z1 microscope at 10.0 V. Time lapse images were taken using 
multidimensional acquisition in the Axiovision software, at every 5 mins for at least 8 h. Imaging 
at higher magnification was performed at every 10 s, for at least 40 mins. 
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6.3.  Results and Discussion 
6.3.1.  Gold Nanoparticles and their Surface Modifications 
In order to probe the sedimentation effect of nanoparticles on cells, large and hence 
heavier nanoparticles were specifically chosen. Two types of Au NPs were used, Au NSs and Au 
NRs. (Note: The abbreviation Au NPs will be used to describe both types of nanoparticles.) Au 
NSs with a diameter of 90.8 ± 0.3 nm and Au NRs with aspect ratio of ∼14 (294 ± 112 nm by 
21.1 ± 3.6 nm) were synthesized as previously published.22,23 The rate of sedimentation, or 
settling velocity, for the spherical 90 nm Au NS can be estimated by equating the frictional and 
buoyancy force to the gravitational force (Stokes’ law)25 
 vs=
2
9
(ρp-ρ)
η gR
2 (1) 
where vs is the Au NSs’ settling velocity (m/s), ρp is the Au NS density (19 320 kg/m3), ρ is the 
water density (1000 kg/m3), η is the viscosity of water (1.002 mPa·s), g is the gravitational 
acceleration (9.8 m/s2), and R is the radius of the Au NS (45 × 10−9 m). Au NSs of 90 nm have a 
settling velocity of 81 nm/s. For Au NRs, due to their anisotropic shape, the translational 
frictional force of each Au NR depends on its orientation in solution.25 However, because the Au 
NRs are randomly dispersed in solution, it can be assumed that all orientations are present at any 
given point of time and the average frictional coefficient can be used. This can be obtained from 
the friction ratio (cylinders/spheres) 
 ft=
μ
6πηRe	 (2) 
where μ is the translational friction coefficient for Au NRs and Re is the equivalent radii of a 
sphere with equal volume.26 For the case of Au NRs with aspect ratio 14,  
 Rୣ ൌ ቀ ଷଶ௣మቁ
భ
య ሺ୐ଶሻ (3) 
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where ݌ ൌ ୐ଶୠ, L being the long axis of the nanorod and b being the radii, which gives Re as 
28.97 nm. Assuming the Au NRs to be cylinders, ft is given as 
 ௧݂ ൌ
ටమ೛మయ
య
୪୬௣ାఊ (4) 
 ߛ ൌ 0.312 ൅ ଴.ହ଺ହ௣ ൅
଴.ଵ଴଴
௣మ  (5) 
For Au NRs of aspect ratio 14, the ft obtained is 1.696, giving μ to be 9.28 × 10−10 Pa·s. The 
buoyancy force is the volume of solvent that is displaced by the Au NR and the gravitational 
force is the weight of the Au NR. By equating the upward frictional and buoyancy force to the 
downward force due to gravity, vs for Au NRs can be estimated 
 vs=
πr2hg(ρp-ρ)
μ  (6) 
where r is the radius and h is the length of the Au NR (assumed cylindrical). The value vs for Au 
NR is 20 nm/s. This translates to ∼3.5 h for 90 nm Au NPs and ∼14.1 h for 300 nm × 20 nm Au 
NRs to fall a distance of 1 mm, half the height of the cell chamber, demonstrating that both Au 
NSs and Au NRs have a high tendency to sediment over time. However, in our experiments Au 
NP aggregation in cell media increases the rate of sedimentation such that the cells’ “vacuuming 
effect” can be observed after ∼1−2 h. 
The surface chemistry of Au NPs was modified using layer-by-layer polyelectrolyte 
deposition.27 Au NSs had initial surface ligands comprising of citrate and hydroquinone, 
imparting an overall negative charge. By incubating positively charged poly(allylamine 
hydrochloride) (PAH, MW ∼15 000 g/mol) followed by negatively charged poly(acrylic acid) 
(PAA, MW ∼15 000 g/mol), the ζ-potential of the Au NSs can be varied (Table 6.1). For Au 
NRs, since they are synthesized with the positively charged surfactant, cetyltrimethylammonium 
bromide (CTAB), a positively charged polyelectrolyte, poly- (diallyldimethylammonium 
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Table 6.1.  Nanoparticle ζ-Potential in Water, Cell Diffusion Coefficients, Cell Velocities, and Apparent Au NP Cellular 
Uptake Per Minute for PC3 and HDF Cells When Incubated with Au NPsa 
 
   PC3 HDF 
 Au NP 
coating 
ζ-potential 
(mV) 
diffusion 
coefficient 
(µm2/min) 
cell velocity 
(µm/min) 
apparent uptake 
rate 
(NP/min) 
diffusion 
coefficient 
(µm2/min) 
cell velocity 
(µm/min) 
apparent uptake 
rate 
(NP/min) 
   12.8 ± 0.2 0.61 ± 0.04  3.7 ± 0.1 0.28 ± 0.01  
A
u
 
PAH +32.3 ± 0.7 10.5 ± 0.2 0.37 ± 0.03 16500 ± 3200 10.8 ± 0.3 0.40 ± 0.03 23100 ± 4900 
PAA -31.9 ± 1.7 4.2 ± 0.1 0.49 ± 0.04 21300 ± 4100 3.2 ± 0.1 0.23 ± 0.02 12000 ± 2600 
mPEG -24.8 ± 0.9 3.2 ± 0.1 0.40 ± 0.15 17600 ± 3400 5.6 ± 0.1 0.26 ± 0.01 14200 ± 3000 
A
u
 
N
R
 PDADM
AC +39.1 ± 3.0 6.6 ± 0.1 0.51 ± 0.03 19300 ± 3700 8.3 ± 0.1 0.37 ± 0.02 19900 ± 4200 
PSS -18.6 ± 2.6 10.6 ± 0.4 0.52 ± 0.04 22900 ± 4400 8.8 ± 0.1 0.35 ± 0.02 19000 ± 4100 
mPEG +3.5 ± 3.0 7.9 ± 0.1 0.33 ± 0.03 19900 ± 3900 4.4 ± 0.1 0.24 ± 0.02 12900 ± 2800 
 
aCell diffusion coefficients (mean ± standard error of mean) are obtained from MSD plots against time (MSD)(t) = 4Dt. Cell velocities 
(mean ± standard error of mean) are measured from plots of distance travelled against time. Apparent Au NP uptake was estimated 
from cell velocities at [Au NP] = 0.02 nM. (Au NS, gold nanospheres; Au NR, long gold nanorods). 
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chloride) (PDADMAC, MW <100 000 g/mol) was first adsorbed, followed by negatively 
charged poly(sodium 4-styrenesulfonate) (PSS, MW ∼70 000 g/mol). Au NPs used in this study 
were at least triple wrapped with polyelectrolyte coatings. A minimum of three layers of 
polyelectrolyte coating on the nanoparticles was found to eliminate the intrinsic cytotoxicity of 
CTAB.28 For a neutral coating, Au NSs and Au NRs were coated with methoxy- (polyethylene 
glycol) thiol (mPEG, MW ∼5000 g/mol).29 The Au NPs were then purified extensively to 
remove excess ligands. 
With the exception of mPEG Au NSs, the ζ-potential of the Au NPs reflects the final 
polymer used to wrap the Au NPs (Table 6.1). It is possible that the initial surface ligands 
(citrate, hydroquinone, and their byproducts) are trapped in the mPEG layer, conferring a net 
resultant nonzero ζ-potential. 
 
6.3.2.  Uptake of Sedimented Gold Nanoparticles by PC3 and HDF Cells 
To study the influence of sedimented Au NPs on cells, a house-made cell chamber was 
constructed using readily available materials: glass slide, coverslip, and polydimethylsiloxane 
(PDMS). This gave us the flexibility of maintaining a small volume of media over the cells 
(∼160 mm3) and thus achieving higher nanoparticle concentrations, as well as the ability to 
image the cells with an inverted darkfield microscope. Cells were plated on the bottom of the 
polylysine-coated coverslip (PC3 cells at 80 000 cells/cm2; HDF cells at 20 000 cells/cm2), were 
allowed to adhere, and then grow to about 60−70% confluent before imaging. At this cell 
density, the cells are still relatively far apart from each other such that their movement is still 
only inherently random diffusion, thus simplifying our analysis for the uptake-influenced 
migration (vide infra). Once the cells were plated and grown to the desired confluency, cell 
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media spiked with gold nanoparticles was used to replace the growth media. The cells were then 
left to incubate in the presence of gold nanoparticles without further external disturbance; the 
media was not changed during the course of the imaging. (The small volume of the media made 
it difficult to change media without disturbing the cells.) 
Darkfield images of PC3 and HDF cells incubated with different Au NSs and Au NRs 
were taken at 5 min intervals for at least 8 h (movies 1, 2)†. In addition, differential interference 
contrast (DIC) imaging (63× magnification) was performed at 10 s intervals for about 40 min, 
allowing for small changes at the cells’ leading edge to be discerned with greater certainty 
(movie 3). Under darkfield imaging, Au NPs appear as bright yellow-orange spots due to their 
inherent large scattering ability. These Au NSs and Au NRs were observed to be stationary over 
long periods of time (before cell interaction), indicating that they have sedimented on the glass 
surface. In some cases, aggregation caused the Au NSs and Au NRs to sediment as clumps. 
Regardless of surface coating, Au NP size and shape, cell migration was observed to vacuum Au 
NPs from the surface, leaving a “cleared” trail of Au NPs in its wake (Figure 6.1). Au NPs were 
vacuumed by the cells at their leading edge, and subsequently transported toward the cell body. 
This phagokinetic cell migration is random in nature and does not seems to preferentially favor 
regions of Au NPs. DIC imaging showed that the filopodia (cytoplasmic projections) and 
lamellipodia (thin, sheetlike membrane protrusions) at the leading edges of cells were constantly 
probing the surface. Interaction of the filopodia and lamellipodia with Au NPs caused the Au 
NPs to be lifted off the substrate onto the cell surface. Over time, the cells became brighter and 
brighter under darkfield imaging, while the nucleus remained dark, suggesting high levels of Au 
NP internalization (Figure 6.2).  
                                                            
† All movies of cell movement in the presence of Au NPs are available online at: 
http://pubs.acs.org/doi/suppl/10.1021/nl400972r. 
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Figure 6.1.  Selected darkfield images (10× magnification) of the interaction of PC3 cells with 
sedimented PDADMAC Au NRs (0.02 nM). Images are taken at a 5 min interval over at least 8 
h. The trail of one cell is outlined with white dashed lines. 
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Figure 6.2. Uptake of PAH Au NSs into HDF cells. (a) Darkfield image of HDF cells 
immediately after the addition of PAH Au NSs, and (b) darkfield image of HDF cells after 24 h. 
The nuclei remained dark while the cell bodies appeared highly scattering due to internalization 
of PAH Au NSs. 
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Live-dead staining of the cells after the 8 h incubation show that the cells are still alive, 
proving that the cells are still viable after sweeping up the Au NPs (Figure 6.3, 6.4). TEM 
images also show that large numbers of Au NPs were clustered in apparent endosomes, 
suggesting that all the Au NPs are taken into the cells by endocytosis (Figure 6.5, 6.6). The Au 
NP uptake by cells was estimated using the cleared tracks from darkfield imaging (Table 6.1). It 
is assumed that all the Au NPs sediment and are homogenously dispersed on the substrate and 
the cells. However, this will overestimate uptake, since some fraction of the nanoparticles are 
also expected to stay suspended in the media. In addition, the evolving nature of nanoparticle 
surface charge and aggregation state makes it difficult to measure sedimented versus suspended 
nanoparticles without stopping the experiment. Since we do not observe the dark tracks that 
result from cellular uptake of nanoparticles being filled in over time with new nanoparticles, we 
do not think that further sedimentation of nanoparticles is occurring within the detection limits of 
the microscope. The cell migration observed is thus a global response due to a combination of 
effects from the sedimented and suspended gold nanoparticles. While it is likely that some gold 
nanoparticles in suspension will be taken up, we believe that the change in migration due to 
suspended gold nanoparticles is minimal compared to the sedimented gold nanoparticles. We are 
currently in the process of improving our experimental setup so as to isolate these two effects. 
The detection limit of Au NPs with darkfield microscopy was estimated from 
observations of scattering from known Au NP concentrations and determined to be about 120 Au 
NP/μm2 (0.001 nM). At this concentration, if only Au NPs on the substrate will be vacuumed up, 
an estimate of 300 000−500 000 Au NPs are estimated to be taken up by cells after 8 h. At Au 
NP concentration of 0.02 nM, HDF cells incubated with PAH Au NSs exhibit the highest uptake 
rate at 23 100 ± 4900 Au NP/min, while when incubated with mPEG Au NRs, the lowest rate of 
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Figure 6.3.  Live dead staining of HDF cells after at least 8 h incubation with a) PAH Au NSs, 
b) PAA Au NSs, c) mPEG Au NSs, d) PDADMAC Au NRs, e) PSS Au NRs and f) mPEG Au 
NRs. From left to right: fluorescence staining for dead cells (ethidium homodimer-1, red 
fluorescence), fluorescence staining for live cells (calcein AM, green fluorescence), dark field 
imaging of corresponding cells and combined images.  
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Figure 6.4.  Live dead staining of PC3 cells after at least 8 h incubation with a) PAH Au NSs, b) 
PAA Au NSs, c) mPEG Au NSs, d) PDADMAC Au NRs, e) PSS Au NRs and f) mPEG Au 
NRs. From left to right: fluorescence staining for dead cells (ethidium homodimer-1, red 
fluorescence), fluorescence staining for live cells (calcein AM, green fluorescence), dark field 
imaging of corresponding cells and combined images.  
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Figure 6.5.  TEM images of HDF cells after an overnight incubation with a) PAH Au NSs, b) 
PAA Au NSs, c) mPEG Au NSs, d) PDADMAC Au NRs, e) PSS Au NRs and f) mPEG Au 
NRs. Micrographs show Au NSs and Au NRs localized in endosomes in all cases. 
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Figure 6.6.  TEM images of PC3 cells after an overnight incubation with a) PAH Au NSs, b) 
PAA Au NSs, c) mPEG Au NSs, d) PDADMAC Au NRs, e) PSS Au NRs and f) mPEG Au 
NRs. Micrographs show Au NSs and Au NRs localized in endosomes in all cases. 
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12 900 ± 2800 Au NP/min was observed. For PC3 cells, the uptake rate ranges from 16, 500 ± 
3200 Au NP/min when incubated with PAH Au NSs to 22 900 ± 4400 Au NP/min when 
incubated with PSS Au NRs. Over 8 h incubation, it is expected that about 6−10 million Au NPs 
will be taken up per cell for both PC3 and HDF cells. These values are a lot higher than the 
reported 2000−4000 Au NP/cell after 6−24 h incubation for HeLa, A549, MDA-MB-435 and 
HT-29 cells.8,11,30 This suggests that most of the Au NPs “swept up” by the cells remain on the 
cell surface and are not internalized. Previous studies have shown that endocytosis of Au NPs by 
cells can occur via a clathrin-mediated (50−200 nm) or caveolin-mediated (>500 nm) pathway.31 
Therefore, in our studies, we blocked these pathways with chlorpromazine (clathrin inhibitor) 
and filipin (caveolin inhibitor) and the cellular uptake of Au NPs was still observed. Darkfield 
images showed that cell migration still resulted in Au NP being vacuumed from the surface onto 
the cell bodies, thus suggesting that clathrin and caveolin are not required for vacuuming (Movie 
4). TEM images showed much fewer Au NPs being endocytosized, demonstrating that 
vacuuming and endocytosis are separate events (Figure 6.7). 
These results demonstrate that Au NPs interaction with cells in vitro can be generally 
divided into three stages: (1) interaction at the cell edge, (2) transfer to the cell body, and (3) 
endocytosis. Interaction of cells and Au NPs mostly occurred via the filopodia and lamellipodia 
at the leading edge. As the Au NPs were not tightly bound to the substrate, the constant probing 
by the cells can dislodge the Au NPs, resulting in them being picked up by cells and transported 
toward the cell body. 
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Figure 6.7.  TEM images of PC3 cells after treatment with filipin and chlorpromazine. PC3 cells 
were incubated with PDADMAC Au NRs. Micrographs show a significantly reduced amount of  
endocytosized Au NRs in cells. 
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6.3.3.  Gold Nanoparticles’ Influence on Cell Migration 
The presence of Au NPs on substrates can potentially assist or hinder cellular adhesion to 
the substrate, and hence influence cell migration. The usual method to measure cell migration is 
by calculating the mean square displacement (MSD) of the cells32,33 
 MSDሺtሻ= 〈[rሺt+t0ሻ-rሺt0ሻ]2〉=	4Dt  (7) 
where r(t0) is the initial position of the cell and r(t + t0) is the new position after time t, ۦ···ۧ 
denotes a combined average overall trajectories for all cells, and D is the diffusion coefficient. If 
the cells are sufficiently far apart and do not interfere with each other, random motion is 
assumed. MSD were measured with respect to the center of each cell’s nucleus.  
From eq 7, a linear relationship is expected when MSD is plotted again time. Results 
show that for both PC3 and HDF cells incubated with and without Au NPs, a linear dependence 
is only observed over 100 min intervals (Figure 6.8a,b). At longer time intervals, breaks and 
jumps were observed. Compared to cells incubated in the absence of Au NPs, PC3 cell migration 
in the presence of Au NPs are slower while for HDF cells, cell migration is faster with all Au 
NPs except PAA Au NSs. Cellular diffusion coefficients calculated from the entire MSD plots 
showed that Au NPs did have an influence on cell migration (Table 6.1). PC3 cellular diffusion 
coefficients decrease from 12.8 ± 0.2 μm2/min in the absence of Au NPs to a range of 3.2 ± 0.1 
to 10.6 ± 0.4 μm2/min when incubated with mPEG Au NSs and PSS Au NRs, respectively. HDF 
cellular diffusion coefficients increase from 3.7 ± 0.1 to 4.4 ± 0.1 μm2/min and 10.8 ± 0.3 
μm2/min when incubated with mPEG Au NRs and PAH Au NSs, respectively. When incubated 
with PAA Au NSs, the cellular diffusion coefficient decreases to 3.2 ± 0.1μm2/min.  
To better represent cell migration over long durations, the mean cumulative square 
distance (MCSD) is used 
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Figure 6.8.  Influence of Au NPs on the migration of PC3 and HDF cells. (a,b) Plot of the mean-
square displacement (MSD) of PC3 and HDF cells with and without Au NPs with respect to 
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time. Au NPs and Au NRs concentrations are fixed at 0.02 nM. Legends are as follows: black 
solid square, PC3 or HDF alone; red hollow square, PAH NPs; green hollow triangle, PAA NPs; 
blue hollow triangle, mPEG NPs; red solid square, PDADMAC Au NRs; green solid triangle, 
PSS Au NRs; blue solid triangle, mPEG Au NRs. (c,d) Plot of the mean cumulative square 
displacement (MCSD) of PC3 and HDF cells with and without Au NPs with respect to time. (e) 
Box plot showing the distribution of PC3’s MCSD at 8 h after incubation. Box represent the 25th 
to 75th percentile of sample with the line denoting the median. Mean of sample is shown as a 
solid square. Whiskers represent the lower and upper inner fence limit (1.5 interquartile range). 
Outliers are denoted as diamonds. Sample size: PC3, 22; PAH, 38; PAA, 41; PEG NPs, 29; 
PDADMAC NRs, 40; PSS NRs, 24; PEG NRs, 45. (f) Box plot showing the distribution of 
HDF’s MCSD at 8 h after incubation. Sample size: HDF, 21; PAH NPs, 14; PAA NPs, 15; PEG 
NPs, 19; PDADMAC NRs, 20; PSS NRs, 24; PEG NRs, 19. 
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 MCSDሺtሻ= 〈∑ ([rሺti+τሻ-rሺtiሻ]2)ni=0 〉  (8) 
where r(ti + τ) is the position of cell at time τ from its previous position, r(ti), where τ = 5 min. 
The summation is taken overall available time points and ۦ···ۧ denotes a combined average over 
all trajectories. The MCSD measures the total distance moved by the cells over the time frame 
observed, while the slope of the MCSD plot against time gives information about its speed. 
Results show that PC3 cell migration is reduced in the presence of Au NPs (Figure 6.8c), similar 
to its respective MSD plot, regardless of the surface charge and shape of Au NPs. The MCSD 
plots show a linear relationship with time, signifying that the cells are migrating at a constant 
speed. The distributions of the samples are compared at 8 h after incubation and plotted in a box 
plot (Figure 6.8e). On average, PC3 cells have reduced cell migration when incubated with Au 
NPs. The MCSD box plots at 8 h after incubation show that PC3 cells have a mean MCSD of 
2200 μm2. Compared to PC3 incubated with Au NPs, the mean MCSD obtained were 960 μm2 
for PAH NPs, 1400 μm2 for PAA NPs, 850 μm2 for mPEG NPs, 1100 μm2 for PDADMAC NRs, 
1100 μm2 for PSS NRs, and 850 μm2 for mPEG NRs. The average velocity of each cell samples 
are deduced from the total distance moved over the 8 h incubation period (Table 6.1). These 
values reflect that PC3 cells move slower in the presence of Au NPs. Interestingly, HDF cells 
show a different MCSD pattern when incubated with Au NPs (Figure 6.8d,f). HDF cells were 
observed to migrate faster in the presence of positively charged Au NPs (NSs and NRs) as well 
as PSS Au NRs than without Au NPs, and slower in the presence of mPEG Au NSs, mPEG Au 
NRs, and PAA Au NSs. The mean MCSD after 8 h incubation for HDF cells was 430μm2, which 
increases to 970 μm2 with PAH NPs, 660 μm2 with PDADMAC NRs and 620 μm2 with PSS 
NRs. The mean MCSD decreases to 320 μm2, 340 μm2, and 290 μm2 when incubated with PAA 
NSs, mPEG NSs, and mPEG NRs, respectively. The cell velocity reflects the same trend: PAH 
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Au NSs causes the largest increase of velocity from 0.28 ± 0.01 to 0.40 ± 0.03 μm/min, followed 
by PDADMAC Au NRs and PSS Au NRs at 0.37 ± 0.02 and 0.35 ± 0.02 μm/min, respectively. 
The effect of Au NS concentration on the migration of PC3cells was further investigated. 
While PC3 cells move slower when incubated with Au NSs, decreasing the Au NS concentration 
from 0.02 to 0.005 nM did not significantly alter PC3 cell migration (Figure 6.9). While the 
mean MCSD decrease from 950 to 630 μm2 for PAH NPs and 1400 to 1000 μm2 for PAA NPs 
when concentration decreases from 0.02 to 0.005 nM, respectively, no difference was observed 
for the MCSD box plot between different Au NS concentrations.  
The results here suggest that the surface charge and shape of Au NPs can potentially 
influence how cells “see” the glass substrate and ultimately influence their migration. First, the 
behavior of the Au NPs in cell media (with 10% fetal bovine serum) reflects that a protein 
corona is most likely forming around the Au NPs. Previous studies have shown that regardless of 
the surface coatings, Au NPs maintain a net negative ζ-potential when incubated in cell media.30 
While the initial net charge of the nanoparticles then might be identical, which therefore might 
make all the nanoparticles have similar electrostatic interactions with the polylysine-coated 
surface the experiments were performed on, the same cannot be said for the protein corona. 
Because of the difference in initial surface charge, the type, orientation, and concentration of 
proteins that form the corona may differ between nanoparticle sets and become the driving force 
that alters cell migration. It becomes interesting to consider, then, how tighter binding of the 
nanoparticles to the surface would influence cellular behavior. Second, the inherent cell 
migration mechanism may influence how the cells interact with the Au NP-coated surface. Most 
carcinoma cells, like PC3 cells, are phenotypically heterogeneous and maintain a 
roundish/elliptoid shape (10−30 μm).34 They  have a migration velocity of about 0.1−20 μm/min,  
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Figure 6.9.  Influence of Au NPs concentration on the migration of PC3 cells. (a) Plot of the 
mean cumulative square displacement (MCSD) of PC3 cells with and without Au NPs with 
respect to time. Au NPs and Au NRs concentrations are at 0.005 and 0.02 nM. Legends are as 
follows: black solid square, PC3 alone; blue hollow square, PAH NPs (0.005 nM); blue solid 
square, PAH NPs (0.02 nM); red hollow square, PAA NPs (0.005 nM); red solid square, PAA 
NPs (0.02 nM). (b) Box plot showing the distribution of PC3’s MCSD at 8 h after incubation. 
Box represent the 25th to 75th percentile of sample with the line denoting the median. Mean of 
sample is shown as a solid square. Whiskers represent the lower and upper inner fence limit (1.5 
interquartile range). Outliers are denoted as diamonds. Sample size: PC3, 22; PAH NPs (0.005 
nM), 40; PAH NPs (0.02 nM), 38; PAA NPs (0.005 nM), 28; PAA NPs (0.02 nM), 41. 
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and their movement is usually characterized by an amoeboid migration mechanism, which is 
dependent on propulsive, cytoplasmic streaming.35 Such movement is characterized as a 
crawling type migration achieved by short-lived and relatively weak interactions with the 
substrate, which pulls the cell forward. The presence of the loosely bound Au NPs implies that 
when the pseudopods extend, a firm grip on the substrate cannot be established and thus PC3 
cells’ migration is reduced. On the other hand, fibroblast cells (large mesenchymal cells 50−200 
μm wide) have elaborate cytoskeletal networks.36 They adhere strongly to substrates (via integrin 
receptors), project broad lamellipodia at the leading edge and use microtubule networks to 
regulate cell migration, resulting in slow movement with net speed of around 0.25−1 μm/min. 
HDF cells are thus more susceptible to variations in Au NP surface charges, size, and shape. 
Experiments are currently in progress to understand these differences. 
 
6.4.  Conclusion 
In conclusion, we show here that Au NPs, when allowed to sediment and incubate with 
cells in vitro, can be taken up via the cells’ intrinsic migration mechanism. For PC3 cells, a 
general decrease in cell migration was observed, while for HDF cells, cell migration is dependent 
on the surface charge and shape of Au NPs. These results signify that the interaction of Au NPs 
with cells in vitro is nontrivial and depends critically on cell type. Provocatively, it may be 
possible that Au NPs have the potential to be used to reduce the metastasis potential of cancer 
cells as well as to aid in wound healing in mesenchymal cells. 
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CHAPTER 7 
Short Term Impact of Gold Nanoparticles on the Genetics of 
Cancerous and Non-Cancerous Cells: the Discovery Phase 
 
 
7.1.  Introduction 
In the past two decades, interest in gold nanoparticles (Au NPs) for various biomedical 
applications has been on the rise, leading to an exponential increase in publications on Au NPs.1 
The rapid rise to fame of Au NPs can be attributed to their excellent physical properties as well 
as the ease manipulation to include multiple functionalities.2–6 In addition, improved synthetic 
routes have allowed for better yield and control of Au NPs, increasing the range of size and 
types, as well as tighten the size distribution of Au NPs that can be produced.7–12 These factors 
have led to the exploration of Au NPs in many biological applications. However, given the wide 
spread impact of Au NPs in nano-biotechnology, there is additional need to carefully 
characterize the influence of Au NPs on cells.  
It has generally been recognized that for most Au NPs (>5 nm), uptake into cells occurs 
via various receptor mediated endocytotic (RME) processes.13 RME of Au NPs by cells has been 
shown to depend on Au NP size, shape and aggregation state, with 50 nm Au NPs being the ideal 
size for efficient uptake.14,15 When uptaken, untargeted Au NPs are found to reside in organelles 
such as endosomes, of which 75% are transported to lysosomes within 45 min of incubation.13,16  
The surface chemistry of NPs can influence its uptake into cells. PEG coated Au NPs can 
reduce Au NP uptake into cells,17 while transferrin coated Au NPs limits uptake of Au NPs into 
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cells via only transferrin receptors.15,18 The surface charge influences NP’s affinity for cell 
membranes, with positively charged NPs being taken up at a greater efficiency than negatively 
charged Au NPs.19 However, more often than not, it is the serum proteins in protein corona of Au 
NPs that interacts with the receptors and determines the uptake.18,20,21 This can be avoided by 
coating Au NPs with mPEG-alkyl-thiol, which greatly reduced both protein adsorption and 
cellular uptake.22 
Morphologically, changes in cell structures have been seen upon incubation with NPs. 
Disruption of actin fibers and tubulin cytoskeleton had been observed in cells after Au NP 
uptake.23,24 The uptake of Au NPs also increases the number of autophagosomes and the 
enlargement of lysosomes.25 Au NPs had been found to selectively accumulate in the 
mitochondria of A549 cancer cells.16 Macroscopically, NPs could influence cellular response due 
to the change in cellular environment. For example, cell mobility had been shown to be altered 
when cells were incubated with Au NPs, with the extend of change dependent on cell type as 
well as Au NP type.26 The adhesion of MC3T3-osteoblast cells to integrin-Au NP covered 
surface was influenced by the spacing between the Au NPs.27 In three-dimensional collagen 
constructs, Au NPs altered the polymerization and mechanical properties of this extracellular 
matrix which cumulatively influenced cardiac fibroblasts response and behavior.28,29 
The varied responses from the incubation of NPs with cells suggest that more 
fundamental, molecular-based interactions exist. These interactions are further complicated due 
to the fact that cellular networks are all inter-linked and a seemingly irrelevant knock down of 
even a single protein can result with adverse effects. For example, endoplasmic reticulum stress 
due to Au NP uptake was linked to cellular responses such as an increase in reactive oxygen 
species and mitochondria damage, which can lead to cell death.30 To fully study and quantify the 
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changes happening in cells, a fundamental and more thorough analysis of cellular response to 
NPs such as probing the global gene expression changes of cells in response to NPs is necessary. 
In this aspect, previous studies had shown that Au NPs’ size and shape can induce 
different cellular pathways related to cellular stress and toxicity.31,32 Nucleic acid functionalized 
Au NPs as well as citrate Au NPs did not induce significant gene expression changes in HeLa 
cells ,33,34 while mercaptohexadecanoic acid functionalized Au NPs induced more changes than 
PEG coated Au NPs over the 84 genes probed in human keratinocyte cells.35 When human skin 
fibroblasts were incubated with carbon nanotubes and nano-onions, the gene responses were 
found to be dependent on NP concentration.36  
We are interested in the short-term exposure (24-48 h) of cells to Au NPs. In this paper, 
we investigate the gene expression changes in human dermal fibroblast (HDF) cells and prostate 
cancer cells (PC3) after incubation of 20 nm Au NPs with different surface coatings. We showed 
that the impact of Au NPs depends on its initial surface chemistry, as well as the cell type. In 
HDF cells, gene expression changes are minimal when incubated with citrate Au NPs and 
hybrid-lipid-coated (HL) Au NPs but not with poly(allylamine hydrochloride)-wrapped (PAH) 
Au NPs and lipid-coated poly(allylamine hydrochloride)-wrapped (L-PAH) Au NPs. PAH and 
L-PAH Au NPs induced changes in all phases of the cell cycle of HDF cells, with a large 
percentage of the expressed genes in the mitosis phase. In PC3 cells, gene expression changes 
are strongly influenced by the surface functionalized of Au NPs. In all, our results showed that 
the different gene clusters are affected by the different surface chemistries on Au NPs, which 
ultimately influenced the degree of change and type of cellular pathways. 
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7.2.  Materials and Methods 
7.2.1.  Materials   
Gold(III) chloride trihydrate (HAuCl4·3H2O, ≥99.9%), sodium citrate tribasic dihydrate 
(Na3Ct.2H2O, ≥99%), 1-octadecanethiol (98%, C18SH), poly(allylamine hydrochloride), (PAH, 
M.W. 15,000 g/mole), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) were 
obtained from Sigma Aldrich and were used as received. 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-L-serine (sodium salt) (POPS), 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine 
(LPC) were obtained from Avanti Polar Lipids and were used as received. Trizol (Invitrogen) 
and RNeasy kit (Qiagen) were used in the extraction of RNA. Ultrapure deionized water (17.9 
MΩ, Barnstead NANOpure II) was used for all solution preparations. Glassware were cleaned 
with aqua regia and rinsed thoroughly before use. 
 
7.2.2.  Synthesis of Gold Nanoparticles  
Au NPs of diameter 20 nm was synthesized via the boiling citrate method as previously 
described.48,49 Briefly, 2.5 mL of 0.01 mM HAuCl4 solution was added to 97.5 mL ultrapure 
deionized water and heated to a gentle boil with stirring. The solution was allowed to boil for 
another 5 min before 2 mL of 5% (w/w) sodium citrate was added. The solution was boiled for 
another 30 min until a deep red color was obtained. Another 0.5 mL of 5% sodium citrate was 
added to the solution and boiled for 10 min, following which the solution was allowed to cool 
while stirring. 
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7.2.3.  PAH Coating of Gold Nanoparticles 
A 1 mL aliquot of as-made Au NPs was centrifuged and purified. The Au pellet was 
collected and resuspended in 1 mL of water. To this purified Au NPs pellet 100 μL NaCl (0.1 M) 
and 200 μL PAH (10 mg/mL) were added simultaneously and the solution vortexed. The NPs 
were allowed to incubate overnight or longer before purifying by centrifugation. 
 
7.2.4.  Preparation of POPS/LPC Lipid Vesicles 
A 1:1 weight ratio of POPS/LPC was used to make hybrid-lipid-coated Au NPs. Briefly, 
a total of 1 mg of lipid (0.5 mg of each POPS and LPC) in chloroform was dried under a stream 
of nitrogen. The lipid film was then further dried in vacuum for about 6 h, after which 1 mL of 
20 mM HEPES buffer was added to give a final concentration of 1 mg/mL. The mixture was 
sonicated for about 1 h to totally suspend the lipids, affording a clear, colorless solution. 
Dynamic light scattering measurements of these vesicles gave an average hydrodynamic 
diameter of ~90 nm. 
 
7.2.5.  Synthesis of Lipid-Coated Gold Nanoparticles 
A 1 mL aliquot of Au NPs were centrifuged to remove the excess ligands from the 
synthesis and redispersed to 0.5 mL in 20 mM HEPES buffer. For lipid-coated PAH Au NPs (L-
PAH Au NPs), 0.5 mL of the 1:1 POPS/LPC lipid solution from the above section was added to 
PAH Au NPs and mixed. For hybrid lipid Au NPs (HL Au NPs), 0.5 mL of the lipid solution was 
added to purified citrate-capped Au NPs, followed by 2 µL of C18SH (0.5 mg/mL in ethanol). 
The mixture was incubated overnight at room temperature. The mixture was then centrifuged 
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(700 rcf, 30 min then 2000 rcf, 30 min for L-PAH Au NPs and 4000 rcf, 25 min for HL Au NPs) 
and the Au pellet resuspended in HEPES buffer. 
 
7.2.6.  Incubation of Gold Nanoparticles with Cells 
HDF and PC3 cells were plated in 6-well plates and grown to confluency. Au NPs were 
first suspended in cell media, and then added to cells (1 nM Au NPs for PC3, 0.1 nM for HDF). 
The cells were incubated with Au NPs for at least 24 h before RNA extraction.  
 
7.2.7.  RNA Extraction 
A combined Trizol extraction, followed by RNeasy purification was used. Briefly, cells 
were first washed thrice with PBS, and 1 mL Trizol added. The cells were homogenized by 
pipetting up and down several times and transferred to an Eppendorf tube. The sample was 
allowed to sit for about 5 min at room temperature before adding 0.2 mL chloroform. The 
mixture was vortexed for 20 sec, incubated for 12 min at room temperature and centrifuged at 
20,000 rcf for 20 min at 4 °C. The upper aqueous phase was extracted, taking care to avoid the 
organic layer. To this aqueous layer, an equal amount of ethanol was added and mixed. This 
sample was loaded into an RNeasy column and spun at 8,000 rcf for 30 sec. The flow through 
was discarded and 700 µL of buffer RW1 was added to the column. The column was spun at 
8,000 rcf for 30 sec and the flow through discarded.  To the column, 500 µL of buffer RPE 
added and spun again at 8,000 rcf for 30 sec (repeated twice). The column was spun at 20,000 rcf 
for 1 min to get rid of remaining buffer and transferred to a new collection tube. RNA was eluted 
with 30 µL DEPC-treated water at 8,000 rcf for 1 min. Collected RNA was checked for purify 
using a Nanodrop and Bioanalyzer and stored at -80 °C until ready for microchip array analysis. 
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7.2.8.  Microarray Labeling and Hybridization 
For each sample 200 ng of total RNA was labeled using the Agilent 2-color Low Input 
Quickamp Labeling kit (Agilent Technologies, Santa Clara, CA) according to the manufacturer's 
protocols. Labeled samples were hybridized to a Human 4 x 44 Agilent microarray and scanned 
on an Axon 4000B microarray scanner at 5 um resolution.  
 
7.2.9.  Data Processing 
Microarray data pre-processing and statistical analyses were done in R (v 3.0.1) using the 
limma package (v 3.16.7).37,38 Median foreground  and median background values from the 15 
arrays were read into R and any spots that had been manually flagged (-100 values) were given a 
weight of zero.39 The background values were ignored because investigations showed that trying 
to use them to adjust for background fluorescence added more noise to the data. The individual 
Cy5 and Cy3 values from each array were all normalized together using the quartile method and 
then log2-transformed.39 Correlations between the replicate spots per probe were high and were 
simply averaged for each sample. The positive and negative control probes were used to assess 
what minimum expression level could be considered "detectable above background noise" (6 on 
the log2 scale) and then discarded. A mixed effects statistical model was fit on the 34,127 unique 
probes to estimate the mean expression level for each of the NP incubations while accounting for 
dye effects and the correlation due to array.40,41 Probes that did not have expression values > 6 in 
at least 3/30 samples were discarded. Pairwise comparisons between the nanoparticles within 
each cell line were pulled as contrasts from the model, along with the equivalent of a one-way 
ANOVA test for NPs within each cell line and the overall interaction test between cell line and 
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NPs. Raw p-values were adjusted separately for each comparison using the False Discovery Rate 
method.42  
 
7.2.10.  Functional Clustering Analysis 
Gene clusters for expressed genes were generated using DAVID (Database for 
Annotation, Visualization and Integrated Discovery) developed at National Cancer Institute at 
Frederick.43 Up- and down-regulated genes were submitted and analyzed using functional 
annotation clustering and functional annotation chart. The classification stringency was set at 
medium and kappa similarity threshold was set at 0.50. Clusters were selected based on their 
Fisher exact p-value as well as their relevance. Cellular pathways were mapped to KEGG 
database, developed by Kanehisa Laboratories.44 
 
7.2.11.  Weighted Gene Correlation Network Analysis 
To computational assess the different expression patterns of PC3 cells when incubated 
with Au NPs, Weighted Gene Correlation Network Analysis (WGCNA) was performed on a 
subset of the probes for the PC3 cells.45,46 We selected 4,496 probes that had a reasonable level 
of statistical evidence for differential expression (PC3 one-way ANOVA FDR p-value < 0.1) and 
reasonable amount of changed expression (at least 1.5 FC between any 2 of the 5 groups)  and 
performed WGCNA (v 1.27-1) using the default values of the blockwiseModules() function 
except for: soft thresholding power β = 22, an unsigned topological overlap matrix, a minimum 
module size of 20 and merging similar modules at 0.1. This resulted in 16 modules containing 
1197 to 21 probes, plus the "module 0" consisting of 12 probe sets that did not fit any of the 16 
patterns. 
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7.2.12.  Instrumentation 
Absorption spectra of Au NPs were taken on a Cary 500 scan UV-vis-NIR 
spectrophotometer while absorption spectra of RNA were taken on Nanodrop 1000. 
Transmission electron microscopy data were obtained with a JEOL 2100 Cryo electron 
microscope operating at 200 kV. Zeta potential and dynamic light scattering measurements were 
performed on a Brookhaven Zeta PALS instrument. RNA quality was determined using a 
Agilent Bioanalyzer and RNA expression was probed using Agilent Human GE 4 x 44K v2 
Microarray and scanned on an Axon 4000B microarray scanner (Molecular Devices, Sunnyvale, 
CA) at 5 µm resolution. Differential expression analysis was carried out using GenePix 6.1 
software (Molecular Devices, Sunnyvale, CA). 
 
7.3.  Results 
7.3.1.  Global Gene Expression Changes on Au NPs Incubation 
The impact of 20 nm spherical Au NPs with four different surface coatings on two types 
of cells was investigated (Scheme 7.1). As-made Au NPs have citrate (anionic) on the surface. 
By polyelectrolyte coating with poly(allylamine hydrochloride) (PAH), the chemistry is changed 
to an amine-terminated surface, making the Au NP cationic. We also investigated the influence 
of pre-coating Au NPs with biomolecules, which are believed to help improve the 
biocompatiblity of Au NPs. Au NPs were coated with a 1:1 mixture of lipids (1-palmitoyl-2-
oleoyl-sn-glycero-3-phospho-L-serine (anionic, POPS)/1-palmitoyl-2-hydroxy-sn-glycero-3-
phosphocholine (zwitterionic, LPC)) and were allowed to adsorb differently based on the initial 
surface chemistry.47 On PAH Au NPs, the electrostatic interactions between PAH Au NPs and 
negatively charged POPS/LPC vesicles was favored, thus forming lipid-coated PAH Au NPs (L- 
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Scheme 7.1.  Potential Exposure to Au NPs and Experimental Setup.a 
 
 
 
a(a) Cartoon of potential routes to NP exposures. NP-based therapy exposes organs (targeted 
sites) to high levels of NPs while environmental elements expose the skin to low levels of NPs. 
(b) Schematics of experimental setup. (c) Different types of Au NPs used. 
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PAH Au NPs). Alternatively, by functionalizing citrate Au NPs with octadecanethiol (C18SH), 
the hydrophobic interactions between the alky tail chains of the lipids and the inner leaflet of 
C18SH formed a hybrid lipid layer on Au NPs (HL Au NPs). 
Two different cell types were studied under different conditions (Scheme 7.1). 
Unintentional exposure to NPs (at low dosage) would most often occur via contact with the skin. 
As such, human dermal fibroblast (HDF) cells were investigated as a model as they would most 
often be the first type of cells that are in direct contact/exposure to NPs. HDF cells were 
incubated with Au NPs at a low concentration of 0.1 nM. Alternatively, NPs are often used at 
higher concentrations in biological applications, either for imaging or therapy. Prostate cancer 
cells (PC3) were chosen to represent typical targeted cells and were exposed to Au NPs at 1.0 
nM concentrations. In both cases, cells were exposed to Au NPs for 24–48 h, during which 
>95% were alive before RNA extraction. 
Global gene expression analysis was performed in triplicates for both cell types with the 
four kinds of Au NPs and differently expressed genes were clustered in heatmaps (Figure 7.1). 
Incubation of HDF cells with citrate and HL Au NPs showed minimal gene expression changes; 
the heatmap for HDF cells with citrate and HL Au NPs showed a similar color response 
compared to control HDF cells. In contrast, incubation of HDF cells with PAH or L-PAH Au 
NPs induced an inverse gene expression response; genes that were initially preferentially 
expressed were now suppressed while genes that were suppressed had higher expressions. 
Incubation of PC3 cells with Au NPs did not follow a similar gene expression response. Instead, 
different types of Au NPs elicited different gene expression responses from PC3 cells. In a 
parallel analysis,  the  gene  expression data  was  analyzed  using  principle component  analysis 
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Figure 7.1.  Heatmap showing changes in global gene expression of a) HDF cells and b) PC3 
cells, after exposure to citrate, HL, PAH and L-PAH Au NPs. Each row represents a RNA 
probed and the change in expression level is shown as red, for up-regulation, and blue, for down-
regulation. All samples are performed in triplicates. 
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(Figure 7.2). These results showed that 1) HDF and PC3 cells are distinct cell types; 2) 
incubation of HDF cells with citrate or HL Au NPs induced very small changes in gene 
expression as compared to controls; 3) incubation of HDF cells with PAH or L-PAH Au NPs 
induced significant changes in gene expression compared to controls; 4) the gene expression 
differences of HDF cells between PAH or L-PAH Au NPs were small; and 5) incubation of PC3 
cells with different Au NPs elicited very different gene expression response from PC3 cells, 
suggesting that PC3 cells are more ‘responsive’ to the different Au NPs than HDF cells. 
Table 7.1 lists the number of genes that were differential expressed with a fold change 
(FC) of at least ±1.5 after treatment with Au NPs (FC less than 1.0 are given as the negative 
inverse). Exposure of HDF cells to either citrate or HL Au NPs resulted in only a small number 
of differentially expressed genes, with a total of 11 and 48 genes that are differential expressed 
respectively (p-value < 0.05, FC < -1.5 or FC > 1.5). Exposure of HDF cells to PAH or L-PAH 
Au NPs elicited a bigger gene expression response, with a total of 1272 and 1285 genes 
expressed differently respectively (FDR < 0.05, FC < -1.5 or FC > 1.5). When incubated with 
citrate, HL or PAH Au NPs, more genes are down-regulated than up-regulated, and with L-PAH 
Au NPs, more genes are up-regulated. Similar to HDF cells, exposure of PC3 cells to PAH or L-
PAH Au NPs elicited a stronger gene expression response than when exposed to citrate or HL 
Au NPs: the total number of genes expressed significantly altered was 80 for citrate Au NPs, 234 
for HL Au NPs, 384 for PAH Au NPs and 1548 for L-PAH Au NPs. More genes were up-
regulated with citrate Au NPs but down-regulated with HL, PAH or L-PAH Au NPs. 
Comparison of the total genes expressed differently between cell types showed that PC3 cells 
induced greater gene expression changes than HDF cells except for when incubated with PAH 
Au NPs, where  less genes were changed (384  genes  in  PC3  and  1272  genes  in  HDF). These  
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Figure 7.2.  Principle component analysis (PCA) of HDF cells and PC3 cells in three principle 
component axes. Each cell sample is represented as a sphere, with control cells colored as 
yellow, citrate Au NP incubation as green, HL Au NP incubation as red, PAH Au NP incubation 
as blue and L-PAH Au NP incubation as magenta.  
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Table 7.1.  Number of Genes in HDF and PC3 Cells Which Differentially Expressed After 
Exposure to Au NPs.  
 
 HDF genes PC3 genes 
Au NP Down-
regulated 
Up-
regulated 
Total Down-
regulated 
Up-
regulated 
Total 
citratea 7 4 11 25 55 80 
HLa 30 18 48 144 90 234 
PAHb 694 578 1272 367 17 384 
L-PAHb 610 675 1285 1147 401 1548 
 
 
aGenes are filtered with a cut-off criteria of raw p-value < 0.05 and either a fold change (FC) < -
1.5 for down-regulated genes or FC > 1.5 for up-regulated genes (FC value of less than 1 are 
replaced by its negative inverse).  
bGenes are filtered with a cut-off criteria of false discovery rate (FDR) < 0.05 and either a FC < -
1.5 for down-regulated genes or FC > 1.5 for up-regulated genes.  
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results suggest that PAH and L-PAH Au NPs induced a greater cellular response from both HDF 
and PC3 cells. 
Genes expressed significantly from each cell types were compared among the different 
types of Au NPs (Figure 7.3). The Venn diagram showed that no differentially expressed genes 
are common among the different Au NP incubation. Very few genes were also similarly changed 
when HDF cells were incubated with either citrate or HL Au NPs. More similarities were found 
between gene expression changes due to PAH and L-PAH Au NPs. Out of 1272 and 1285 
differently expressed genes when HDF cells was incubated with PAH and L-PAH Au NPs 
respectively, 916 genes are commonly changed. On incubation of Au NPs with PC3 cells, very 
few expressed gene similarities were found between citrate and HL Au NPs. However, 20 genes 
after citrate Au NP incubation and 56 genes after HL Au NP incubation were expressed similarly 
to L-PAH Au NPs incubation. Comparison of PAH and L-PAH Au NPs also showed that 305 
genes were changed similarly.  Taken together, the data suggested that incubation of Au NPs 
elicit different responses from different cell type, and the surface chemistry strongly influenced 
cellular response.  
 
7.3.2.  Gene Expression Changes in HDF cells after Au NP Incubation 
To highlight the impact of Au NP incubation, genes that were most significantly changed 
and showed the greatest FC were tabulated in Table 7.2. Incubation of HDF cells with citrate or 
HL Au NPs did not produce genes with FC > 2.5 or FC < -2.5, suggesting that Au NP impact is 
small. HDF cells incubated with PAH or L-PAH Au NPs shared a common set of genes that 
were differentially expressed. In addition, most of these genes were commonly regulated in both 
PAH and L-PAH Au NP conditions.  Genes such as keratin associated protein 2-3 (KRTAP2-3), 
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Figure 7.3.  Venn diagram comparing the genes (up and down-regulated) that showed 
expression changes (FC > 1.5, FC <-1.5) for a) HDF cells and b) PC3 cells. Each Venn diagram 
is divided according to the type of Au NP treatment. The numbers in the diagrams represent the 
genes detected. The number of genes that are commonly differential expressed are shown in the 
overlapping regions. 
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Table 7.2.  List of Genes With the Highest Fold Change in HDF Cells After Incubation 
With PAH or L-PAH Au NPs. 
 
  PAH Au NP L-PAH Au NP 
Gene 
Symbol Gene Name FC
a FDRb FCa FDRb 
KRTAP2-3 keratin associated protein 2-3 3.62 9.94 x 10-8 4.39 2.12 x 10-8 
CXCL1 chemokine (C-X-C motif) ligand 1 1.99 2.92 x 10-3 4.34 7.52 x 10-7 
CCNE2 cyclin E2 3.41 9.14 x 10-8 3.56 9.24 x 10-8 
DTL denticleless E3 ubiquitin protein ligase homolog  3.34 4.17 x 10
-12 3.36 4.24 x 10-12
GAL galanin/GMAP prepropeptide 2.14 5.10 x 10-5 3.14 3.81 x 10-7 
RRM2 ribonucleotide reductase M2 3.68 2.91 x 10-11 3.09 5.16 x 10-10
FAM111B family with sequence similarity 111, member B 2.72 1.64 x 10
-6 3.01 6.35 x 10-7 
HAS2 hyaluronan synthase 2 3.20 1.04 x 10-8 2.59 2.17 x 10-7 
WFDC1 WAP four-disulfide core domain 1 3.11 1.65 x 10-7 2.14 3.76 x 10-5 
RCAN2 regulator of calcineurin 2 -3.41 3.43 x 10-8 -2.61 1.15 x 10-6 
SLC9A9 solute carrier family 9, subfamily A member 9 -3.07 1.92 x 10
-8 -2.68 1.57 x 10-7 
SECTM1 secreted and transmembrane 1 -3.99 6.07 x 10-9 -2.80 4.70 x 10-7 
C5orf4 chromosome 5 open reading frame 4 -3.25 5.33 x 10-9 -3.06 1.65 x 10-8 
ADH1A alcohol dehydrogenase 1A (class I), alpha polypeptide -4.16 4.27 x 10
-7 -3.13 1.00 x 10-5 
AKR1C3 aldo-keto reductase family 1, member C3 -3.41 1.04 x 10
-7 -3.35 1.96 x 10-7 
MAN1C1 mannosidase, alpha, class 1C, member 1 -3.59 3.19 x 10
-7 -4.58 5.07 x 10-8 
ADH1C alcohol dehydrogenase 1C (class I), gamma polypeptide -5.48 4.17 x 10
-12 -5.56 4.24 x 10-12
 
aFold change value of less than 1 are replaced by its negative inverse.  
bSignificance is judged with false discovery rate (FDR) adjusted p-values, and is based on the 
total gene expression sample.  
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cyclin E2 (CCNE2), denticleless E3 ubiquitin protein ligase (DTL) and ribonucleotide reductase 
M2  (RRM2)  were  up-regulated  and  alcohol dehydrogenase 1A and 1C (ADH1A,  ADH1C),  
mannosidase alpha (MAN1C1) and aldo-ketoreductase family 1 (AKR1C3) were down-
regulated in both cases.  
To understand the significance of the differential gene expression changes, and the 
possible biological pathway/terms that are affected, the changed genes were analyzed using high-
throughput bioinformatics analytical tool DAVID (Database for Annotation, Visualization and 
Integrated Discovery). Incubation of HDF cells with citrate Au NPs did not yield statistically 
significant gene categories, suggesting that at a 0.1 nM concentration, the impact of citrate Au 
NPs is minimal. When incubated with HL Au NPs, changed genes impacted gene categories such 
as GTPase activation and phosphorylation (Table 7.3). However, it should be noted that the 
statistical significance of these categories were low and the number of altered genes against all 
the genes in the categories was also small, suggesting that the impact of HL Au NP on HDF cells 
is also small. We hence focus out subsequent study of HDF cells to incubation with PAH and L-
PAH Au NPs. 
Incubation with PAH Au NPs induced greater gene changes in gene categories related to 
cell cycle, organelle lumen, cell migration, nucleotide binding, apoptosis regulation, 
phosphorylation, transcription and protein ubiquitination. A large number of altered gene 
expressions were related to cell cycle, organelle lumen, cytoskeleton and nucleotide binding. Of 
note, genes related to cell cycle, organelle lumen, cytoskeleton and protein ubiquitination were 
observed to be more up-regulated than down-regulated, while in categories of cell migration, 
apoptosis regulation and transcription regulation, more genes were down-regulated than up-
regulated.  A  similar  trend  was  seen  with  L-PAH Au NP incubation with HDF  cells:  a large 
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Table 7.3.  Selected Gene Category After Treatment of HDF Cells With Au NPs.a 
Gene category Fisher 
Exact       
p-valueb 
FDRc No. of 
genes 
% genes 
down-
regulatedd 
% genes 
up-
regulatedd 
HL Au NPs 
GTPase activation 0.047 44 3 0.63 1.26 
Phosphorylation 0.62 100 3 0.38 0.00 
PAH Au NPs 
Cell cycle 2.5x10-36 4.6x10-33 150 3.74 15.59 
Organelle lumen 5.7x10-12 8.1x10-9 181 3.35 6.59 
Cytoskeleton 7.8x10-5 0.11 119 2.24 6.37 
Cell migration 1.8x10-4 0.32 25 8.28 6.51 
Nucleotide binding 5.6x10-3 8.4 168 2.98 4.50 
Apoptosis regulation 2.0x10-3 3.5 73 5.35 3.73 
Phosphorylation regulation 2.0x10-3 3.6 47 4.51 5.58 
Transcription regulation 7.5x10-3 13 195 4.61 2.88 
Protein ubiquitination 0.011 18 14 4.00 10.00 
L-PAH Au NPs 
Cell cycle 2.8x10-38 5.1x10-35 153 2.71 17.01 
Organelle lumen 1.5x10-10 2.1x10-7 176 2.31 7.36 
Cytoskeleton 5.0x10-6 7.2x10-3 125 2.17 6.88 
Cell migration 2.3x10-5 0.043 27 9.47 6.51 
Phosphorylation regulation 9.8x10-5 0.18 52 4.08 7.08 
Nucleotide binding 1.2x10-3 1.9 171 2.36 5.26 
Apoptosis regulation 1.2x10-3 2.1 74 5.22 3.98 
Protein ubiquitination 0.052 62 12 1.00 11.00 
peroxisome 0.098 77 11 9.71 0.97 
Metal ion binding 0.4 100 258 3.55 2.68 
 
aGene categories were generated using DAVID program with a medium stringency threshold.  
bOne-tail Fisher Exact p-value is used for gene-enrichment analysis. The smaller the value, the 
more enriched the gene category. 
cFalse discovery rate (FDR) adjusted p-value. 
d% genes up or down-regulation based on number of genes in category listed compared to total 
genes in this category with the same Gene Ontology (GO) term.  
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proportion of changed genes were related to cell cycle, organelle lumen, cytoskeleton and 
nucleotide binding, of which genes related to cell cycle, organelle lumen, cytoskeleton and 
protein ubiquitination were more up-regulated than down-regulated. On the other hand, genes 
related to cell migration, apoptosis regulation and peroxisome were more down-regulated than 
up-regulated.  
Table 7.4 and 7.5 lists the genes that are most significantly changed after Au NP 
incubation in gene categories cell cycle and cytoskeleton respectively. It was observed that genes 
up or down-regulated with PAH Au NPs were similarly expressed with L-PAH Au NPs (FC < -
1.5, FC > 1.5). CCNE2 (cyclin E2) was the most up-regulated gene in the cell cycle category (FC 
= 3.41 for PAH Au NPs and FC = 3.56 for L-PAH Au NPs). With down-regulated genes, 
HMG20B (high mobility group 20B) was the most down-regulated gene for PAH Au NP (FC = -
2.88) while CDKN1C (cyclin dependent kinase inhibitor 1C) was the most down-regulated for 
L-PAH Au NPs (FC = -2.64). In the cytoskeleton category, KRTAP2-3 (keratin associated 
protein 2-3) was the most up-regulated gene (FC = 3.62 for PAH Au NPs, FC = 4.39 for L-PAH 
Au NPs) and PPL (periplakin) was the most down-regulated gene (FC = -2.76 for PAH Au NPs, 
FC = -2.88 for L-PAH Au NPs). 
We further investigated the cell cycle of HDF cells as it showed the greatest change when 
incubated with PAH and L-PAH Au NPs. Cellular division, mitosis, can be separated into the 
G1, S, G2 and M phases. The gene categories of the G1/S transition, G2/M transition checkpoint 
and M phase are tabulated in Table 7.6. Both PAH and L-PAH Au NPs implicated gene 
expression changes in all three categories, suggesting that PAH and L-PAH Au NPs impact the 
cell cycle in all phases. However, most of the gene expressions altered were linked to the M 
phase, with  64  expressed genes  altered  when  incubated  with PAH  Au  NPs and 71 expressed 
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Table 7.4.  Most Significantly Changed Genes of HDF Cells After Au NP Incubation That 
Fall Under the Gene Category of Cell Cycle. 
 
  Fold change 
Gene 
symbol Gene name 
citrate 
Au NP 
HL 
Au NP 
PAH 
Au NP 
L-PAH 
Au NP 
CCNE2 cyclin E2 1.10 1.28 3.4 3.56 
CDC45 cell division cycle 45 1.25 1.01 2.90 2.99 
BARD1 BRCA1 associated RING domain 1 1.16 1.27 2.67 2.52 
ZWINT ZW10 interactor, kinetochore protein 1.23 1.31 2.65 2.22 
RAD51 RAD51 homolog (S. cerevisiae) 1.09 1.17 2.44 2.54 
UBE2C ubiquitin-conjugating enzyme E2C 1.00 1.12 2.27 2.16 
CHAF1B chromatin assembly factor 1, subunit B 
(p60) 1.20 1.08 2.22 2.43 
MCM3 minichromosome maintenance complex 
component 3 1.10 1.32 2.20 2.23 
E2F2 E2F transcription factor 2 1.15 1.15 2.17 2.51 
CDC25A cell division cycle 25A 1.23 1.11 2.02 2.42 
G0S2 G0/G1 switch 2 1.11 1.28 1.99 2.42 
HMG20B high mobility group 20B -1.35 -1.24 -2.88 -1.54 
MAP2K6 mitogen-activated protein kinase kinase 6 -1.13 1.11 -2.58 -2.33 
CDKN1C cyclin-dependent kinase inhibitor 1C (p57, 
Kip2) -1.02 -1.25 -2.41 -2.64 
TXNIP thioredoxin interacting protein -1.22 -1.40 -2.40 -2.25 
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Table 7.5.  Most Significantly Changed Genes of HDF Cells After Au NP Incubation That 
Fall Under the Gene Category of Cytoskeleton. 
  Fold change 
Gene 
symbol Gene name 
citrate 
Au NP 
HL  
Au NP 
PAH 
Au NP 
L-PAH 
Au NP 
KRTAP2-3 keratin associated protein 2-3 1.32 1.48 3.62 4.40 
CDC45 cell division cycle 45 1.25 1.01 2.90 2.99 
KRT34 keratin 34 1.26 1.19 2.80 2.64 
TPM1 tropomyosin 1 (alpha) -1.07 -1.24 2.73 2.12 
TUBB6 tubulin, beta 6 class V 1.28 1.15 2.41 2.71 
ACTG2 actin, gamma 2, smooth muscle, enteric 1.08 1.04 2.34 2.90 
AURKA aurora kinase A 1.09 1.21 2.22 2.36 
KIF23 kinesin family member 23 1.07 1.05 2.22 2.23 
MCM3 minichromosome maintenance complex 
component 3 1.10 1.32 2.20 2.23 
CDCA8 cell division cycle associated 8 1.08 -1.18 2.11 2.36 
FAM83D family with sequence similarity 83, 
member D 1.13 -1.09 2.05 2.27 
CCNE1 cyclin E1 1.14 1.23 2.02 2.24 
PPL periplakin -1.08 1.057 -2.76 -2.88 
FILIP1L filamin A interacting protein 1-like -1.28 1.08 -1.31 -2.00 
MYLIP myosin regulatory light chain interacting 
protein -1.14 -1.14 -1.92 -1.99 
RHOQ ras homolog family member Q -1.02 -1.00 -1.20 -1.91 
IFFO1 intermediate filament family orphan 1 -1.03 -1.10 -1.88 -1.85 
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Table 7.6.  Analysis of Cell Cycle Gene Category After Treatment of HDF Cells With Au 
NPs. 
 
Gene category 
Fischer Exact 
p-value 
FDR No. of 
genes 
% down-
regulated 
% up-
regulated 
PAH Au NPs 
G1/S transition of mitotic cell cycle 0.025 36 9 1.79 14.29 
G2/M transition checkpoint 2.5x10-3 4.4 6 6.25 31.25 
M phase of mitotic cell cycle 9.8x10-25 1.8x10-21 64 2.23 26.34 
 
L-PAH Au NPs 
G1/S transition of mitotic cell cycle 0.063 69 8 1.79 12.50 
G2/M transition checkpoint 2.5x10-3 4.4 6 12.50 25.00 
M phase of mitotic cell cycle 1.5x10-30 2.6x10-27 71 1.34 30.36 
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genes with L-PAH Au NPs. In all three categories, genes were more up-regulated than down-
regulated. For incubation with PAH Au NPs, genes in the G1/S transition was 14.29% up-
regulated and 1.79% down-regulated, genes in the G2/M transition checkpoint was 31.25% up-
regulated and 6.25% down-regulated and genes in the M phase was 26.34% up-regulated and 
2.23% down-regulated. Similarly for incubation with L-PAH Au NPs, a 12.50% (vs. .79%), 
25.00% (vs. 12.50%) and 30.36% (vs. 1.34%) up-regulation (vs. down-regulation) of genes was 
observed in the G1/S transition, G2/M transition checkpoint and M phase respectively.  
Differentially expressed genes were mapped into the cell cycle pathway (KEGG pathway 
database).44 The altered genes could be mapped to the G1, S and G2 phase of cell cycle (Figure 
7.4). PAH and L-PAH Au NPs induced similar gene changes, with most of the genes commonly 
up-regulated by both types of Au NPs. L-PAH Au NPs induced two additional gene changes: 
down-regulation of CDKN1A (CIP1, cyclin-dependent kinase inhibitor 1A) and up-regulation of 
PLK1 (polo-like kinase 1). 
 
7.3.3.  Gene Expression Changes in PC3 cells after Au NP Incubation 
Similar to HDF cells, PC3 cells incubated with citrate or HL Au NPs did not produce 
genes that had FC > 2.5 or FC < -2.5 and were statistically significant. However, gene expression 
fold changes of PC3 cells incubated with PAH or L-PAH Au NPs were much greater when 
compared to HDF cells (Table 7.7). More genes showed greater FC when incubated with L-PAH 
Au NPs, especially genes that were up-regulated. The largest up-regulated gene was chemokine 
ligand 1 (CXCL1), which with L-PAH Au NPs showed a FC of 10.83, but only FC of -1.03 with 
PAH Au NP. Similarly, other up-regulated genes such as interleukin 8 (IL8), lymphotoxin beta 
(LTB), chromosome 15  open reading  frame  48  (C15orf48), chemokine ligand 6  (CXCL6) and
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Figure 7.4.  Altered genes in HDF cell cycle after incubation with PAH Au NPs (red) and L-
PAH Au NPs (blue). Gene mapping was obtained using DAVID and cell cycle pathway was 
obtained from KEGG (ref 44). 
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Table 7.7.  List of Genes With the Highest Fold Change in PC3 Cells After Incubation With 
PAH or L-PAH Au NPs. 
 
  PAH Au NP L-PAH Au NP 
Gene 
Symbol Gene Name FC
a FDRb FCa FDRb 
CXCL1 chemokine (C-X-C motif) ligand 1 -1.03 9.64 x 10-1 10.83 2.04 x 10-9 
IL8 interleukin 8 1.18 6.31 x 10-1 6.86 3.27 x 10-9 
LTB lymphotoxin beta 1.03 9.53 x 10-1 4.13 3.69 x 10-9 
C15orf48 chromosome 15 open reading frame 48 1.11 5.85 x 10-1 4.036 9.34 x 10-11 
CXCL6 chemokine (C-X-C motif) ligand 6 1.10 8.09 x 10-1 3.85 7.52 x 10-8 
BCL2A1 BCL2-related protein A1 1.13 8.48 x 10-1 3.54 2.94 x 10-5 
ZNF768 zinc finger protein 768 -3.52 1.08 x 10-6 -3.05 1.12 x 10-6 
BAK1 BCL2-antagonist/killer 1 -2.09 2.48 x 10-3 -3.19 7.81 x 10-6 
LAMB2 laminin, beta 2 (laminin S) -2.39 3.97 x 10-4 -3.22 4.07 x 10-6 
DDR1 discoidin domain receptor tyrosine kinase 1 -1.88 3.22 x 10
-2 -3.23 3.95 x 10-5 
BAP1 BRCA1 associated protein-1 -3.28 1.06 x 10-6 -3.36 1.51 x 10-7 
MIB2 mindbomb E3 ubiquitin protein ligase 2 -1.76 1.75 x 10-3 -3.51 4.74 x 10-8 
EIF4G1 eukaryotic translation initiation factor 4 gamma, 1 -3.16 2.21 x 10
-4 -3.71 1.43 x 10-5 
MUC6 mucin 6, oligomeric mucus/gel-forming -2.08 2.48 x 10
-2 -3.83 2.87 x 10-5 
PLEC plectin -3.03 7.82 x 10-4 -3.84 2.82 x 10-5 
TNK2 tyrosine kinase, non-receptor, 2 -3.33 2.50 x 10-6 -4.37 4.74 x 10-8 
RRBP1 ribosome binding protein 1 -3.34 7.15 x 10-5 -4.79 6.16 x 10-7 
NES nestin -5.60 8.60 x 10-6 -6.62 4.74 x 10-7 
 
aFold change value of less than 1 are replaced by its negative inverse.  
bSignificance is judged with false discovery rate (FDR) adjusted p-values, and is based on the 
total gene expression sample.   
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BCL-related protein A1 (BCL2A1) were only significantly up-regulated with L-PAH Au NP and 
not with PAH Au NPs. On the other hand, down-regulated genes were commonly expressed in 
both PAH or L-PAH Au NPs, with nestin (NES) having the highest FC of all the down-regulated 
genes.  
In contrast to HDF cells, the heatmap for PC3 cells showed a much more complex 
expression pattern across the four Au NP types. To facilitate and simplify the identification of 
altered cellular functions, we used a weighted gene correlation network analysis (WGCNA) to 
find clusters (modules) of highly correlated genes across all Au NP incubations.45 This resulted 
in a total of 16 modules detected (FDR p-value < 0.1, at least 1.5 FC), with the number of genes 
ranging from 19-1131 (Figure 7.5 and 7.6). In each module, the gene expression levels for all 
genes from each Au NP incubation was summarized into a singular value, eigengene (i.e. first 
principle component), which roughly correspond to the average (over-expression) of gene 
expression values in the Au NP incubation (Figure 7.5a). These eigengenes thus allow for a 
simplified method to compare gene expression differences between Au NP incubations and 
modules. Results showed that gene expressions were significantly very different in all modules, 
across all Au NP incubations when compared to control cells. The eigengene values for PAH and 
L-PAH Au NPs were down-regulated in modules 1, 2 and 8, and up-regulated in modules 6, 10 
and 13. Compared to the control, citrate and HL Au NP incubations, which showed an opposite 
gene expression trend, this data suggest that these modules might be linked to the molecular 
effect of PAH. On the other hand, HL and L-PAH Au NP incubations up-regulated the eigengene 
values in modules 3 and 14, and down-regulated in modules 5, 9, 15 and 16 (compared to 
control, citrate Au NPs and PAH Au NPs incubation which showed opposite regulation), thus 
suggesting that these modules might be related to the lipid layer on Au NPs.  
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Figure 7.5.  a) Identification of modules (co-related genes) using WGCNA and conversion into a 
single eigengene value for each Au NP incubation (module 1). b) Bar plots of modules (modules 
2–7) after PC3 cells incubation with citrate Au NP (red), HL Au NPs (green), PAH Au NPs 
(dark blue) and L-PAH Au NPs (light blue). Control PC3 cells are given as black. Error bar 
denotes triplicates.   
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Figure 7.6.  Bar plots of modules (modules 8–16) after PC3 cells incubation with citrate Au NP 
(red), HL Au NPs (green), PAH Au NPs (dark blue) and L-PAH Au NPs (light blue). Control 
PC3 cells are given as black. Error bar denotes triplicates.   
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To allocate functional significance to these modules, the genes grouped in each module 
were analyzed using DAVID separately. In this analysis, an EASE score of 0.01 was used, and 
gene category were selected for using first the highest number of genes matched, followed by the 
lowest p-value (most significant) (Table 7.8). At least 55% of the module genes were matched to 
genes in the gene category. Analysis of the module genes showed that they did not simply 
correspond to specific cellular organelles or processes. Instead, we were able to match the genes 
to transcription factor binding sites (TFBS). Several modules were mapped to the same TFBS: 
modules 1, 2 and 8 were mapped to AREB6 (synonym: ZEB1, zinc finger E-box binding 
homeobox 1), modules 3, 7 and 10 were mapped to OCT1 (organic cation transporter), modules 
5 and 6 were mapped to EVI1 (ecotropic viral integration site 1) and modules 4 and 14 were 
mapped to RFX1 (regulatory factor X 1). MEF2 (myocyte enhancer factor 2), PAX5 (paired box 
5), AP4 (activating enhancer binding protein 4), YY1 (Yin Yang 1), CDPCR3 (CCAAT 
displacement protein cut repeats 3) and FOXJ2 (forkhead box J2) were represented by modules 
9, 11, 12, 13, 14, 15 and 16 respectively.  
 
7.4.  Discussion 
Gene expression analysis allowed for the global impact of Au NPs on cells to be 
investigated. Our results illustrate that the surface chemistry of Au NPs influences cells 
differently, and the extent of influence is dependent on cell type. For HDF cells, greater gene 
expression changes were observed with PAH and L-PAH Au NPs when compared to control 
cells. However, differences between these two Au NP types were minimal, with about two-thirds 
of the genes commonly expressed. In contrast, fewer genes were expressed differently after 
incubation with citrate and HL Au NPs, of  which very  few are common between the two Au NP 
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Table 7.8.  List of Modules and Their Respective Transcription Factor Binding Sites 
(TBSF) of PC3 Cells. 
 
Module No. Ontology Class (TFBS) Module genes Class genes (%) P-value 
1 AREB6 1131 79.5 1.8 x 10-13 
2 AREB6 726 83.7 3.3 x 10-14 
3 OCT1 549 80.0 1.5 x 10-3 
4 RFX1 344 56.0 4.6 x 10-3 
5 EVI1 355 75.8 2.5 x 10-4 
6 EVI1 215 82.2 1.9 x 10-5 
7 OCT1 172 85.7 4.0 x 10-3 
8 AREB6 161 82.0 8.3 x 10-4 
9 MEF2 136 67.7 7.3 x 10-3 
10 OCT1 95 90.3 1.4 x 10-3 
11 PAX5 77 58.3 8.1 x 10-1 
12 AP4 81 67.5 1.3 x 10-2 
13 YY1 68 72.1 2.9 x 10-3 
14 RFX1 26 73.1 3.7 x 10-2 
15 CDPCR3 19 63.2 9.6 x 10-2 
16 FOXJ2 21 81.0 9.6 x 10-3 
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types. A similar gene distribution pattern was observed with PC3 cells, where a significant 
portion of genes were common between PAH and L-PAH Au NPs, and minimal similarity 
between citrate and HL Au NPs. Such differences can be understood by taking into account the 
lability of the surface ligands with Au NPs. The electrostatic interaction of lipid with the 
underlying PAH of L-PAH Au NPs is relatively weak; lipids can dissociate from the 20 nm Au 
NP to form larger, more stable liposomes.47 This exposes the underlying PAH layer, which could 
result in the similar gene expression changes when compared to PAH Au NPs. On the other 
hand, the hydrophobic interaction between lipids and C18SH on HL Au NPs are probably a lot 
stronger and its dissociation unfavorable, resulting in cells responding differently from the Au 
NP exposure. Interestingly, only a few genes were commonly expressed between both lipid 
coated Au NPs samples, suggesting that the underlying chemistry on Au NPs impact lipid layer 
formation and ultimately influence how the cells interact with these Au NPs. 
It was previously shown that the gene expression depended on NP concentration.36 
Incubation of human skin fibroblasts with carbon nanotubes at different concentrations resulted 
in drastically different genes being expressed, with very few genes commonly expressed.36 In our 
study, while cells were incubated with Au NPs at fixed concentrations (0.1 nM for HDF, 1.0 nM 
for PC3), the uptake of Au NP per cell depended on the Au NP surface chemistry. Comparing 
the uptake of Au NP per cell to gene changed, a similar relationship was observed. The uptake of 
HL Au NPs was significantly lower compared to PAH and L-PAH Au NPs in both HDF cells, 
while in PC3 cells, uptake of L-PAH Au NPs is significantly greater than PAH and HL Au NPs. 
The number of expressed genes changed in HDF cells when incubated with HL Au NPs was 
significantly lower than PAH and L-PAH Au NPs, while for PC3 cells, expressed genes changed 
with L-PAH Au NP incubation is a lot larger than HL and PAH Au NPs. The trend, however, 
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cannot be used to account for gene expression changes with citrate Au NPs in HDF and PC3 
cells. Uptake of citrate Au NPs was similar to PAH Au NP uptake in HDF cells and L-PAH Au 
NPs in PC3 cells; expressed genes changed due to citrate Au NP incubation was the lowest 
compared to other Au NP types for both HDF and PC3 cells. This suggests that the genes 
expressed are likely to be in part influenced by the endocytotic process, and in part influenced by 
the chemical impact per Au NP: for citrate Au NPs, even though much more Au NP is 
endocytosized, the influence is small as the impact per Au NP is small. 
A similar number of altered expressed genes was observed in both incubations with PAH 
and L-PAH Au NPs, of which at least two-thirds of the expressed genes are common between 
these two Au NP incubations, suggesting that many similar processes/pathways are changed 
through incubation with PAH or L-PAH Au NPs. This is also reflected in Table 7.2, where 
highly expressed genes were common between PAH and L-PAH Au NPs. It is possible to rule 
out the influence of the metallic Au NP core: these genes were not differentially expressed across 
all four Au NP incubation. Since the only similarity between these two Au NPs is the PAH layer, 
the data suggest that the PAH layer exert a significant change in gene expression of HDF cells. 
Incubation of HDF cells with PAH and L-PAH Au NPs resulted in the up-regulation of 
the cell cycle in all phases. CCNE2 (cyclin E2), the most up-regulated gene, is involved in the 
cell cycle via the G1 to S phase transition.48 It exerts its effect through a complex formation with 
CDK2 (cyclin-dependent kinase), which regulates cellular processes by phosphorylating 
downstream proteins.49 Other genes such as CDC45 (cell division cycle 45) and CDCA5 (cell 
division associated 5) are similarly up-regulated, as is CHAF1B (chromatin assembly factor 1, 
subunit b), which implied that the rate of DNA replication had increased. In parallel, CDKN1C 
(cyclin-dependent kinase inhibitor 1C), TXNIP (thioredoxin interacting protein) and MAP2K6 
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(mitogen-activated protein kinase kinase 6) were down-regulated, suggesting that transcriptional 
activities were less suppressed. The up-regulation of the HDF cell cycle, and in particular the 
over-expression of CCNE2, is a source of concern, especially in toxicology. Cell cycle genes had 
been used as profile genes for metastatic cancer, with their over-expression usually signifying its 
presence.50 In particular, CCNE2 is often used as a prognostic marker for breast and prostate 
cancer.51,52 Up-regulation of CCNE2, without proper control, can lead to genomic instability 
such as chromosomal aberrations and genetic mutations, a result of the higher frequency of 
transcription.53 The up-regulation of CCNE2 in HDF cells upon PAH and L-PAH Au NP 
incubation suggests a possibility of HDF’s cancer progression. At a 0.1 nM Au NP 
concentration, the cell viability of HDF cells is still relatively high, which suggest that mutations 
in genes can be propagated onto daughter cells. 
Gene expression for PC3 cells showed a different pattern. Heatmap of PC3 cells after Au 
NP incubated showed that each incubation elicited a different gene response. While little 
difference were observed between citrate and HL Au NPs, similar to HDF cells, a smaller 
difference was also seen between PAH and L-PAH Au NPs; only 308 genes were common 
between these two Au NP incubation. In particular, up-regulated genes between PAH and L-
PAH Au NPs were not the same. The most up-regulated genes with L-PAH Au NP incubation 
were only minimally changed when PC3 cells was incubated with PAH Au NPs (FC < 1.2). On 
the other hand, down-regulated genes were commonly expressed, suggesting that the down-
regulation of genes might be due to the PAH layer, while the up-regulated genes might be related 
to the lipids.  
CXCL1 was only up-regulated when PC3 cells was incubated with L-PAH Au NPs. 
CXCL1 is a CXC chemokine which mediates communication between different cells.54 It plays 
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an extensive role in inflammation, angiogenesis, tumorigenesis and wound healing.55 Previous 
studies have shown that up-regulation of CXC chemokines promoted prostate tumor malignancy 
in PC3 cells as well as tumorigenesis of melanoma.55,56 A more recent study suggests that over-
expression of CXCL1 represses tumor establishment in TRAMP-C2 cell line and also altered cell 
adhesion and migration in an in vitro setting.57 The BCL2 proteins are important cell death 
regulators and serves to control the release of cytochrome c from mitochondria.58 The protein 
family consists of both pro- and anti-apoptotic proteins and work in synergy to regulate 
apoptosis. BCL2A1 was up-regulated in only L-PAH Au NP incubation, while its antagonist, 
BAK1, was down-regulated in both PAH and L-PAH Au NP incubations, suggesting that the 
anti-apoptotic function is preferred after PAH or L-PAH Au NP incubation. Increased expression 
of BCL2A1 had been associated with cancer and tumor progression, while the down-regulation 
of BAK1 had been linked to gastrointestinal cancers.59,60 While significance of the up-regulation 
of CXCL1 (FC = 10.83) and BCL2A1 (FC = 3.54) with L-PAH Au NP incubation remains to be 
tested, the results suggest that this up-regulation may be due to the lipid layer on L-PAH Au 
NPs. On the other hand, down-regulation of BAK1 might be due to the PAH layer on both PAH 
or L-PAH Au NPs. Taken together, the data seems to suggest that Au NP uptake influences PC3 
cell proliferation. 
WGCNA allowed unique properties of gene expression data to be expressed and had 
been used to reveal unique characteristics in gene expression data.61,62 However, in our study, the 
modules were not found to be simple representations of cellular functions or processes. Instead, 
they were mapped to TFBS with higher significance, suggesting that the Au NPs does not just 
impact isolated cellular functions, but had a deeper molecular impact on cells. Most crucial is the 
AREB6 transcription factor, which was shown to map to three modules at high significance, 
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influencing a total of 1638 genes. AREB6 (synonym: ZEB1, zinc finger E-box binding 
homeobox 1) encodes a zinc finger transcription factor and transcriptionally represses cell 
adhesion molecules.63 ZEB1 is also known to negatively regulate interleukin 2, a cytokine 
signaling molecule in the immune system.64 In human prostate cancer, ZEB1 over-expression 
can lead to E-cadherin down-regulation, thus promoting epithelial-to-mesenchymal transition 
and tumor migration and invasion.65 As such, ZEB1 has been suggested for use as a biomarker 
for metastatic prostate cancer.66 Incubation of PC3 cells with Au NPs showed that when PAH or 
L-PAH Au NPs were used, negative eigengene values were obtained, suggesting the down-
regulation of genes in all three modules (modules 1, 2 and 8), and hence the possible suppression 
of ZEB1. In contrast, incubation with HL Au NPs up-regulated eigengene values when compared 
to control cells, suggesting that HL Au NPs activated ZEB1. The different cellular responses to 
Au NP’s surface chemistries thus indicate that Au NPs can influences cells via more 
fundamental, molecular interactions. 
 
7.5.  Conclusion 
By making use of microarray to probe differentially expressed genes, and through data 
mining using readily available analysis programs, the global impact of Au NPs on cells was 
uncovered. Incubation of HDF cells with citrate and HL Au NPs did not result in much gene 
expression changes at 0.1 nM, suggesting that the impact of Au NPs at this concentration is 
minimal. In contrast, incubation of HDF cells with PAH and L-PAH Au NPs resulted in larger 
gene expression changes and the cell cycle was found to be up-regulated in all phases. Analysis 
of PC3 cells after incubation with Au NPs showed that the different surface chemistries of Au 
NPs induced different gene responses. By using network analysis (WGCNA), it was shown that 
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Au NPs impact PC3 cells via more fundamental, molecular interactions. Overall, our results 
showed that the surface chemistries on Au NPs as well as the cell type can influence cellular 
response, and as such needed to be specifically fine-tuned if to be used in biomedical 
applications.  
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CHAPTER 8 
Future Paths for Exploration 
 
 
8.1.  Probing Biomolecules Distribution, Orientation and Conformation on Gold 
Nanoparticles 
The importance of the nanoparticle-biomolecule interface is only recently starting to be 
recognized, and there are still many unknowns about these interactions: much of this complexity 
is contributed by the numerous types and possible surface functionalization of nanoparticles, as 
well as the various kinds of interactions with about 105 different proteins. The protein corona 
composition on nanoparticles is also actively being studied and had been shown to change 
significantly in terms of the amount of bound proteins over time.1 We have focused our work on 
simplified systems containing either one or two types of biomolecules (phospholipids and α-
synuclein), and have demonstrated that biomolecules have each their own preferred adsorption 
pattern which can affect their overall physiology. However even these studies have proved to be 
challenging and several key issues need to be addressed for more progress in this field: 
1) Stellacci et al. had previously used scanning tunneling microscopy to analyze ligand 
separation on nanoparticle surfaces.2 As his method is intriguing and has been the subject 
of much debate, alternative methods are required to corroborate his findings.3 We have 
used staining methods followed by TEM imaging to look for patchiness on Au NPs, 
however this method is qualitative at best. A better alternative might be Cryo-TEM, 
which can be used to preserve the organic layer while imaging. Dyes that undergo J-
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aggregation can be conjugated to surface ligands and the shift in fluorescence wavelength 
studied, to learn how ligands phase separate on surfaces (although this is difficult on Au 
NPs). Alternatively, ligands can be cross linked to ‘fix’ their position and analyzed using 
NMR.  
2) Given that proteins fold according to various intra-molecular interactions such as 
electrostatic, hydrophobic bonding, Van der Waals forces and salt bridges, a generalized 
picture of nanoparticle-biomolecule interaction can be obtained by investigating the 
contributions of each factor at the nanoparticle interface. To this end, the biomolecular 
interaction at the Au NP interface can be simplified into two regions: 1) interaction 
between biomolecules and 2) interaction at the biomolecule-NP interface. The study can 
be further simplified by first understanding the interactions of amino acids with Au NP 
surface, and subsequently with peptides. Methods such as FTIR, ITC and NMR would 
allow such interactions to be mapped4, however hitting the correct concentrations to 
make such measurements might be an issue. 
3) In our quest to investigate protein’s binding orientation and conformation, we have 
developed a trypsin digestion method coupled with mass spectroscopy. However, given 
the stochastic nature of the digestion, a large amount of material is required and more 
specific information such as the order of digestion cannot be deduced. Improvements to 
the experimental setup can be made by transiting to a single nanoparticle flow cell setup, 
and peptide fragments flowed out once cleaved. In addition, modifications to proteins, 
such as mutants or reacting lysines positions with acetic anhydride, can be made to 
highlight additional folding changes when adsorbed onto Au NPs.5 
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4) New tools are required to more quantitatively and precisely measure protein’s binding 
orientation and folding. In this aspect, 2D NMR could be a potential solution to a global 
analysis of protein conformation upon Au NP adsorption. By comparing the spectrum of 
free versus bound proteins, the change in the local environment of individual amino acids 
can be detected and quantified. Coupled with the known 3D structure of the protein, the 
exact binding site as well as conformation change can be deduced. 
 
8.2.  Gold Nanoparticle Influences on Cell Migration 
The use of Au NPs in therapeutic devices and as theranostic agents is another rapidly 
developing field that shows great potential for future applications. Our work on Au NPs 
influencing cellular migration further contributes to this field and reinforces the point that Au 
NPs can alter the way cells ‘see’ their environment.6 However, while we have demonstrated that 
the surface chemistry of Au NPs is important in influencing cell migration, other interesting and 
potentially impactful questions surfaced from our work. 
1) How much of the Au NP uptake by cells occurs at the leading edge, as compared to from 
the top of the cells? Is the uptake of Au NPs at the leading edge different from uptake 
from the cell surface? Which cell surface receptors are involved? 
2) Why does Au NP size, shape and surface chemistry affects HDF to a greater extend as 
compared to PC3? How does the cell type influence their interaction with Au NPs?  
3) Can Au NP coated surfaces be used for directed cell migration and promote cell 
alignment?  
To answer these questions, a better understanding the molecular interaction of Au NPs 
with cell surface receptors is necessary. Cell receptors can be selectively blocked or tagged to 
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obtain insights about the relevant factors in play. Au NPs can be spin coated onto glass substrates 
prior to cell addition, which affords the advantages of reducing aggregation such that cellular 
response is more reflective of Au NP properties and controlling surface coverage.  By patterning 
Au NPs on a surface using printing methods, the tendency of cells to track a given Au NP path 
can be studied.7  
 
8.3.  Gold Nanoparticle Influences on Gene Expression and Cellular Pathways 
The use of nanoparticles in general has been slowly on the rise. To this date, close to 
1000 consumer products boast the use of nanoparticles, and this number is expected to rise in the 
near future.8 This suggests that humans will be constantly exposed to some quantity of 
nanoparticles, thus making the understanding of health, safety and environmental implications 
and risk of high priority. It is therefore critical that the global impact of Au NPs on cells, and not 
just its purported function, be carefully characterized. To this end, we have used microarray gene 
analysis to map global gene expression changes of cells after Au NP incubation and have shown 
that significant changes occur depending on cell type and NP chemistry. However, to extract 
crucial pattern and pathway changes in cells, further analysis of the data is required. Network 
mapping would allow for an understanding of how changed genes interaction with each other, 
and when coupled with functional group analysis can provide insights on prominent cellular 
functions that are affected.9,10 In addition, our study, as well as others, has only focus on the 
short term impact of Au NP exposure on cells. In such studies, cells were only incubated with Au 
NPs for at most 48 h. The long term response of cells to Au NPs (for ~6 months) is thus an 
equally important, if not more critical, study to map the influence of Au NP exposure on cells. In 
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a more practical sense, such studies are increasingly becoming more relevant given our potential 
increased exposure to nanoparticles in the future.  
 
8.4.  Final Remarks 
The research outlined in this dissertation highlights the importance of understanding the 
nanoparticle-biomolecular interface and its possible consequence using cell lines. The surface 
chemistries on Au NPs influences biomolecule interaction and adsorption, which can have 
interesting and unpredictable effects on cells. It was shown that proteins binding orientation and 
conformation can differ depending on surface charge on Au NPs, which impacts the protein’s 
stability and potential function. On a cellular level, functionalized Au NPs influenced cell 
migration, which can have potential applications in promoting cell alignment and reducing 
cancer metathesis. The cellular global gene expression change was also studied, demonstrating 
that cell response to Au NPs depend on cell type and surface chemistries of Au NPs. The 
knowledge from this work not only contribute to our basis understanding of this complex 
interaction, but also remind us that we have to be careful and responsible in our applications of 
Au NPs. 
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